
<html lang="en"     class="pb-page"  data-request-id="9acf2ba4-85e1-44f3-9240-8fd15f870f95"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.7b01927;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-9;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions" /></meta><meta name="dc.Creator" content="Wensheng  Yu" /></meta><meta name="dc.Creator" content="Ling  Tong" /></meta><meta name="dc.Creator" content="Oleg  Selyutin" /></meta><meta name="dc.Creator" content="Lei  Chen" /></meta><meta name="dc.Creator" content="Bin  Hu" /></meta><meta name="dc.Creator" content="Bin  Zhong" /></meta><meta name="dc.Creator" content="Jinglai  Hao" /></meta><meta name="dc.Creator" content="Tao  Ji" /></meta><meta name="dc.Creator" content="Shuai  Zan" /></meta><meta name="dc.Creator" content="Jingjun  Yin" /></meta><meta name="dc.Creator" content="Rebecca T.  Ruck" /></meta><meta name="dc.Creator" content="Stephanie  Curry" /></meta><meta name="dc.Creator" content="Patricia  McMonagle" /></meta><meta name="dc.Creator" content="Sony  Agrawal" /></meta><meta name="dc.Creator" content="Laura  Rokosz" /></meta><meta name="dc.Creator" content="Donna  Carr" /></meta><meta name="dc.Creator" content="Paul  Ingravallo" /></meta><meta name="dc.Creator" content="Karin  Bystol" /></meta><meta name="dc.Creator" content="Frederick  Lahser" /></meta><meta name="dc.Creator" content="Rong  Liu" /></meta><meta name="dc.Creator" content="Shiying  Chen" /></meta><meta name="dc.Creator" content="Kung-I  Feng" /></meta><meta name="dc.Creator" content="Mark  Cartwright" /></meta><meta name="dc.Creator" content="Ernest  Asante-Appiah" /></meta><meta name="dc.Creator" content="Joseph A.  Kozlowski" /></meta><meta name="dc.Description" content="We describe the discovery of MK-6169, a potent and pan-genotype hepatitis C virus NS5A inhibitor with optimized activity against common resistance-associated substitutions. SAR studies around the c..." /></meta><meta name="Description" content="We describe the discovery of MK-6169, a potent and pan-genotype hepatitis C virus NS5A inhibitor with optimized activity against common resistance-associated substitutions. SAR studies around the c..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 21, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01927" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01927" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01927" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01927" /></link>
        
    
    

<title>Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01927" /></meta><meta property="og:title" content="Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0021.jpeg" /></meta><meta property="og:description" content="We describe the discovery of MK-6169, a potent and pan-genotype hepatitis C virus NS5A inhibitor with optimized activity against common resistance-associated substitutions. SAR studies around the combination of changes to both the valine and aminal carbon region of elbasvir led to the discovery of a series of compounds with substantially improved potency against common resistance-associated substitutions in the major genotypes, as well as good pharmacokinetics in both rat and dog. Through further optimization of key leads from this effort, MK-6169 (21) was discovered as a preclinical candidate for further development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01927"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01927">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01927&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01927&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01927&amp;href=/doi/10.1021/acs.jmedchem.7b01927" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3984-4003</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01903" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00001" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Wensheng Yu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wensheng Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#eb9c8e8598838e858cc5929eab868e998880c5888486"><span class="__cf_email__" data-cfemail="b0c7d5dec3d8d5ded79ec9c5f0ddd5c2d3db9ed3dfdd">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wensheng++Yu">Wensheng Yu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5978-9454" title="Orcid link">http://orcid.org/0000-0001-5978-9454</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ling Tong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ling Tong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ling++Tong">Ling Tong</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3302-8184" title="Orcid link">http://orcid.org/0000-0003-3302-8184</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Oleg Selyutin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Oleg Selyutin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Oleg++Selyutin">Oleg Selyutin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lei Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Chen">Lei Chen</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Bin Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bin Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec, 288 Fute Zhong Road, Shanghai 200131, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bin++Hu">Bin Hu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Bin Zhong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bin Zhong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec, 288 Fute Zhong Road, Shanghai 200131, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bin++Zhong">Bin Zhong</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jinglai Hao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jinglai Hao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec, 288 Fute Zhong Road, Shanghai 200131, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jinglai++Hao">Jinglai Hao</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Tao Ji</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tao Ji</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec, 288 Fute Zhong Road, Shanghai 200131, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Ji">Tao Ji</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Shuai Zan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuai Zan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec, 288 Fute Zhong Road, Shanghai 200131, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuai++Zan">Shuai Zan</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jingjun Yin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jingjun Yin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Process Research & Development, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jingjun++Yin">Jingjun Yin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Rebecca T. Ruck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rebecca T. Ruck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Process Research & Development, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca+T.++Ruck">Rebecca T. Ruck</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9980-9675" title="Orcid link">http://orcid.org/0000-0001-9980-9675</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Stephanie Curry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephanie Curry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Infectious Diseases, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie++Curry">Stephanie Curry</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Patricia McMonagle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patricia McMonagle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Infectious Diseases, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patricia++McMonagle">Patricia McMonagle</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sony Agrawal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sony Agrawal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of In Vitro Pharmacology, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sony++Agrawal">Sony Agrawal</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Laura Rokosz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Rokosz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of In Vitro Pharmacology, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Rokosz">Laura Rokosz</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Donna Carr</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Donna Carr</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of In Vitro Pharmacology, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Donna++Carr">Donna Carr</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Paul Ingravallo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Ingravallo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Infectious Diseases, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Ingravallo">Paul Ingravallo</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Karin Bystol</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karin Bystol</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Infectious Diseases, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karin++Bystol">Karin Bystol</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Frederick Lahser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frederick Lahser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Infectious Diseases, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frederick++Lahser">Frederick Lahser</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Rong Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rong Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Infectious Diseases, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rong++Liu">Rong Liu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Shiying Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shiying Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of PPDM, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shiying++Chen">Shiying Chen</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Kung-I Feng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kung-I Feng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Discovery Pharmaceutical Sciences, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kung-I++Feng">Kung-I Feng</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Mark Cartwright</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark Cartwright</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug Safety, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Cartwright">Mark Cartwright</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ernest Asante-Appiah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ernest Asante-Appiah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Infectious Diseases, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ernest++Asante-Appiah">Ernest Asante-Appiah</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Joseph A. Kozlowski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph A. Kozlowski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+A.++Kozlowski">Joseph A. Kozlowski</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01927&amp;href=/doi/10.1021%2Facs.jmedchem.7b01927" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3984â4003</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 21, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 December 2017</li><li><span class="item_label"><b>Published</b> online</span>21 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 May 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01927" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01927</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3984%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWensheng%2BYu%252C%2BLing%2BTong%252C%2BOleg%2BSelyutin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D9%26contentID%3Dacs.jmedchem.7b01927%26title%3DDiscovery%2Bof%2BMK-6169%252C%2Ba%2BPotent%2BPan-Genotype%2BHepatitis%2BC%2BVirus%2BNS5A%2BInhibitor%2Bwith%2BOptimized%2BActivity%2Bagainst%2BCommon%2BResistance-Associated%2BSubstitutions%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4003%26publicationDate%3DMay%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01927"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1411</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01927" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wensheng&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Ling&quot;,&quot;last_name&quot;:&quot;Tong&quot;},{&quot;first_name&quot;:&quot;Oleg&quot;,&quot;last_name&quot;:&quot;Selyutin&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Bin&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Bin&quot;,&quot;last_name&quot;:&quot;Zhong&quot;},{&quot;first_name&quot;:&quot;Jinglai&quot;,&quot;last_name&quot;:&quot;Hao&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Ji&quot;},{&quot;first_name&quot;:&quot;Shuai&quot;,&quot;last_name&quot;:&quot;Zan&quot;},{&quot;first_name&quot;:&quot;Jingjun&quot;,&quot;last_name&quot;:&quot;Yin&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;T. Ruck&quot;},{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;Curry&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;McMonagle&quot;},{&quot;first_name&quot;:&quot;Sony&quot;,&quot;last_name&quot;:&quot;Agrawal&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Rokosz&quot;},{&quot;first_name&quot;:&quot;Donna&quot;,&quot;last_name&quot;:&quot;Carr&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Ingravallo&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;Bystol&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;Lahser&quot;},{&quot;first_name&quot;:&quot;Rong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Shiying&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Kung-I&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Cartwright&quot;},{&quot;first_name&quot;:&quot;Ernest&quot;,&quot;last_name&quot;:&quot;Asante-Appiah&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;A. Kozlowski&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3984-4003&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01927&quot;},&quot;abstract&quot;:&quot;We describe the discovery of MK-6169, a potent and pan-genotype hepatitis C virus NS5A inhibitor with optimized activity against common resistance-associated substitutions. SAR studies around the combination of changes to both the valine and aminal carbon region of elbasvir led to the discovery of a series of compounds with substantially improved potency against common resistance-associated substitutions in the major genotypes, as well as good pharmacokinetics in both rat and dog. Through further optimization of key leads from this effort, MK-6169 (21) was discovered as a preclinical candidate for further development.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01927&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01927" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01927&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01927" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01927&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01927" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01927&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01927&amp;href=/doi/10.1021/acs.jmedchem.7b01927" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01927" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01927" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01927%26sid%3Dliteratum%253Aachs%26pmid%3D29681153%26genre%3Darticle%26aulast%3DYu%26date%3D2018%26atitle%3DDiscovery%2Bof%2BMK-6169%252C%2Ba%2BPotent%2BPan-Genotype%2BHepatitis%2BC%2BVirus%2BNS5A%2BInhibitor%2Bwith%2BOptimized%2BActivity%2Bagainst%2BCommon%2BResistance-Associated%2BSubstitutions%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D9%26spage%3D3984%26epage%3D4003%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=291945" title="Ketones">Ketones</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/jmcmar.2018.61.issue-9/20180510/jmcmar.2018.61.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We describe the discovery of MK-6169, a potent and pan-genotype hepatitis C virus NS5A inhibitor with optimized activity against common resistance-associated substitutions. SAR studies around the combination of changes to both the valine and aminal carbon region of elbasvir led to the discovery of a series of compounds with substantially improved potency against common resistance-associated substitutions in the major genotypes, as well as good pharmacokinetics in both rat and dog. Through further optimization of key leads from this effort, MK-6169 (<b>21</b>) was discovered as a preclinical candidate for further development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the recently published <i>Global Hepatitis Report, 2017</i> from the World Health Organization, it was estimated that 71 million people worldwide were chronically infected with hepatitis C virus (HCV) as of 2015, representing approximately 1% of the global population.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Studies have suggested that the incidence of HCV infection has decreased since the second half of the 20th century; however, there were still 1.75 million new infections in 2015, mainly due to unsafe health-care practices (including unsafe health-care injections) and injection drug use.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Without treatment, chronic HCV infection could lead to severe liver damage and life-threatening disease. For example, the risk of cirrhosis of the liver among patients with chronic HCV infection is between 15â30% within 20 years.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In 2015, there were 1.34 million deaths worldwide attributable to viral hepatitis, with 30% a result of complications of chronic HCV infection, mostly from cirrhosis and hepatocellular carcinoma.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The treatment for HCV infection has evolved significantly during the past decade. Early treatment involved interferon injections and use of ribavirin for a long treatment duration. The regimen suffered from low sustained virologic response (SVR) rates (40â65%) and many debilitating side effects. Addition of first-generation HCV nonstructural (NS) 3/4A protease inhibitors (boceprevir or telaprevir) to the interferon/ribavirin standard-of-care improved the SVR rate to 65â85%, but the side effects of interferon remained. Current treatment for HCV infection involves interferon-free all oral direct-acting antiviral agent (DAA)<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5â7)</a> combinations chosen from three different categories: NS3/4A protease inhibitors, nonstructural protein 5A (NS5A) replication complex inhibitors, and nucleoside or non-nucleoside NS5B polymerase inhibitors.</div><div class="NLM_p">HCV NS5A protein is a multifunctional RNA binding protein that interacts with several host proteins and is essential for HCV replication.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> The protein has no enzymatic activity or a known human orthologue from which a function can be inferred. A detailed understanding of how NS5A directly influences HCV replication is lacking, and therefore the mechanism of inhibitors remains unclear. While crystal structures of the N-terminal region of the protein have been reported,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> the noted differences in the dimer orientation and the absence of an inhibitorâprotein complex render a structure-based rational drug design approach pretty difficult. In the absence of enzymatic activity for NS5A, structureâactivity relationships (SARs) for inhibitors have been driven by cell-based replicon activities. First generation NS5A inhibitors showed a low resistance barrier to genotype 1 subtype a (GT1a) as well as weak activity against several other genotypes.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Thus, the need for identification of more potent NS5A inhibitors against a wider variety of genotypes as well as NS5A resistance mutations particularly in the prevalent GT1a became a focus for many groups. Six HCV NS5A inhibitors have been approved for chronic HCV treatment, in combination with other DAAs: daclatasvir (BMS-790052),<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> ledipasvir (GS-5885),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> ombitasvir (ABT-267),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> elbasvir (MK-8742),<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> velpatasvir (GS-5816),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and pibrentasvir (ABT-530).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Our efforts in the research on HCV NS5A inhibitors have progressed over time.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19â21)</a> Multiple NS5A inhibitors, including MK-4882,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> MK-8325,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and MK-8742,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> have been identified. MK-8742 (elbasvir, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) is one of the two components in Zepatier which has gained FDA approval for the treatment of GT1 and GT4 chronic HCV infection. Through our continued effort in optimization of NS5A inhibitors, we aim to identify an inhibitor with a âflatâ potency profile, which exhibits less than a 10-fold potency reduction from the wild type genotype 1a (GT1a) virus relative to other genotypes and resistance-associated substitutions (RASs). Since no X-ray structures of inhibitor and protein complexes are available to facilitate a structure-based inhibitor design approach, we plan to modify every part of the MK-8742 molecule to identify SAR that could improve the potency against the least sensitive RASs, such as GT1a Y93H and GT2b L31M (a naturally resistant substitution). Our experience has shown that activity vs these variants could often lead to improved flatness across a broad range over genotypes and mutations. Previously, we reported SAR studies toward an improved âcoreâ,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> âcapâ,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> proline,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and âZâ group region (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27â30)</a> Key findings from SAR studies included potency improvements against GT2b L31M through introducing a tetrahydro-2<i>H</i>-pyran (THP) group in the âcapâ region,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> potency improvements against both GT1a Y93H and GT2b L31M through introducing a fluorine substitution at the C-1 position of the tetracyclic indole core,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> or a relatively large aryl Z group, such as the 4-cyclopropylphenyl,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> 4-diphenyl,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and 7â²-chromane.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> More recently, substituted thiazole and thiophene as âZâ groups were also identified to improve the potency against NS5A RASs.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Through these efforts we identified MK-8408 (ruzasvir).<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30â32)</a> Herein, we disclose the discovery of an additional pan-genotype HCV NS5A inhibitor, preclinical candidate MK-6169.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HCV NS5A inhibitors approved by FDA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Strategy for the modification of MK-8742 molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As reported previously, we found that replacing the isopropyl group of the valine âcapâ of elbasvir with a (<i>S</i>)-THF group was able to improve the activity on GT2b L31M while maintaining potency against the other NS5A RASs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> We therefore wanted to incorporate this SAR with the âZâ groups identified more recently in an attempt to improve the activity on GT1a Y93H and GT2b L31M. Thus, the (<i>S</i>)-THP group was initially incorporated on the left-hand side of the molecule with a range of âZâ groups; the in vitro potencies (replicon EC<sub>90</sub>) are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Incorporation of the (<i>S</i>)-THP âcapâ with chromane as âZâ group (<b>1</b>, <b>2</b>) showed a 10Ã improvement against GT1a Y93H and GT2b L31M vs the corresponding bis-valine analogs.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> On the basis of the EC<sub>90</sub> values in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, we observed a reduced shift in potency of the wild type GT1a vs GT1a Y93H and GT2b L31M which for <b>1</b> is 9Ã and 4Ã, respectively. A similar result was observed for <b>3</b> whose âZâ group is 4-methyl-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazine. Encouraged by these data, a series of compounds with substituted thiophene moieties as the âZâ group (<b>4</b>â<b>12</b>) was prepared. The substituents on the thiophene included methyl (<b>4</b>), ethyl (<b>5</b>), <i>n</i>-propyl (<b>6</b>), isopropyl (<b>7</b>), cyclopropyl (<b>8</b>), di-F-methyl (<b>9</b>), and tri-F-methyl (<b>10</b>). Analogs with benzothiophene (<b>11</b>) and 5,6-dihydro-4<i>H</i>-cyclopenta[<i>b</i>]thiophene (<b>12</b>) were also prepared. All these compounds showed a potency shift less than 10Ã from GT1a wild type to the other genotypes and mutants tested, except <b>11</b> whose âZâ group is a benzothiophenyl group. Compound <b>11</b> showed a slightly larger potency shift (20Ã) against GT1a Y93H. Compounds with the (<i>S</i>)-THP on the right-hand side of the molecules were also prepared (<b>13</b>, <b>14</b>), and their in vitro potencies are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Both compounds, with the âZâ group as either chromane or 4-methyl-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazine, showed single or double digit pM EC<sub>90</sub> values for all the genotypes and mutants tested. It was interesting to observe that compound <b>14</b> showed 15-fold potency loss against GT1a relative to compound <b>3</b> in which the THP group is on the left-hand side.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Potency Profiles of Elbasvir<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="8" align="center">replicon EC<sub>90</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">GT1a<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">GT1b</th><th class="colsep0 rowsep0" align="center">GT2a</th><th class="colsep0 rowsep0" align="center">GT2b L31M</th><th class="colsep0 rowsep0" align="center">GT3a</th><th class="colsep0 rowsep0" align="center">GT4a</th><th class="colsep0 rowsep0" align="center">GT1a Y93H</th><th class="colsep0 rowsep0" align="center">GT1a L31V</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">elbasvir</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">0.016</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>90</sub> is the concentration of inhibitor that reduces the effective response by 90%.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">See <a class="ref internalNav" href="#dl1" aria-label="abbreviations list">abbreviations list</a> for the full name of genotype and mutant names.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. NS5A Inhibitors with a (<i>S</i>)-THP Group on the Left-Hand Side</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0011.gif" alt="" id="GRAPHIC-d130e798-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0012.gif" alt="" id="gr11" /></img><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. NS5A Inhibitors with a (<i>S</i>)-THP Group on the Right-Hand Side</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0013.gif" alt="" id="GRAPHIC-d130e809-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0014.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> value, which is the concentration of inhibitor that reduces the effective response by 50%.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">nt = not tested.</p></div></div><div></div></div><div class="NLM_p">The rat and dog PK profiles of selected compounds in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Unfortunately, all compounds tested exhibited low exposure in rat with their AUC normally less than 1 Î¼MÂ·h at 10 mpk oral dosing. The oral bioavailability of these compounds is quite low as well. This is expected due to their high plasma protein binding and low permeability. Compound <b>3</b> displayed a relatively higher exposure with oral AUC = 1.23 Î¼MÂ·h at 10 mpk, but its bioavailability was only 1.5%. Compound <b>3</b> had a low PK exposure in dog as well. Surprisingly, both compounds <b>4</b> and <b>8</b> showed good dog PK exposure even though their rat PK exposures were low. The single rising dose rat PK study of <b>8</b> is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, which revealed a linear increase in exposure from 10 to 100 mpk whereas a less than dose-proportional increase in exposure was observed from 100 to 300 mpk.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Profiles of <b>1</b>, <b>3</b>â<b>5</b>, <b>7</b>, <b>8</b>, <b>13</b>, and <b>14</b> in Rat or Dog<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">iv</th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">po</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mLÂ min<sup>â1</sup>Â kg<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">dose (mpk)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (Î¼MÂ·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>24</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>Â (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">0.032</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">1.23</td><td class="colsep0 rowsep0" align="char" char=".">0.162</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">0.031</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="char" char=".">0.048</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">0.050</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">0.034</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">1.32</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2.61</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="char" char=".">11.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Fasted male Wistar Han rats or Beagle dogs were used. The iv dose was formulated with 60% PEG200, and the compounds were dosed at 2 mg/kg in rat or 1 mg/kg in dog. The po dose was formulated with 10% TWEEN, and the compounds were dosed as indicated in the table.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Rat Single Rising Dose PK Profile of <b>8</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">dose (mpk)</th><th class="colsep0 rowsep0" align="center" char=".">po AUC (Î¼MÂ·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>24h</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">MRT (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">1.64</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">3.99</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">0.032</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">9.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Fed male Wistar Han rats were used.  Compound was dosed at indicated doses po in 10% TWEEN.</p></div></div></div><div class="NLM_p">As reported previously, the bis-valine analog with chromane as the âZ groupâ showed reasonable exposure in rat with AUC (po) at 10 mpk being 1.65 Î¼MÂ·h.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, replacing the isopropyl group of the valine moiety with a tetrahydro-2<i>H</i>-pyran (THP) group, either in the left-hand side (<b>1</b>) or right-hand side (<b>13</b>), resulted in a significant drop of PK exposure in rat. Therefore the THP group was believed to be responsible for the poor rat PK of compounds in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. A metabolite study on a similar compound not shown in this publication revealed that a possible hydroxylation occurred on the carbon next to the oxygen that led to the ring opening of the THP group. To prevent this potential metabolic pathway, analogs with a variety of Î±-substituted THP groups were synthesized and their replicon EC<sub>90</sub> data are listed in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. It should be noted that compounds in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> have multiple diastereomers. All diastereomers were separated by chiral SFC, but only one or two diastereomers with the best potency are reported here. Their absolute stereochemistry was either introduced from the starting material with known stereochemistry, determined by VCD with confidence, or assigned arbitrarily. See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for details. Both (<i>R</i>)- or (<i>S</i>)-2-methyl-THP analogs (<b>15</b>, <b>16</b>) exhibited good activity on the genotypes tested, and similar potency profiles were observed for both <i>cis</i>- and <i>trans</i>-2,6-dimethyl THP analogs (<b>17</b>, <b>18</b>). However, <i>cis</i>-2,6-diethyl THP analog <b>19</b> exhibited reduced potency against all the genotypes tested, especially on GT2b L31M with a â¼100-fold loss in potency as compared with the corresponding <i>cis</i>-2,6-dimethyl THP analog <b>17</b>, indicating that a larger substituent was not tolerated. 2,2-Dimethyl substituted THP analogs (<b>20</b>, <b>21</b>) as well as the 2-spiro-cyclopropyl THP analog (<b>22</b>) all displayed good potency against all the genotypes tested. Additionally, the 8-oxabicyclo[3.2.1]octane substituted analog <b>23</b> and the 2,2,6,6-tetramethyl-THP analog <b>24</b> also displayed good potency on the genotypes tested.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. NS5A Inhibitors with a Substituted-THP Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0015.gif" alt="" id="GRAPHIC-d130e1497-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0016.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">nt = not tested.</p></div></div><div></div></div><div class="NLM_p">The PK parameters of all compounds except <b>19</b> in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. Both monomethyl substituted analogs <b>15</b> and <b>16</b> showed low PK exposure in rat at 10 mpk oral dosing. The 2,6-dimethyl substituted analogs <b>17</b> and <b>18</b> had higher exposures in rat than <b>15</b> and <b>16</b>. Interestingly, while one diastereomer (<b>20</b>) of the 2,2-dimethyl substituted THP analogs displayed low rat PK exposure, one of the other diastereomers (<b>21</b>) exhibited a much improved PK exposure in rat with AUC (po) at 10 mpk being 1.65 Î¼MÂ·h. It also showed improved <i>C</i><sub>24h</sub> relative to the other compounds. The rat PK exposure of the 2-spiro-cyclopropyl THP analog (<b>22</b>) was low and so were the rat PK exposures of <b>23</b> and <b>24</b>. The dog PK profiles of <b>17</b>, <b>18</b>, and <b>21</b> were also examined. All of them displayed good dog PK exposures at 5 mpk oral dosing. They also had low clearance and relatively higher bioavailability than in rat. Rat single rising dose PK study of compounds <b>17</b>, <b>18</b>, and <b>21</b> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>. All three compounds showed less than dose-proportional increase in exposure from 10 to 300 mpk.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Profiles of <b>15</b>â<b>18</b> and <b>20</b>â<b>24</b> in Rat or Dog<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">iv</th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">po</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">dose (mpk)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mLÂ min<sup>â1</sup>Â kg<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">dose (mpk)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (Î¼MÂ·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>24</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.92</td><td class="colsep0 rowsep0" align="char" char=".">0.067</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.93</td><td class="colsep0 rowsep0" align="char" char=".">0.119</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">1.65</td><td class="colsep0 rowsep0" align="char" char=".">0.183</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">0.057</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="char" char=".">0.076</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2.42</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">11.3</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">5.05</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td><td class="colsep0 rowsep0" align="char" char=".">0.087</td><td class="colsep0 rowsep0" align="char" char=".">18.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">4.19</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">0.029</td><td class="colsep0 rowsep0" align="char" char=".">14.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Fasted male Wistar Han rats or Beagle dogs were used.  The iv dose was formulated with 60% PEG200. The po dose was formulated with 10% TWEEN.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Rat Single Rising Dose PK Profiles of <b>17</b>, <b>18</b>, <b>21</b><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">dose (mpk)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (Î¼MÂ·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>24h</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">MRT (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">1.95</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">0.027</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">4.08</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">0.040</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2.07</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">5.58</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">0.029</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">7.82</td><td class="colsep0 rowsep0" align="char" char=".">0.76</td><td class="colsep0 rowsep0" align="char" char=".">0.072</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">12.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">1.06</td><td class="colsep0 rowsep0" align="char" char=".">0.164</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">10.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Fed male Wistar Han rats were used.  Compounds were formulated with 10% TWEEN and dosed orally.</p></div></div></div><div class="NLM_p">The 2,2-dimethyl-THP isomer employed in <b>21</b> was used as a test to determine its impact in combination with other âZ groupsâ that had previously been identified to show good potency. Compounds <b>25</b>â<b>35</b> have the dimethyl-THP cap on the left-hand side, and their replicon EC<sub>90</sub> data are listed in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>. Not surprisingly, most of them showed âflatâ potency profile against all genotypes and mutants tested, with the exceptions of <b>26</b>, <b>30</b>, <b>33</b>, and <b>35</b> which exhibited slightly reduced potency against GT1a Y93H with the corresponding EC<sub>90</sub> values in the triple digit pM range. Two compounds (<b>36</b>, <b>37</b>) with the same 2,2-dimethyl-THP isomer on the right-hand side were also prepared. Their EC<sub>90</sub> data are listed in <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>. Both compounds were pretty potent against the genotypes and mutants tested, except <b>36</b> exhibited slightly reduced potency in GT1a, GT2b L31M, and GT1a Y93H.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. NS5A Inhibitors with a 2,2-Dimethyl-THP Group on the Left-Hand Side</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0017.gif" alt="" id="GRAPHIC-d130e2391-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0018.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Single chromane isomer, absolute stereochemistry assigned arbitrarily.</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last">nt = not tested.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. NS5A Inhibitors with a 2,2-Dimethyl-THP Group on the Right-Hand Side</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0019.gif" alt="" id="GRAPHIC-d130e2410-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0020.gif" alt="" id="gr15" /></img><div></div></div><div class="NLM_p">The rat PK profile of selected compounds in both <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Tables <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>. While the majority of these compounds showed a moderate to low PK exposure in rat, <b>30</b> had comparable PK exposure in rat as <b>21</b>, as well as reasonable bioavailability.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Pharmacokinetic Profiles of Compounds <b>25</b>, <b>27</b>, <b>29-32</b>, <b>34</b>, <b>36</b>, and <b>37</b> in Rat<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">iv</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">po</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mLÂ min<sup>â1</sup>Â kg<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (Î¼MÂ·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>24</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>Â (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">0.78</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">1.90</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">10.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup><sup>a</sup></sup><p class="last">Fasted male Wistar Han rats were used.  The iv dose was formulated with 60% PEG200, and the compounds were dosed at 2 mg/kg. The po dose was formulated with 10% TWEEN, and the compounds were dosed at 10 mg/kg.</p></div></div></div><div class="NLM_p">With all the potency and PK data in hand, <b>21</b> emerged as a lead with both âflatâ potency and acceptable PK profile in both rat and dog. Comparing with other compounds, <b>21</b> shows the best <i>C</i><sub>24h</sub> in both rat and dog. To reduce the HCV resistance, it is important to achieve adequate <i>C</i><sub>24h</sub> in human to cover the EC<sub>90</sub> values for as many HCV NS5A genotypes and RASs as possible. Compound <b>21</b> has the best potential to achieve that in relatively low dose with QD dosing. Its potency profile against additional HCV NS5A genotypes and RASs is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a></a>. Compound <b>21</b> showed <10Ã shift on a majority of the genotypes and mutants tested, other than several mutants, such as GT3a Y93H and GT3a L31 V, with the corresponding EC<sub>90</sub> values still in the single digit nM range. As NS5A inhibitors are often developed in combination with other DAAs such as NS3 inhibitors, we tested the potency of <b>21</b> on NS3 RASs. As anticipated, compound <b>21</b> retained its potency and showed good potency on prototypical GT1a NS3 RASs such as GT1a R155K and GT1a V36M + R155K double substitution, as well as prototypical GT1b NS3 RASs such as GT1b A156T and GT1b D168Y. These data suggested that a cross resistance is unlikely. The potency profile of <b>21</b> is among the most flat profiles we have achieved so far.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. In Vitro Potency Profile of Compound <b>21</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">replicon</th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> (nM)</th><th class="colsep0 rowsep0" align="center">shift<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">replicon</th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> (nM)</th><th class="colsep0 rowsep0" align="center">shift</th><th class="colsep0 rowsep0" align="center">replicon</th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> (nM)</th><th class="colsep0 rowsep0" align="center">shift</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A</td><td class="colsep0 rowsep0" align="left">0.0042</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">1B</td><td class="colsep0 rowsep0" align="left">0.0044</td><td class="colsep0 rowsep0" align="left">1Ã</td><td class="colsep0 rowsep0" align="left">2B L31M</td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">4Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (A92P)<a class="ref internalNav" href="#t12fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.00014</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">1B (A156T)<a class="ref internalNav" href="#t12fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.0040</td><td class="colsep0 rowsep0" align="left">1Ã</td><td class="colsep0 rowsep0" align="left">2B (A146S)</td><td class="colsep0 rowsep0" align="left">0.0034</td><td class="colsep0 rowsep0" align="left">1Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (K24R)</td><td class="colsep0 rowsep0" align="left">0.00034</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">1B (A92K)</td><td class="colsep0 rowsep0" align="left">0.026</td><td class="colsep0 rowsep0" align="left">6Ã</td><td class="colsep0 rowsep0" align="left">2B (M31V)</td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left">5Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (L31M:Y93C)</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">43Ã</td><td class="colsep0 rowsep0" align="left">1B (A92T)</td><td class="colsep0 rowsep0" align="left">0.0039</td><td class="colsep0 rowsep0" align="left">1Ã</td><td class="colsep0 rowsep0" align="left">3A</td><td class="colsep0 rowsep0" align="left">0.0066</td><td class="colsep0 rowsep0" align="left">2Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (L31V)</td><td class="colsep0 rowsep0" align="left">0.0043</td><td class="colsep0 rowsep0" align="left">1Ã</td><td class="colsep0 rowsep0" align="left">1B (D168Y)<a class="ref internalNav" href="#t12fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.0018</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">3A (L31F)</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">69Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (M28K)</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">100Ã</td><td class="colsep0 rowsep0" align="left">1B (L28M:Y93H)</td><td class="colsep0 rowsep0" align="left">0.065</td><td class="colsep0 rowsep0" align="left">15Ã</td><td class="colsep0 rowsep0" align="left">3A (A30K)</td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">4Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (M28T)</td><td class="colsep0 rowsep0" align="left">0.0020</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">1B (L31I)</td><td class="colsep0 rowsep0" align="left">0.021</td><td class="colsep0 rowsep0" align="left">5Ã</td><td class="colsep0 rowsep0" align="left">3A (A30T)</td><td class="colsep0 rowsep0" align="left">0.0036</td><td class="colsep0 rowsep0" align="left">1Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (Q30R)</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">28Ã</td><td class="colsep0 rowsep0" align="left">1B (L31M)</td><td class="colsep0 rowsep0" align="left">0.0016</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">3A (L31V)</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">762Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (R155K)<a class="ref internalNav" href="#t12fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.0019</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">1B (L31M:Y93H)</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">45Ã</td><td class="colsep0 rowsep0" align="left">3A (Y93H)</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">571Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1AÂ (R155K:V36M)<a class="ref internalNav" href="#t12fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.0025</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">1B (L31V)</td><td class="colsep0 rowsep0" align="left">0.0058</td><td class="colsep0 rowsep0" align="left">1Ã</td><td class="colsep0 rowsep0" align="left">4A</td><td class="colsep0 rowsep0" align="left">0.0060</td><td class="colsep0 rowsep0" align="left">2Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (R81W)</td><td class="colsep0 rowsep0" align="left">0.00032</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">2A</td><td class="colsep0 rowsep0" align="left">0.0027</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">4A (L30H)</td><td class="colsep0 rowsep0" align="left">0.072</td><td class="colsep0 rowsep0" align="left">17Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (Y93H)</td><td class="colsep0 rowsep0" align="left">0.033</td><td class="colsep0 rowsep0" align="left">8Ã</td><td class="colsep0 rowsep0" align="left">2A (F28L)</td><td class="colsep0 rowsep0" align="left">0.00050</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">4A (P32L)</td><td class="colsep0 rowsep0" align="left">0.0044</td><td class="colsep0 rowsep0" align="left">1Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A (Y93N)</td><td class="colsep0 rowsep0" align="left">0.069</td><td class="colsep0 rowsep0" align="left">16Ã</td><td class="colsep0 rowsep0" align="left">2A (F28Y)</td><td class="colsep0 rowsep0" align="left">0.069</td><td class="colsep0 rowsep0" align="left">16Ã</td><td class="colsep0 rowsep0" align="left">4A (L31V)</td><td class="colsep0 rowsep0" align="left">0.0077</td><td class="colsep0 rowsep0" align="left">2Ã</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A R81S</td><td class="colsep0 rowsep0" align="left">0.00033</td><td class="colsep0 rowsep0" align="left"><1Ã</td><td class="colsep0 rowsep0" align="left">2A (L31M)</td><td class="colsep0 rowsep0" align="left">0.025</td><td class="colsep0 rowsep0" align="left">6Ã</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup><sup>a</sup></sup><p class="last">Shift from GT1a EC<sub>90</sub> value.</p></div><div class="footnote" id="t12fn2"><sup><sup>b</sup></sup><p class="last">The single amino acid code is indicated for all substitutions, e.g. 1A (A92P) refers to a genotype 1a substitution where an alanine at position 92 is replaced with a proline.</p></div><div class="footnote" id="t12fn3"><sup><sup>c</sup></sup><p class="last">HCV NS3 RAS.</p></div></div></div><div class="NLM_p">The in vitro cytotoxicity potential of compound <b>21</b> was tested in Huh-7 cells up to a maximum concentration of 25 Î¼M by monitoring GAPDH mRNA levels. No cytotoxicity was observed.</div><div class="NLM_p last">The structure of compound <b>21</b> has been fully determined. The stereochemistry of the six chiral centers either originated from known chiral starting materials or were determined by vibrational circular dichroism (VCD) spectroscopy with confidence (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for details). Given its superior potency and pharmacokinetic properties, compound <b>21</b> was recommended as a preclinical candidate for further development.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We incorporated (<i>S</i>)-THP amino acid âcapâ with varying substituents at the aminal carbon (the âZâ group) and identified HCV NS5A inhibitors with significantly improved potency against the least sensitive RASs of elbasvir, such as GT1a Y93H and GT2b L31M. These leads also showed an excellent in vitro profile in many other genotypes and mutants. Some of the compounds we identified possess âflatâ potency profiles, with EC<sub>90</sub> values against a majority of the mutants tested within a 10-fold range of the EC<sub>90</sub> value for GT1a H77 (wild type). Compounds with an unsubstituted (<i>S</i>)-THP amino acid âcapâ exhibited low PK exposure in rat, likely attributable to oxidative metabolism. Small alkyl substituted (<i>S</i>)-THP replacements for the isopropyl group of valine showed improved PK exposure in both rat and dog. Among them, the compound with the (<i>S,R</i>)-2,2-dimethyl-THP amino acid âcapâ (compound <b>21</b>) had the best PK profile in both rat and dog and an increased exposure-dose response up to 300 mpk in rat as well. Compound <b>21</b> was recommended as a preclinical candidate (MK-6169) for further development.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The chemistry for the preparation of compounds <b>1</b>â<b>12</b> is outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The preparation of compound <b>38</b> was described previously.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Aldehydes <b>39a</b>â<b>l</b> were either purchased or prepared based on known procedures.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30â32)</a> Treatment of <b>38</b> with aldehydes <b>39a</b>â<b>l</b> under acidic condition to give the tetracyclic indoline intermediates which were in turn oxidized to the corresponding racemic indoles. These compounds were separated by chiral SFC to give <b>40a</b>â<b>l</b>, representing the enantiomers that give the more potent final compounds. The stereochemistry of the aminal carbons in <b>40a</b>â<b>l</b> was not determined, but we believe it is reasonable to assume it is â<i>S</i>â since in previous studies we have determined that the â<i>S</i>â isomers at the aminal carbon of the tetracyclic indole cores always give the more potent final compounds including MK-8742 and MK-8408.<a onclick="showRef(event, 'ref15 ref30'); return false;" href="javascript:void(0);" class="ref ref15 ref30">(15,30)</a> Compounds <b>40a</b>â<b>l</b> were converted to the corresponding pinnacol boronate esters <b>41a</b>â<b>l</b> which upon treatment under Suzuki coupling conditions with <b>42</b> afforded intermediates <b>43a</b>â<b>l</b>. Compound <b>42</b> was prepared based on published procedures.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Treatment of <b>43a</b>â<b>l</b> under Pd<sub>2</sub>(dba)<sub>3</sub>/X-Phos conditions afforded pinnacol boronate esters <b>44a</b>â<b>l</b> that coupled with <b>45</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> to give <b>46a</b>â<b>l</b>. The Boc groups of <b>46a</b>â<b>l</b> were removed and a methoxycarbonyl-<span class="smallcaps smallerCapital">l</span>-valine moiety was introduced to give compounds <b>1</b>â<b>12</b>. Compound <b>13</b> and <b>14</b> were also prepared in a similar method by switching the valine and (<i>S</i>)-THP âcapsâ in the synthesis.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compounds <b>1</b>â<b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) TFA, CH<sub>3</sub>CN, 25 Â°C, 6 h; (ii) DDQ, toluene, 115 Â°C, 2 h, then chiral SFC separation; (iii) bis(pinacolato)diboron, Pd(dppf)Cl<sub>2</sub>, KOAc, dioxane, 90 Â°C, 16 h; (iv) <b>42</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), 90 Â°C, 16 h; (v) bis(pinacolato)diboron, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, dioxane, 110 Â°C, 2 h; (vi) <b>45</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), 90 Â°C, 16 h; (vii) HCl, MeOH, 0.5 h; (viii) (<i>S</i>)-2-((methoxycarbonyl)amino)-2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetic acid, BOP, DIPEA, DMF, 10 h.</p></p></figure><div class="NLM_p">The preparation of <b>52a</b>â<b>h</b> was outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Ketone intermediates <b>47a</b>â<b>j</b> were either purchased from commercial resources or prepared (<a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a>â<a class="ref internalNav" href="#sch7" aria-label="7">7</a>). Treatment of <b>47a</b>â<b>h</b> with <b>48</b> under DBU conditions gave condensed products <b>49a</b>â<b>h</b>, which were reduced by hydrogen under Pd/C to afford amine intermediates <b>50a</b>â<b>h</b>. Compounds <b>50a</b>â<b>h</b> were hydrolyzed to give racemic amino acids <b>51a</b>â<b>h</b>, to which a methyl carbamate functionality was introduced and the diastereomers were separated by chiral SFC to provide <b>52a</b>â<b>h</b>, representing the diastereomers which lead to the most potent final compounds. The stereochemistry of the R group on the amino acid was not determined except <b>52g</b>. We believe it is reasonable to assume they have the â<i>S</i>â configuration since in previous studies we have determined that (<i>S</i>)-2-amino-2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetic acid always leads to the more potent final compounds than (<i>R</i>)-2-amino-2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetic acid.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The stereochemistry of the chiral centers on the THP groups was either introduced via starting materials (see <a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a>â<a class="ref internalNav" href="#sch7" aria-label="7">7</a>) or assigned arbitrarily except <b>52g</b>, whose stereochemistry were fully determined by VCD with confidence (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compounds <b>52a</b>â<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) DBU, CH<sub>2</sub>Cl<sub>2</sub>, 25 Â°C, 5 h; (ii) Pd/C (10%), H<sub>2</sub> (35 psi), MeOH, 25 Â°C, 8 h; (iii) LiOH, MeOH, H<sub>2</sub>O, 25 Â°C, 15 h; (iv) methyl chloroformate, LiOH, H<sub>2</sub>O, 25 Â°C, 3 h, then chiral SFC separation.</p></p></figure><div class="NLM_p">Compounds <b>52i</b> and <b>52j</b> were prepared by a different synthesis outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Ketone <b>47i</b>,<b>j</b> were reduced to the corresponding alcohols and then converted to tosylates <b>53i</b>,<b>j</b>. Replacement of the tosyl groups of <b>53i</b>,<b>j</b> by the enolate generated from compound <b>54</b> afforded compounds <b>55i</b>,<b>j</b>, which were deprotected under acidic conditions to provide amine <b>56i</b>,<b>j</b>, which were subsequently converted to methyl carbamates <b>57i</b>,<b>j</b> and further hydrolyzed to give acids <b>52i</b>,<b>j</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compounds <b>52i</b>â<b>j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) L-selectride, THF, â78 to 25 Â°C, 12 h, then NaOH, H<sub>2</sub>O; (ii) TsCl, pyridine, DCM, 25 Â°C, 12 h; (iii) <b>54</b>, LiHMDS, toluene, 100 Â°C, 4 h; (iv) HCl, THF, 25 Â°C, 2 h; (v) methyl chloroformate, DCM, Et<sub>3</sub>N, 25 Â°C, 12 h; (vi) Pd/C (10%), H<sub>2</sub> (40 psi), MeOH, 25 Â°C, 12 h.</p></p></figure><div class="NLM_p">The preparation of (<i>R</i>)-2-methyltetrahydro-4<i>H</i>-pyran-4-one (<b>47a</b>) is described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Commercially available methyl (<i>R</i>)-3-hydroxybutanoate (<b>58</b>) was protected with a TBS group to give compound <b>59</b>, which was converted to Weinreb amide <b>60</b>. Addition of a vinyl group to compound <b>60</b> gave Î±,Î²âunsaturated ketone <b>61</b>, which was deprotected and provided ketone <b>47a</b>. (<i>S</i>)-2-Methyltetrahydro-4<i>H</i>-pyran-4-one (<b>47b</b>) was prepared in a similar manner starting with commercially available methyl (<i>S</i>)-3-hydroxybutanoate.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compound <b>47a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) TBSCl, imidazole, EtOAc, 0â25 Â°C, 12 h, 95%; (ii) <i>N</i>,<i>O</i>-dimethylhydroxylamine, <i>i</i>-PrMgCl, THF, â20 Â°C, 2 h, 72%; (iii) vinylmagnesium bromide, THF, 0â5 Â°C, 1 h, 79%; (iv) Amberlyst 15 resin, CHCl<sub>3</sub>, 25 Â°C, 15 h, used without purification.</p></p></figure><div class="NLM_p">The preparation of <i>cis</i>-2,6-dimethyltetrahydro-4<i>H</i>-pyran-4-one (<b>47c)</b> is described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Reduction of compound <b>62</b> led to <i>cis</i>-alcohol <b>63</b>, which was oxidized to ketone <b>47c</b>. The preparation of ketone <b>47h</b> is described in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Cyclopropylation of <b>64</b> was achieved under Ti(<i>i</i>-PrO)<sub>4</sub>/EtMgBr conditions to afford compound <b>65</b>, which was protected with a TBS group. The dimethyl acetal also fell off under the TBSOTf condition, and aldehyde <b>66</b> was obtained. Addition of a vinyl group to the aldehyde <b>66</b> led to alcohol <b>67</b>, which was oxidized to Î±,Î²-unsaturated ketone <b>68</b>. Deprotection of the TBS group led to the formation of desired ketone <b>47h</b>. Ketone <b>47i</b> was prepared in a two-step synthesis (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Reaction between furan and 1,1,3,3-tetrabromopropan-2-one under Zn/(EtO)<sub>3</sub>B conditions gave dibromo ketone <b>69</b>, which was reduced to the desired ketone <b>47i</b> under Pd catalyzed hydrogenation.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Compound <b>47c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd/C (10%), H<sub>2</sub> (50 psi), EtOH, 35 Â°C, 17 h, 99%; (ii) TEMPO, NaHCO<sub>3</sub>, KBr, NaClO, DCM, H<sub>2</sub>O, 25 Â°C, 5 h, 99%.</p></p></figure><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Compound <b>47h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Ti(<i>i</i>-PrO)<sub>4</sub>, EtMgBr, THF/Et<sub>2</sub>O (1:1), 0â25 Â°C, 12 h, 89%; (ii) TBSOTf, 2,6-lutidine, DCM, 10 Â°C, 1 h, 41%; (iii) vinylmagnesium bromide, THF, â78 Â°C, 0.5 h, 41%; (iv) IBX, CH<sub>3</sub>CN, 80 Â°C, 2 h, 50%; (v) Amberlyst 15 resin, DCM, reflux, 4 h, used without purification.</p></p></figure><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of Compound <b>47i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 1,1,3,3-tetrabromopropan-2-one, Zn, (EtO)<sub>3</sub>B, THF, 25 Â°C, 17 h; (ii) Zn, CuCl, MeOH, 25 Â°C, 19 h, 30% for two steps.</p></p></figure><div class="NLM_p">With <b>52a</b>â<b>j</b> in hand, compounds <b>15</b>â<b>24</b> were synthesized as described in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>. The preparation of <b>75</b> from <b>38</b> and <b>39h</b> was similar to the chemistry described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Compound <b>75</b> was resolved by chiral SFC. The active isomer, which was identified by carrying both isomers to the final compounds and comparing their replicon activity, was deprotected to give amine <b>76</b>. The substituted THP âcapâ was introduced by BOP mediated amide coupling reaction to provide final compounds <b>15</b>â<b>24</b></div><figure id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of Compounds <b>15</b>â<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) TFA, CH<sub>3</sub>CN, 25 Â°C, 6 h, 81%; (ii) DDQ, toluene, reflux, 2 h, 88%; (iii) bis(pinacolato)diboron, Pd(dppf)Cl<sub>2</sub>, KOAc, dioxane, 90 Â°C, 16 h, 88%; (iv) <b>45</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), 90 Â°C, 16 h, 77%; (v) bis(pinacolato)diboron, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, dioxane, 110 Â°C, 2 h, 89%; (vi) <b>72</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), 90 Â°C, 16 h, 74%, then chiral SFC separation, 26%; (vii) HCl, MeOH, 2 h, 98%; (viii) <b>52a</b>â<b>j</b>, BOP, DIPEA, DMF, 10 h.</p></p></figure><div class="NLM_p last">Compounds <b>25</b>â<b>37</b> were synthesized by similar methods as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> by replacing the unsubstituted (<i>S</i>)-THP âcapâ with <b>52g</b>.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chemicals purchased from commercial suppliers were used as received unless specified. Silica gel column chromatography was carried out on ISCO CombiFlash Companion. Prepacked silica gel cartridges were used. TLC (thin layer chromatography) visualization was performed under 254 nm ultraviolet light. Reverse-phase preparative HPLC purifications were done on a Gilson 215 liquid handler with Unpoint software, typically with a Sun Fire Prep C18 OBD 5 Î¼m, 19 mm Ã 50 mm column. The following method was typically used. Run time: 15 min. Flow rate: 14 mL/min. Mobile phase: 10% to 90% CH<sub>3</sub>CN/H<sub>2</sub>O, with 0.1%TFA. UV detection at 254 or 210 nm was typically used. SFC separations were normally done on a TharSFC instrumentation. Columns and separation conditions were specified in each separation.</div><div class="NLM_p">Nuclear magnetic resonance spectra were obtained on a Varian 400 MHz, 500 MHz or Bruker 400 MHz spectrometers. Spectra were taken at ambient temperature. Chemical shifts were assigned by using residual solvent signal as internal standard and are reported in parts per million (ppm). Resonance patterns are reported by using the following notations: br (broad), s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet).</div><div class="NLM_p">The purity of all final compounds were determined to be >95% according to the LCMS data obtained on Agilent 1200 series HPLC equipped with DAD and 6110 single quadrupole MSD and ELSD with Agilent TC-C18, 50 mm Ã 2.1 mm, 5 Î¼m for acid methods, Waters X-Bridge Shield RP18, 50 mm Ã 2.1 mm, 5 Î¼m for basic methods. HRMS analysis was performed on Waters Acquity UPLC, column Acquity UPLC BEH C18 1.7 Î¼m, and Waters Xevo G2 Qtof with ionization mode as positive ESI+ for all compounds except <b>21</b>. The HRMS analysis of <b>21</b> was carried on Thermo LTQ obitrap mass spectrometer with ionization mode as positive ESI+ and HPLC system consisting of a Phenomenex Kinetex C18 column, 150 mm Ã 4.6 mm, 2.6 Î¼m particle size. The flow rate was 1.0 mL/min. The column temperature was 30 Â°C. The mobile phase was water and acetonitrile with 0.1% formic acid added to each. A linear gradient from 20% to 90% acetonitrile in 8 min was used.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Virology Assay</h3><div class="NLM_p last">Detailed assay method was published previously.<a onclick="showRef(event, 'ref31 ref32 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref34 ref35">(31,32,34,35)</a> All EC<sub>50</sub> or EC<sub>90</sub> data are average values of at least two measurements, with a maximum variation of 3-fold.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> PK Assessment</h3><div class="NLM_p">Rat and dog PK studies were done in 24 h period. Overnight fasted or fed rats and dogs were used. Dose was administered either by iv or po with two animals in each dosing group. Plasma was obtained by centrifugation of the blood collected. Compound concentrations in plasma were determined by LC/MS analysis.</div><div class="NLM_p last">Aldehyde <b>39a</b> was prepared based on published procedures.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31â33)</a> Aldehydes <b>39b</b>,<b>c</b> were purchased from commercial resources. Aldehyde <b>39d</b>â<b>l</b> were either purchased from commercial resources or prepared based on published procedures.<a onclick="showRef(event, 'ref29 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref29 ref31 ref32 ref33">(29,31â33)</a></div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(Chroman-7-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>1</b>)</h3><div class="NLM_p last">Compound <b>1</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.933 (s, 1 H), 7.81 (s, 1 H), 7.68 (s, 1 H), 7.74â7.08 (m, 6 H), 6.88 (d, <i>J</i> = 8.0 Hz, 1 H), 6.41 (d, <i>J</i> = 8.4 Hz, 1 H), 6.29 (s, 1H), 5.23â5.18 (m, 2 H), 4.29 (d, 7.6 Hz, 1 H), 4.21 (d, <i>J</i> = 6.4 Hz, 1 H), 4.08â3.88 (m, 8 H), 3.64 (d, <i>J</i> = 20 H, 6 H), 3.38â3.31 (m, 2 H), 2.65â2.53 (m, 2 H), 2.51â2.50 (m, 2 H), 2.26â2.02 (m, 8 H), 1.83â1.85 (m, 2 H), 1.55â1.35 (m, 4 H), 0.90 (dd, <i>J</i> = 6.8, 20 Hz, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>61</sub>FN<sub>9</sub>O<sub>9</sub> [M + H]<sup>+</sup>, 998.4576; found, 998.4587.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(Chroman-6-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>2</b>)</h3><div class="NLM_p last">Compound <b>2</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.00 (s, 1 H), 7.88 (s,1 H), 7.72 (s, 1 H), 7.45 (d, <i>J</i> = 4.8 Hz, 2 H), 7.32 (d, <i>J</i> = 11.2 Hz, 1 H), 7.25â7.21 (m, 3 H), 6.74 (d, <i>J</i> = 7.2 Hz, 2 H), 6.61 (d, <i>J</i> = 9.2 Hz, 1 H), 5.24â5.16 (m, 2 H), 4.26 (d, <i>J</i> = 8.0 Hz, 1 H), 4.19 (d, <i>J</i> = 7.6 Hz, 1 H), 4.10â4.07 (m, 4 H), 3.93â3.82 (m, 4 H), 3.64 (s, 6 H), 3.40â3.30 (m, 2 H), 2.61â2.51 (m, 4 H), 2.40â2.13 (m, 8 H), 2.03â1.87 (m, 2 H), 1.56â1.27 (m, 4 H), 0.90â0.85 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>61</sub>FN<sub>9</sub>O<sub>9</sub> [M + H]<sup>+</sup>, 998.4576; found, 998.4586.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-Fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(4-methyl-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazin-7-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>3</b>)</h3><div class="NLM_p last">Compound <b>3</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.86â7.80 (m, 1 H), 7.75â7.74 (m, 1 H), 7.60â7.59 (m, 1 H), 7.32â6.89 (m, 6 H), 6.49â6.36 (m, 3 H), 5.22â5.15 (m, 2 H), 4.28 (d, <i>J</i> = 7.2 Hz, 1 H), 4.20 (d, <i>J</i> = 6.8 Hz, 1 H), 4.08 (s, 4 H), 3.87â3.85 (m, 4 H), 3.62 (s, 6 H), 3.35â3.30 (m, 2 H), 3.13 (s, 2 H), 2.73 (d, <i>J</i> = 3.2 Hz, 3 H), 2.49â2.47 (m, 2 H), 2.22â2.03 (m, 8 H), 1.55â1.33 (m, 4 H), 0.92â0.85 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>62</sub>FN<sub>10</sub>O<sub>9</sub> [M + H]<sup>+</sup>, 1013.4685; found, 1013.4699.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-Fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(5-methylthiophen-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>4</b>)</h3><div class="NLM_p last">To a solution of the compound <b>46d</b> (2.1 g, 2.32 mmol) in dry dioxane (8 mL) was added HClâdioxane (4 M, 6 mL) through syringe and stirred at 25 Â°C for 2 h, then concentrated and dried under high vacuum to give HCl salt of methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-fluoro-6-(5-methylthiophen-2-yl)-3-(2-((<i>S</i>)-pyrrolidin-2-yl)-1<i>H</i>-imidazol-4-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (1.87g, 98%). LC/MS calcd for [M + H]<sup>+</sup> C<sub>43</sub>H<sub>45</sub>FN<sub>8</sub>O<sub>5</sub>S: 805.3; found 805.4. To a mixture of the methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-fluoro-6-(5-methylthiophen-2-yl)-3-(2-((<i>S</i>)-pyrrolidin-2-yl)-1<i>H</i>-imidazol-4-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (500 mg, 0.62 mmol), (methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valine (108.5 mg, 0.62 mmol) and DIPEA (160 mg, 1.24 mmol) in DMF (3 mL) was added HATU (235.6 mg, 0.62 mmol). The resulting mixture was stirred at 25 Â°C for 2 h before the solution was applied to HPLC purification to afford the desired compound <b>4</b> (340 mg, 57%). <sup>1</sup>H NMR (MeOD) Î´: 8.02 (d, <i>J</i> = 4 Hz, 1H), 7.94 (s, 1H), 7.83 (s, 1H), 7.76 (d, <i>J</i> = 4 Hz, 1H), 7.52 (s, 2 H), 7.40â7.39 (m, 1 H), 7.32â7.31 (m, 1 H), 7.20 (s, 1 H), 6.52â6.49 (m, 2 H), 5.24â5.20 (m, 2 H), 4.29â4.27 (m, 2 H), 4.20â4.10 (m, 2 H), 3.97â3.90 (m, 4 H), 3.86 (s, 6 H), 3.55â3.45 (m, 2 H), 2.60â2.52 (m, 2 H), 2.32â2.01 (m, 11 H), 1.62â1.31 (m, 4 H), 0.92â0.85 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>50</sub>H<sub>57</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 962.4035; found, 962.4055.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Ethylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>5</b>)</h3><div class="NLM_p last">Compound <b>5</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.99 (s, 1 H), 7.88 (s, 1 H), 7.81 (s, 1 H), 7.73 (s, 1 H), 7.50â7.46 (m, 2 H), 7.37â7.34 (m, 1 H), 7.28 (s, 1 H), 7.16 (s, 1 H), 6.55â6.49 (m, 2 H), 5.24â5.16 (m, 4 H), 4.27 (d, <i>J</i> = 8.4 Hz, 1 H), 4.20 (d, <i>J</i> = 7.2 Hz, 1 H), 4.18â4.10 (m, 2 H), 4.07â3.70 (m, 5 H), 3.63 (s, 6 H), 3.40â3.29 (m, 2 H), 2.70â2.65 (m, 2 H), 2.60â2.53 (m, 2 H), 2.35â1.85 (m, 8 H), 1.65â1.34 (m, 4 H), 1.13 (t, <i>J</i> = 7.6 Hz, 3 H), 0.92â0.86 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>51</sub>H<sub>59</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 976.4191; found, 976.4222.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-Fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(5-propylthiophen-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>6</b>)</h3><div class="NLM_p last">Compound <b>6</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.01 (s, 1 H), 7.92 (s, 1 H), 7.82 (s, 1 H), 7.75 (s, 1 H), 7.51â7.49 (m, 2 H), 7.39â7.31 (m, 2 H), 7.20 (s, 1 H), 6.56â6.52 (m, 2 H), 5.24â5.20 (m, 2 H), 4.29â4.20 (m, 2 H), 4.13â4.10 (m, 2 H), 3.94â3.66 (m, 4 H), 3.65 (s, 5 H), 3.56â3.41 (m, 3 H), 2.66â2.64 (m, 2 H), 2.62â2.55 (m, 2 H), 2.28â2.26 (m, 2 H), 2.18â2.16 (m, 4 H), 2.05â2.03 (m, 2 H), 1.59â1.53 (m, 3 H), 1.51â1.34 (m, 3 H), 0.97â0.84 (m, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>52</sub>H<sub>61</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 990.4348; found, 990.4362.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-Fluoro-6-(5-isopropylthiophen-2-yl)-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>7</b>)</h3><div class="NLM_p last">Compound <b>7</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.01 (s, 1 H), 7.91 (s, 1 H), 7.83 (s, 1 H), 7.76 (s, 1 H), 7.55â7.53 (m, 2 H), 7.50â7.41 (m, 1 H), 7.38â7.30 (m, 1 H), 7.19â7.18 (m, 1 H), 6.61â6.53 (m, 2 H), 5.26â5.21 (m, 2 H), 4.32â4.24 (m, 2 H), 4.13â4.12 (m, 2 H), 3.96â3.88 (m, 4 H), 3.68 (s, 5 H), 3.43â3.32 (m, 2 H), 3.05â3.02 (m, 1 H), 2.58â2.55 (m, 2 H), 2.30â2.05 (m, 9 H), 1.65â1.56 (m, 1 H), 1.55â1.38 (m, 3 H), 1.20â1.19 (m, 6 H), 0.99â0.91 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>52</sub>H<sub>61</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 990.4348; found, 990.4361.</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.01 (s, 1 H), 7.93 (s, 1 H), 7.81 (s, 1 H), 7.75 (s, 1 H), 7.52â7.48 (m, 2 H), 7.40â7.37 (m, 1 H), 7.30 (s, 1 H), 7.19â7.18 (m, 1 H), 6.51â6.45 (m, 2 H), 5.23â5.18 (m, 2 H), 4.29â4.20 (m, 2 H), 4.13â4.10 (m, 2 H), 3.94â3.86 (m, 4 H), 3.66â3.65 (m, 6 H), 3.40â3.36 (m, 2 H), 2.55â2.54 (m, 2 H), 2.28â1.93 (m, 9 H), 1.59â1.34 (m, 4 H), 0.93â0.88 (m, 8 H), 0.55â0.53 (m, 2 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>52</sub>H<sub>59</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 988.4191; found, 988.4212.</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-(Difluoromethyl)thiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>9</b>)</h3><div class="NLM_p last">Compound <b>9</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.98 (d, <i>J</i> = 5.6 Hz, 2 H), 7.83 (s, 1 H), 7.74 (s, 1 H), 7.60â7.56 (m, 2 H), 7.40â7.29 (m, 2 H), 7.18 (s, 1 H), 7.17â7.06 (m, 1 H), 6.88 (t, <i>J</i> = 56 Hz, 1 H), 6.62 (m, 1 H), 5.25â5.16 (m, 2 H), 4.27â4.21 (m, 2 H), 4.19â4.08 (m, 2 H), 3.90â3.84 (m, 4 H), 3.64 (s, 6 H), 3.36â3.31 (m, 2 H), 2.54â2.50 (m, 2 H), 2.28â1.99 (m, 8 H), 1.56â1.35 (m, 4 H), 0.92â0.87 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>50</sub>H<sub>55</sub>F<sub>3</sub>N<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 998.3846; found, 998.3872.</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-Fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(5-(trifluoromethyl)thiophen-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.88 (m, 2 H), 7.53 (m, 1 H), 7.42 (m, 2 H), 7.36 (s, 1 H), 7.28 (m, 2H), 7.22 (m, 2H), 5.15 (m, 2 H), 4.30 (m, 1H), 4.22 (m, 1H), 3.83â4.14 (m, 4H), 3.65 (s, 6H), 3.46â3.36(m, 3H), 1.90â2.40 (m, 13H), 1.44â1.68 (m, 5H), 0.94 (m, 8 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>50</sub>H<sub>54</sub>F<sub>4</sub>N<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1016.3752; found, 1016.3757.</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(Benzo[<i>b</i>]thiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.83 (m, 1 H), 7.59 (m, 1 H), 7.09â7.49 (m, 6 H), 6.98 (m, 1 H), 5.15 (m, 2 H), 4.30 (m, 1H), 4.23(m, 1H), 3.85â4.09 (m, 4H), 3.65 (s, 6H), 2.73 (s, 2H), 2.52 (s, 2H), 1.73â2.42 (m, 13H), 1.22â1.68 (m, 10H), 0.94 (m, 8 H). LCMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>53</sub>H<sub>57</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 998.40; found, 999.21.</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5,6-Dihydro-4<i>H</i>-cyclopenta[<i>b</i>]thiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was prepared based on the same procedures as compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.90 (m, 2 H), 7.70 (m, 1 H), 7.59 (m, 1 H), 7.20â7.50 (m, 6 H),7.10 (s, 1 H), 6.80 (m, 2H), 5.15 (m, 2 H), 4.30 (m, 1H), 4.20 (m, 1H), 3.81â4.13 (m, 4H), 3.65 (s, 6H), 1.80â2.40 (m, 13H), 1.20â1.68 (m, 8H), 0.92 (m, 8 H). LCMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>52</sub>H<sub>59</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 988.41; found,989.20.</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Methyl ((<i>S</i>)-1-((<i>S</i>)-2-(5-((<i>S</i>)-6-(Chroman-7-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((<i>S</i>)-2-((methoxycarbonyl)amino)-2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.92 (s, 1 H), 7.80 (s, 1 H), 7.69 (s, 1 H), 7.46â7.42 (m, 2 H),7.29â7.25 (m, 2 H), 7.14 (s, 1 H), 7.09 (s, 1 H), 6.90 (s, 1 H), 6.43â6.44 (m, 1 H), 6.26 (s, 1 H), 5.23â5.15 (m, 2 H), 4.27â4.25 (m, 2 H), 4.24â4.22 (m, 2 H), 4.10â4.00 (m, 2 H), 3.88â3.86 (m, 4 H), 3.64 (s, 6 H), 3.34â3.31 (m, 2 H), 2.65â2.62 (m, 2 H), 2.55â2.51 (m, 2 H), 2.25â2.26 (m, 2 H), 2.19â2.11 (m, 4 H), 2.09â2.05 (m, 2 H), 1.86â1.83 (m, 2 H), 1.55 (s, 1 H), 1.36â1.34 (m, 3 H), 0.95â0.89 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>61</sub>FN<sub>9</sub>O<sub>9</sub> [M + H]<sup>+</sup>, 998.4576; found, 998.4570.</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Methyl ((<i>S</i>)-1-((<i>S</i>)-2-(5-((<i>S</i>)-1-Fluoro-3-(2-((<i>S</i>)-1-((<i>S</i>)-2-((methoxycarbonyl)amino)-2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(4-methyl-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazin-7-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.02 (s, 1 H), 7.88 (s, 1 H), 7.74 (s, 1 H), 7.48â7.46 (m, 1 H), 7.41 (s, 1 H), 7.33â7.31 (m, 2 H), 7.28â7.20 (m, 2 H), 6.54â6.52 (m, 1 H), 6.44â6.38 (m, 2 H), 5.26â5.16 (m, 2 H), 4.27â4.22 (m, 2H), 4.15â4.12 (m, 2 4), 3.93â3.85 (m, 5 H), 3.65 (s, 6 H), 3.19 (s, 2 H), 2.80 (s, 3 H), 2.58â2.53 (m, 2 H), 2.27â2.03 (m, 10 H), 1.33â1.31 (m, 5 H), 0.98â0.89 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>62</sub>FN<sub>10</sub>O<sub>9</sub> [M + H]<sup>+</sup>, 1013.4685; found, 1013.4720.</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Methyl ((1<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((2<i>R</i>)-2-methyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>15</b>)</h3><div class="NLM_p last">Compound <b>15</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.03 (s, 1 H), 7.91 (s, 1 H), 7.79â7.77 (m, 2 H), 7.56â7.54 (m, 1 H), 7.49â749 (m, 1 H), 7.39â7.37 (m, 1 H), 7.29 (s, 1 H), 7.17 (s, 1 H), 6.51â6.45 (m, 2 H), 5.29â5.19 (m, 2 H), 4.29â4.22 (m, 2H), 4.12â4.11 (m, 2 H), 3.95â3.87 (m, 3 H), 3.66 (s, 6 H), 3.42â3.35 (m, 2 H), 2.58â2.56 (m, 2 H), 2.27â1.94 (m, 9 H), 1.54 (s, 1 H), 1.37â1.31 (m, 2 H), 1.09â1.07 (m, 4 H), 0.94â0.89 (m, 8 H), 0.55â0.54 (m, 2 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>53</sub>H<sub>61</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1002.4348; found, 1002.4362.</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Methyl ((1<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((2<i>S</i>)-2-methyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>16</b>)</h3><div class="NLM_p last">Compound <b>16</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.02 (s, 1 H), 7.91 (s, 1 H), 7.80â7.76 (m, 2 H), 7.55â7.47 (m, 2 H), 7.40â7.37 (m, 1 H), 7.29 (s, 1 H), 7.18 (s, 1 H), 6.51â6.46 (m, 2 H), 5.26â5.19 (2 H), 4.30â4.22 (m, 2 H), 4.12â4.11 (m, 2 H), 3.92â3.86 (m, 3 H), 3.66 (s, 6 H), 3.41â3.36 (m, 2 H), 2.55 (s, 2 H), 2.28â1.94 (m, 9 H), 1.60 (s, 1 H), 1.38â1.33 (m, 2 H), 1.30â0.89 (m, 12 H), 0.55â0.54 (d, <i>J</i> = 4.8 Hz, 2 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>53</sub>H<sub>61</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1002.4348; found, 1002.4367.</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Methyl ((1<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((2<i>R</i>,6<i>S</i>)-2,6-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>17</b>)</h3><div class="NLM_p last">Compound <b>17</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.06 (s, 1 H), 7.91 (s, 1 H), 7.80 (s, 1 H), 7.74 (s, 1 H), 7.57â7.55 (m, 1 H), 7.49â7.46 (m, 1 H), 7.39â7.36 (m, 1 H), 7.30 (s, 1 H), 7.18â7.17 (m, 1 H), 6.51â6.45 (m, 2 H), 5.36â5.33 (m, 1 H), 5.20 (s, 1 H), 4.29 (d, <i>J</i> = 8 Hz, 1 H), 4.21 (d, <i>J</i> = 8 Hz, 1 H), 4.11â4.08 (m, 2 H), 3.85â3.83 (m, 2 H), 3.65 (s, 3 H), 3.59 (s, 3 H), 3.55â3.48 (m, 2 H), 2.56â2.52 (m, 2 H), 2.20â1.93 (m, 9 H), 1.76â1.73 (m, 1 H), 1.60â1.57 (m, 1 H), 1.17 (d, <i>J</i> = 6 Hz, 6 H), 1.07â0.88 (m, 10 H), 0.55â0.53 (m, 2 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>63</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1016.4504; found, 1016.4539.</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((2<i>R</i>,6<i>R</i>)-2,6-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>18</b>)</h3><div class="NLM_p last">Compound <b>18</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.03 (s, 1 H), 7.91 (s, 1 H), 7.80â7.79 (m, 2 H), 7.52â7.47 (m, 2 H), 7.38â7.35 (m, 1 H), 7.30 (s, 1 H), 7.18 (s, 1 H), 6.49â6.44 (m, 2 H), 5.22â5.18 (m, 2 H), 4.19â4.15 (m, 4 H), 4.08â4.07 (m, 1 H), 3.85â3.81 (m, 2 H), 3.38 (d, <i>J</i> = 11 Hz, 6 H), 2.57â2.53 (m, 2 H), 2.24â2.15 (m, 6 H), 2.13â1.93 (m, 2 H), 1.59â1.54 (m, 1 H), 1.43â1.42 (m, 1 H), 1.26â1.18 (m, 4 H), 1.10 (s, 1 H), 1.00â0.96 (m, 4 H), 0.91â0.87 (m, 8 H), 0.53 (d, <i>J</i> = 4 Hz, 2 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>63</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1016.4504; found, 1016.4554.</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Methyl ((1<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((2<i>R</i>,6<i>S</i>)-2,6-diethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>19</b>)</h3><div class="NLM_p last">Compound <b>19</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.02 (s, 1 H), 7.91 (s, 1 H), 7.78â7.76 (m, 2 H), 7.54â7.51 (m, 2 H), 7.37â7.35 (m, 1 H), 7.28 (s, 1 H), 7.17 (s, 1 H), 6.49â6.45 (m, 2 H), 5.22â5.19 (m, 2 H), 4.26â4.20 (m, 2 H), 4.19â4.09 (m, 2 H), 3.86â3.83 (m, 2 H), 3.64 (s, 6 H), 3.12â3.11 (m, 2 H), 2.55â2.54 (m, 2 H), 2.25â2.14 (m, 6 H), 2.03â1.92 (m, 3 H), 1.44â1.29 (m, 6 H), 0.96â0.78 (m, 16 H), 0.53â0.51 (m, 2 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>56</sub>H<sub>67</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1044.4817; found, 1044.4835.</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((<i>S</i>)-2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.00 (s, 1 H), 7.90 (s, 1 H), 7.79 (s, 1 H), 7.75 (s, 1 H), 7.51â7.47 (m, 2 H), 7.38â7.35 (m, 1 H), 7.18 (d, <i>J</i> = 3 Hz, 1 H), 6.50â6.44 (m, 2 H), 5.23â5.18 (m, 2 H), 4.20â4.16 (m, 4 H), 3.86â3.82 (m, 2 H), 3.64â3.57 (m, 8 H), 2.55â2.53 (m, 2 H), 2.26â2.11 (m, 8 H), 2.01â1.93 (m, 1 H), 1.62â1.59 (m, 1 H), 1.28â1.04 (m, 10 H), 0.97â0.86 (m, 8 H), 0.55â0.51 (m, 2 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>63</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1016.4504; found, 1016.4490.</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((<i>R</i>)-2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>21</b>)</h3><div class="NLM_p">To a mixture of <b>76h</b> (120 mg, 0.15 mmol), (<i>S</i>)-2-((<i>R</i>)-2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetic acid (<b>52g</b>, 37 mg, 0.15 mmol) and HATU (58 mg, 0.15 mmol) in DMF (4 mL) was added DIPEA (39 mg, 0.30 mmol). The resulting mixture was stirred at 20 Â°C overnight, and the reaction solution was subjected directly to reverse phase HPLC purification to afford <b>21</b> (81 mg, 53%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 8.23â8.21 (m, 2 H), 8.13 (s, 1 H), 7.99 (s, 1 H), 7.75â7.73 (m, 2 H), 7.67â7.66 (m, 2 H), 7.26â7.22 (m, 2 H), 7.10 (s, 1 H), 6.56â6.55 (m, 2 H), 5.18â5.16 (m, 2 H), 3.98â4.22 (m, 4 H), 3.82 (s, 1 H), 3.62â3.54 (m, 2 H), 3.51â3.49 (m, 10 H), 2.19â2.44 (m, 7 H), 2.18â2.08 (m, 1 H), 1.94â2.06 (m, 3 H), 1.25â1.08 (m, 12 H), 0.89â0.84 (m, 6 H), 0.77 (d, <i>J</i> = 2 Hz, 3 H), 0.53â0.51 (m, 2 H). <sup>13</sup>C NMR: (DMSO-<i>d</i><sub>6</sub>) Î´: 170.91, 170.33, 159.34, 157.68, 156.88, 150.53, 149.98, 149.94, 149.84, 148.65, 135.01, 134.06, 133.06, 128.55, 127.06, 125.79, 121.80, 121.29, 120.19, 118.13, 116.52, 113.55, 110.97, 107.22, 107.07, 102.37, 80.07, 70.74, 60.09, 57.84, 56.89, 52.90, 51.54, 51.49, 47.15, 38.21, 32.21, 31.58, 31.51, 31.03, 30.94, 28.93, 27.17, 24.97, 24.85, 22.11, 19.52, 17.70, 10.71, 9.90, 9.88. HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>64</sub>FN<sub>9</sub>O<sub>8</sub>S [M+2H]<sup>2+</sup>: 508.7277; found 508.7286.</div><div class="NLM_p last">The absolute stereochemistry of the aminal carbon of <b>21</b> was determined to be â<i>S</i>â in a different synthetic scheme, by which <b>21</b> was prepared from (6<i>S</i>)-3-bromo-10-chloro-6-(5-cyclopropylthiophen-2-yl)-1-fluoro-12,12a-dihydro-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole, whose stereochemistry was determined by vibrational circular dichroism (VCD) spectroscopy with confidence.</div></div><div id="sec5_2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Methyl ((1<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(4-oxaspiro[2.5]octan-7-yl)ethyl)carbamate (<b>22</b>)</h3><div class="NLM_p last">Compound <b>22</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´: 8.11 (s, 1 H), 8.04 (s, 1 H), 7.97 (s, 1 H), 7.70â7.68 (m, 1 H), 7.59â7.53 (m, 2 H), 7.45â7.42 (m, 1 H), 7.30 (d, <i>J</i> = 8 Hz, 1 H), 7.10 (s, 1 H), 6.55â6.54 (m, 1 H), 6.48 (s, 1 H), 5.14â5.08 (m, 2 H), 4.23â4.20 (m, 1 H), 4.12â4.08 (m, 1 H), 3.87â3.54 (m, 10 H), 3.37â3.31 (m, 2 H), 2.50â2.42 (m, 1 H), 2.41â2.29 (m, 1 H), 2.14â2.02 (m, 4 H), 1.99â1.96 (m, 5 H), 1.82 (m, 1 H), 1.43â1.23 (m, 3 H), 0.90â0.87 (m, 5 H), 0.86â0.75 (m, 3 H), 0.64â0.63 (m, 1 H), 0.52â0.51 (m, 2 H), 0.50â0.45 (m, 2 H), 0.08 (s, 1 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>61</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1014.4348; found, 1014.4390.</div></div><div id="sec5_2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Methyl ((1<i>S</i>)-1-(8-Oxabicyclo[3.2.1]octan-3-yl)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)carbamate (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´: 8.34 (s, 1 H), 8.24â8.21 (m, 2 H), 8.00 (s, 1 H), 7.83â7.81 (m, 1 H), 7.78â7.76 (m, 2 H), 7.49 (s, 1 H), 7.26 (d, <i>J</i> = 8 Hz, 1 H), 7.25â7.23 (s, 1 H), 7.13 (s, 1 H), 5.17â5.13 (m, 2 H), 4.17â4.13 (m, 2 H), 4.11â4.00 (m, 2 H), 3.98â3.82 (m, 3 H), 3.61â3.47 (m, 6 H), 3.12â3.09 (m, 1 H), 2.49â2.38 (m, 2 H), 2.36â2.24 (m, 5 H), 2.20â2.18 (m, 1 H), 2.09â2.00 (m, 2 H), 1.22â1.15 (m, 4 H), 1.14â1.12 (m, 8 H), 1.09â1.05 (m, 5 H), 0.83â0.81 (m, 3 H), 0.75â0.73 (m, 3H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>61</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1014.4348; found, 1014.4337.</div></div><div id="sec5_2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(2,2,6,6-tetramethyltetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.03 (s, 1 H), 7.56 (s, 1 H), 7.79 (s, 2 H), 7.54â7.52 (m, 1 H), 7.48â7.46 (m, 1 H), 7.43â7.37 (m, 1 H), 7.35â7.29 (m, 1 H), 7.17â7.16 (m, 1 H), 6.50â6.43 (m, 2 H), 5.26â5.18 (m, 2 H), 4.21â4.4.17 (m, 3 H), 4.16â4.15 (m, 1 H), 3.85 (s, 2 H), 3.65â3.64 (m, 6 H), 3.39â3.29 (m, 2 H),2.56â2.50 (m,2 H), 2.25â2.22 (m, 4 H), 2.16â2.14 (m, 3 H), 2.04â2.03 (m, 1 H), 1.94â1.93 (m, 1 H), 1.70â1.65 (m, 1 H), 1.24â1.03 (m, 13 H), 0.92â0.87 (m, 8 H), 0.54â0.53 (m, 2 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>56</sub>H<sub>67</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1044.4817; found, 1044.4840.</div></div><div id="sec5_2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(Chroman-7-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((<i>R</i>)-2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>25</b>)</h3><div class="NLM_p last">Compound <b>25</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.08 (s, 1 H), 7.92 (s, 1 H), 7.76 (s, 1 H), 7.53â7.51 (m, 2 H), 7.35â7.27 (m, 3 H), 7.16 (s, 1 H), 6.91 (d, <i>J</i> = 8 Hz, 1 H), 6.43â6.41 (m, 1 H), 6.30 (s, 1 H), 5.25â5.19 (m, 2 H), 4.23 (s, 2 H), 4.22â3.89 (m, 7 H), 3.69â3.65 (m, 6 H), 3.38â3.35 (m, 2 H),2.66â2.49 (m, 5 H), 2.29â2.15 (m, 9 H), 1.87 (s, 2 H), 1.53â1.51 (m, 1 H), 1.12â1.10 (m, 6 H), 0.93â0.87 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>56</sub>H<sub>65</sub>FN<sub>9</sub>O<sub>9</sub> [M + H]<sup>+</sup>, 1026.4889; found, 1026.4894.</div></div><div id="sec5_2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Methyl ((1<i>S</i>)-1-((<i>R</i>)-2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((2S)-2-(5-((6S)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(2-methylchroman-7-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)carbamate (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.08 (m, 1 H), 7.91 (m, 1 H), 7.81 (m, 1 H), 7.62 (m, 2 H), 7.40â7.18 (m, 4 H), 6.96 (m, 1 H), 6.48 (m, 1 H), 6.24 (m, 1 H), 5.21 (m, 1 H), 4.22â3.78 (m, 8 H), 3.66 (m, 6 H), 2.75â2.56 (m, 3 H), 2.38â1.82 (m, 9 H), 1.65 (m, 2 H), 1.32â0.86 (m, 21H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>57</sub>H<sub>67</sub>FN<sub>9</sub>O<sub>9</sub> [M + H]<sup>+</sup>, 1040.5046; found, 1040.5046.</div></div><div id="sec5_2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Methyl ((<i>S</i>)-1-((<i>R</i>)-2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-ethylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)carbamate (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.03 (s, 1 H), 7.89 (s, 1 H), 7.82 (s, 1 H), 7.77 (s, 1 H), 7.52 (m, 2 H), 7.36 (m, 2 H), 7.17 (d, <i>J</i> = 7.2 Hz, 1 H), 6.54â6.48 (m, 2H), 5.22 (m, 2 H), 4.20â4.06 (m, 4 H), 3.85 (m, 2 H), 3.66 (m, 8 H), 2.64 (q, <i>J</i> = 8.0 Hz, 2 H), 2.52 (m, 2 H), 2.28â1.98 (m, 8 H), 1.54 (m, 1 H), 1.23â1.04 (m, 12 H), 0.89 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>53</sub>H<sub>63</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1004.4504; found, 1004.4503.</div></div><div id="sec5_2_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Methyl ((<i>S</i>)-1-((<i>R</i>)-2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(5-propylthiophen-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)carbamate (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was prepared based on the same procedures as compound <b>21</b>. HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>65</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1018.4661; found, 1018.4680.</div></div><div id="sec5_2_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Methyl ((<i>S</i>)-1-((<i>R</i>)-2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-fluoro-6-(5-isopropylthiophen-2-yl)-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)carbamate (<b>29</b>)</h3><div class="NLM_p last">Compound <b>29</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.02 (s, 1 H), 7.93 (s, 1 H), 7.85 (s, 1 H), 7.77 (s, 1 H), 7.52 (m, 2 H), 7.40â7.33 (m, 2 H), 7.22 (s, 1 H), 6.59â6.52 (m, 2 H), 5.22 (m, 2 H), 4.21â4.08 (m, 4 H), 3.87â3.65 (m, 10 H), 3.41 (m, 1 H), 3.02 (m, 1 H), 2.48 (m, 2 H), 2.28â2.04 (m, 9 H), 1.85 (m, 1 H), 1.63 (m, 1 H), 1.31â1.17 (m, 12 H), 0.88 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>65</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1018.4661; found, 1018.4698.</div></div><div id="sec5_2_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5,6-Dihydro-4<i>H</i>-cyclopenta[<i>b</i>]thiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((<i>R</i>)-2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>30</b>)</h3><div class="NLM_p last">Compound <b>30</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.06 (s, 1 H), 7.96 (s, 1 H), 7.81â7.87 (m, 2 H), 7.57â7.51 (m, 2 H), 7.39â7.32 (m, 2 H), 7.19 (s, 1 H), 6.33 (s, 1 H), 5.21 (m, 2 H), 4.19â3.83 (m, 7 H), 3.64 (s, 6 H), 2.72 (m, 2 H), 2.52 (m, 4 H), 2.32â2.15 (m, 8 H), 1.58 (m, 1 H), 1.27â0.86 (m, 18 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>63</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1016.4504; found, 1016.4545.</div></div><div id="sec5_2_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Methyl ((<i>S</i>)-1-((<i>R</i>)-2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(2-ethylthiazol-5-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)carbamate (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.02 (m, 2 H), 7.92 (1, 1 H), 7.76 (s, 1 H), 7.62 (m, 2 H), 7.43â7.31 (m, 2 H), 7.20 (m, 2 H), 5.22 (m, 2 H), 4.23â4.19 (m, 4 H), 3.88 (m, 2 H), 3.66 (m, 8 H), 3.42 (m, 1 H), 2.86 (q, <i>J</i> = 7.6 Hz, 2 H), 2.56 (m, 2 H), 2.27â2.16 (m, 8 H), 1.65 (m, 1 H), 1.22â1.14 (m, 11 H), 0.89 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>52</sub>H<sub>62</sub>FN<sub>10</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1005.4457; found, 1005.4467.</div></div><div id="sec5_2_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Methyl ((<i>S</i>)-1-((<i>R</i>)-2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(2-propylthiazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)carbamate (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.02 (m, 2 H), 7.91 (s, 1 H), 7.62 (s, 1 H), 7.59 (m, 2 H), 7.43â7.34 (m, 2 H), 7.22 (m, 2 H), 5.22 (m, 2 H), 4.23â4.19 (m, 4 H), 3.88 (m, 2 H), 3.66 (m, 8 H), 2.82 (m, 2 H), 2.55 (m, 2 H), 2.27â2.16 (m, 8 H), 1.64 (m, 3 H), 1.28â1.14 (m, 8 H), 0.93â0.85 (m, 10 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>53</sub>H<sub>64</sub>FN<sub>10</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1019.4613; found, 1019.4628.</div></div><div id="sec5_2_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Methyl ((<i>S</i>)-1-((<i>R</i>)-2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-fluoro-6-(2-isopropylthiazol-5-yl)-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)carbamate (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.34 (s, 1 H), 8.21 (m, 1 H), 8.01 (s, 1 H), 7.83â7.70 (m, 3 H), 7.49 (s, 1 H), 7.24â7.13 (m, 2 H), 5.24 (m, 2 H), 4.17â3.98 (m, 4 H), 3.82â3.49 (m, 8 H), 3.12 (m, 1 H), 2.51 (m, 6 H), 2.38â2.02 (m, 9 H), 1.22â1.06 (m, 15 H), 0.83â0.73 (m, 5 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>53</sub>H<sub>64</sub>FN<sub>10</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1019.4613; found, 1019.4666.</div></div><div id="sec5_2_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(2-Cyclopropylthiazol-5-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((<i>R</i>)-2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.80 (s, 2 H), 7.54- 7.43 (m, 3 H), 7.28 (m, 2 H), 7.12â6.90 (m, 3 H), 5.20 (m, 2 H), 4.23 (m, 2 H), 4.08 (m, 2 H), 3.89 (m, 2 H), 3.60 (s, 6 H), 2.45â1.92 (m, 12 H), 1.58 (m, 1 H), 1.27â0.84 (m, 20 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>53</sub>H<sub>62</sub>FN<sub>10</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1017.4457; found, 1017.4453.</div></div><div id="sec5_2_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5,6-Dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazol-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-1-((<i>R</i>)-2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-oxoethyl)carbamate (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 8.06 (s, 1 H), 7.96 (s, 1 H), 7.78 (m, 1 H), 7.53 (m, 2 H), 7.32 (m, 2 H), 7.19 (m, 1 H), 6.33 (s, 1 H), 5.22 (m, 2 H), 4.19â4.08 (m, 4 H), 3.85 (m, 2 H), 3.63 (m, 6 H), 2.72 (m, 2 H), 2.52 (m, 4 H), 2.32â1.92 (m, 9 H), 1.58 (m, 1 H), 1.27â0.86 (m, 18 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>53</sub>H<sub>62</sub>FN<sub>10</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1017.4457; found, 1017.4486.</div></div><div id="sec5_2_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl ((<i>S</i>)-1-((<i>S</i>)-2-(5-((<i>S</i>)-3-(2-((<i>S</i>)-1-((<i>S</i>)-2-((<i>R</i>)-2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(5-ethylthiophen-2-yl)-1-fluoro-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.99 (s, 1 H), 7.89 (m, 2 H), 7.81 (s, 1 H), 7.74 (s, 1 H), 7.51â7.41 (m, 2 H), 7.35â7.18 (m, 3 H), 6.49 (m, 2 H), 5.22 (m, 2 H), 4.26â4.08 (m, 4 H), 3.84 (m, 2 H), 3.67 (m, 7 H), 2.72â2.48 (m, 4 H), 2.18â2.02 (m, 8 H), 1.60 (m, 1 H), 1.27â1.04 (m, 12 H), 0.91 (m, 6 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>53</sub>H<sub>63</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1004.4504; found, 1004.4541.</div></div><div id="sec5_2_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Methyl ((<i>S</i>)-1-((<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-3-(2-((<i>S</i>)-1-((<i>S</i>)-2-((<i>R</i>)-2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-1-fluoro-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> was prepared based on the same procedures as compound <b>21</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 7.94 (s, 1 H), 7.87 (s, 1H), 7.71â7.68 (m, 2 H), 7.48â7.12 (m, 5 H), 6.51 (m, 1 H), 5.22 (m, 2 H), 4.21 (m, 2 H), 4.08 (m, 2 H), 3.84 (m, 2 H), 3.64 (m, 8 H), 2.52 (m, 2 H), 2.26â2.06 (m, 8 H), 1.82 (m, 1 H), 1.55 (m, 1 H), 1.21â0.86 (m, 18 H), 0.51 (m, 2 H). HRMS (ESI+) <i>m</i>/<i>z</i> calcd for C<sub>54</sub>H<sub>63</sub>FN<sub>9</sub>O<sub>8</sub>S [M + H]<sup>+</sup>, 1016.4504; found, 1016.4510.</div></div><div id="sec5_2_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>S</i>)-10-Bromo-3-chloro-1-fluoro-6-(5-methylthiophen-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole (<b>40d</b>)</h3><div class="NLM_p last">To a solution of 2-(5-bromoindolin-2-yl)-5-chloro-3-fluorophenol<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<b>38</b>, 10 g, 29 mmol) and 5-methylthiophene-2-carbaldehyde (<b>39a</b>, 4.4 g, 35 mmol) in MeCN (50 mL) was added TFA (990 mg, 8.7 mmol), and the mixture was stirred at 25 Â°C for 1 h. Solid appeared. The solid was collected by filtration, washed with MeCN, dried under vacuum to give 10-bromo-3-chloro-1-fluoro-6-(5-methylthiophen-2-yl)-12,12a-dihydro-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole as white solid (11.0 g, 85%). To the solution of compound 10-bromo-3-chloro-1-fluoro-6-(5-methylthiophen-2-yl)-12,12a-dihydro-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole (11 g, 24.4 mmol) in dry toluene (100 mL) was added DDQ (8.3 g, 36.6 mmol). After refluxing for 2 h under N<sub>2</sub>, the reaction mixture was concentrated and diluted with EtOAc. The organic layer was washed with saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> aqueous solution, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude mixture was washed with MeOH (20 mL) and filtered to give 10-bromo-3-chloro-1-fluoro-6-(5-methylthiophen-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole (10.0 g, 92%). LC/MS calcd for C<sub>20</sub>H<sub>12</sub>BrClFNOS [M + H]<sup>+</sup>: 450.0; found 450.0. 10-Bromo-3-chloro-1-fluoro-6-(5-methylthiophen-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole (5.9 g) was separated by chiral SFC to give <b>40d</b> (2.9 g, 49% yield) and another isomer. LC/MS calcd for [M + H]<sup>+</sup> C<sub>20</sub>H<sub>12</sub>BrClFNOS: 450.0; found 450.0. SFC conditions: column, Chiralpak AS-H 150 mm Ã 4.6 mm i.d., 5 Î¼m; mobile phase, methanol (0.05% DEA) in CO<sub>2</sub> from 5% to 40%; flow rate, 3 mL/min; wavelength, 220 nm.</div></div><div id="sec5_2_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>S</i>)-3-Chloro-1-fluoro-6-(5-methylthiophen-2-yl)-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole (<b>41d</b>)</h3><div class="NLM_p last">A suspension of <b>40d</b> (5.9 g, 13.1 mmol), bis(pinacolato)diboron (4 g, 15.8 mmol), KOAc (2.6 g, 26.2 mmol), and Pd(dppf)Cl<sub>2</sub> (0.48 g, 0.655 mmol) in dioxane (120 mL) was degassed and stirred at 100 Â°C under N<sub>2</sub> for 2 h. The reaction mixture was cooled and concentrated. EtOAc and saturated aqueous NaHCO<sub>3</sub> were added. The organic layer was separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The product was purified by chromatographed on silica gel (petroleum ether/EtOAc from 100:1 to 20:1) to give <b>41d</b> (6.0 g, 92%). LC/MS calcd for C<sub>26</sub>H<sub>25</sub>BClFNO<sub>3</sub>S [M + H]<sup>+</sup>: 496.1; found 496.2.</div></div><div id="sec5_2_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-3-Chloro-1-fluoro-6-(5-methylthiophen-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>43d</b>)</h3><div class="NLM_p last">A suspension of <b>41d</b> (3.5 g, 7.06 mmol), <b>42</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (3.2 g, 7.77 mmol), Na<sub>2</sub>CO<sub>3</sub> (1.5 g, 14.12 mmol), and Pd(dppf)Cl<sub>2</sub> (258 mg, 0.35 mmol) in THF/H<sub>2</sub>O (36 mL, 5:1) was degassed, filled with N<sub>2</sub>, and stirred at 100 Â°C under N<sub>2</sub> overnight. The reaction mixture was cooled and concentrated. EtOAc and saturated aqueous NaHCO<sub>3</sub> were added. The organic layer was separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The product was purified by chromatography on silica gel (petroleum ether/ethyl acetate = 1/5 to DCM/MeOH 50/1) to give <b>43d</b> (4.5 g, 90.6%). LC/MS calcd for C<sub>36</sub>H<sub>36</sub>ClFN<sub>5</sub>O<sub>5</sub>S [M + H]<sup>+</sup>: 704.2; found 704.2.</div></div><div id="sec5_2_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Methyl ((<i>S</i>)-2-((<i>S</i>)-2-(5-((<i>S</i>)-1-Fluoro-6-(5-methylthiophen-2-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-2-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethyl)carbamate (<b>44d</b>)</h3><div class="NLM_p last">To a 50 mL flask was added <b>43d</b> (1.0 g, 1.42 mmol), bis(pinacolato)diboron (397 mg, 1.56 mmol), KOAc (278 mg, 2.84 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (130 mg, 0.14 mmol), and X-Phos (135 mg, 0.284 mmol). The flask was degassed, filled with N<sub>2</sub>, and dry dioxane (12 mL) was added. The mixture was stirred at 100 Â°C under N<sub>2</sub> overnight. The reaction mixture was cooled and concentrated. EtOAc, and saturated aqueous NaHCO<sub>3</sub> was added. The organic layer was separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The product was purified by chromatographed on silica gel (DCM/MeOH from 100:1 to 50:1) to afford the <b>44d</b> (0.79 g, 70%). LC/MS calcd for C<sub>42</sub>H<sub>48</sub>BFN<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup>: 796.3; found 796.4.</div></div><div id="sec5_2_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>tert</i>-Butyl (<i>S</i>)-2-(4-((<i>S</i>)-1-Fluoro-10-(2-((<i>S</i>)-1-((<i>S</i>)-2-((methoxycarbonyl)amino)-2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6-(5-methylthiophen-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-3-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidine-1-carboxylate (<b>46d</b>)</h3><div class="NLM_p last">A suspension of the <b>44d</b> (3.5 g, 4.4 mmol), <i>tert</i>-butyl (<i>S</i>)-2-(4-bromo-1<i>H</i>-imidazol-2-yl)pyrrolidine-1-carboxylate<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<b>45</b>, 1.7 g, 5.28 mmol), Na<sub>2</sub>CO<sub>3</sub> (933 mg, 8.8 mmol), and Pd(dppf)Cl<sub>2</sub> (161 mg, 0.22 mmol) in THF/H<sub>2</sub>O (48 mL, 5:1) was degassed and stirred at 100 Â°C under N<sub>2</sub> overnight. The reaction mixture was cooled and concentrated. EtOAc and saturated aqueous NaHCO<sub>3</sub> were added. The organic layer was separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The product was purified by chromatographed on silica gel (DCM/MeOH from 100:1 to 50:1) to give the <b>46d</b> (2.1 g, 53%). LC/MS calcd for C<sub>48</sub>H<sub>54</sub>FN<sub>8</sub>O<sub>7</sub>S [M + H]<sup>+</sup>: 905.4; found 905.5.</div></div><div id="sec5_2_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (<i>R</i>)-2-Methyltetrahydro-4<i>H</i>-pyran-4-one (<b>47a</b>)</h3><div class="NLM_p last">To a solution of <b>61</b> (180 g, 789 mmol) in chloroform (500 mL) was added Amberlyst 15 resin (100 g). The mixture was stirred at 25 Â°C overnight. The mixture was filtered and the filtrate was concentrated to give crude <b>47a</b> which was used for the next step without further purification.</div></div><div id="sec5_2_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (2<i>R</i>,6<i>S</i>)-2,6-Dimethyltetrahydro-4<i>H</i>-pyran-4-one (<b>47c</b>)</h3><div class="NLM_p last">To a solution of <b>63</b> (74.7 g, 0.57 mol) in DCM (750 mL) was added a solution of NaHCO<sub>3</sub> (4.83 g, 57 mmol) and KBr (6.84 g, 57 mmol) in water (200 mL). TEMPO (0.9 g, 5.7 mmol) was added. The mixture was treated at 0 Â°C under vigorous stirring with aqueous NaClO solution (47.1 g, 0.63 mol, 5% to 7%) added over a period of 1 h. The reaction mixture was stirred at 25 Â°C for another 5 h, and the aqueous layer was extracted with DCM. The organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and the solvent evaporated to give <b>47c</b> as pale yellow oil (72.2 g, 99%). <sup>1</sup>H NMR: (CDCl<sub>3</sub>) Î´: 3.75â3.70 (m, 2 H), 2.33 (d, <i>J</i> = 16 Hz, 2 H), 2.19 (t, <i>J</i> = 24 Hz, 2 H), 1.31 (d, <i>J</i> = 6 Hz, 6 H).</div></div><div id="sec5_2_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 4-Oxaspiro[2.5]octan-7-one (<b>47h</b>)</h3><div class="NLM_p last">To a solution of <b>67</b> (4.8 g, 20 mmol) in DCM (20 mL) was added Amberlyst 15 (2 g). The mixture was refluxed for 4 h, filtered, and the filtrate was concentrated to give <b>47h</b> (2.5 g, 100%). <sup>1</sup>H NMR: (CDCl<sub>3</sub>) Î´: 3.86 (t, <i>J</i> = 5.6 Hz, 2 H), 2.43â2.46 (m, 2 H), 2.38 (s, 2 H), 0.74â0.76 (m, 2 H), 0.40â0.41 (m, 2 H).</div></div><div id="sec5_2_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 8-Oxabicyclo[3.2.1]octan-3-one (<b>47i</b>)</h3><div class="NLM_p last">To a solution of <b>69</b> (26.1 g, 93 mmol) in MeOH (30 mL) was added Zn powder (36.3 g, 558 mmol), CuCl (4.6 g, 46.5 mmol), and NH<sub>4</sub>Cl (34.5 g, 0.64 mol) in MeOH (80 mL). The reaction mixture was maintained below 15 Â°C during reagent addition. The mixture was stirred at 25 Â°C for 19 h. The reaction mixture was concentrated. EtOAc and saturated aqueous NaHCO<sub>3</sub> were added. The organic layer was separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give <b>47i</b> (3.5 g, 30.4% yield). <sup>1</sup>H NMR: (CDCl<sub>3</sub>) Î´: 6.23 (s, 2 H), 5.00 (d, <i>J</i> = 5.2 Hz, 2 H), 2.73 (dd, <i>J</i> = 16.4, 4.8 Hz, 2 H), 2.32 (d, <i>J</i> = 16.4 Hz, 2 H).</div></div><div id="sec5_2_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Methyl 2-(((Benzyloxy)carbonyl)amino)-2-(2,2-dimethyltetrahydro-4<i>H</i>-pyran-4-ylidene)acetate (<b>49f</b>)</h3><div class="NLM_p last">To a solution of <b>48</b> (1.163 g, 3.52 mmol) in dry DCM (20 mL) at 0 Â°C was added DBU (0.534 g, 3.52 mmol) followed by a solution of <b>47f</b> (1.8 g, 14.08 mmol) in dry DCM (20 mL) dropwise. The reaction mixture was stirred at 25 Â°C for 3 days. After removal of the solvent, the residue was purified by SiO<sub>2</sub> chromatography (petroleum ether/ethyl acetate = 5:1 to 3:1) to afford <b>49f</b> as white solid (0.15 g, 13% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>): Î´ 7.30â7.35 (m, 5 H), 5.11 (s, 2 H), 3.82â3.88 (m, 3 H), 3.09â3.16 (m, 2 H), 1.84 (s, 2 H), 1.48 (s, 2 H).</div></div><div id="sec5_2_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Methyl 2-Amino-2-(2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)acetate (<b>50f</b>)</h3><div class="NLM_p last">To a solution of <b>49f</b> (3 g, 9.01 mmol) in MeOH (100 mL) was added Pd/C (0.6 g) carefully under N<sub>2</sub>. The reaction mixture was stirred at 25 Â°C under H<sub>2</sub> (45 psi) for 3 h. Pd/C was filtered and the solvent was removed to give <b>50f</b> as colorless oil (1.8 g, 99% yield). LC/MS calcd for C<sub>10</sub>H<sub>20</sub>NFO<sub>3</sub> [M + H]<sup>+</sup>: 202.1; found, 202.1.</div></div><div id="sec5_2_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Methyl 2-(2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetate (<b>51f</b>)</h3><div class="NLM_p last">To a solution of <b>50f</b> (1.7 g, 8.46 mmol) in dry DCM (40 mL) were added DIPEA (1.65 g, 12.69 mmol) and methyl chloroformate (0.964 g, 10.15 mmol) dropwise at 0 Â°C. The reaction solution was stirred at 25 Â°C for 2 h. Water and DCM were added. The organic phase was separated, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give <b>51f</b> as colorless oil (1.9 g, 87% yield). LC/MS calcd for C<sub>12</sub>H<sub>22</sub>NFO<sub>5</sub> [M + H]<sup>+</sup>: 260.1; found, 260.2.</div></div><div id="sec5_2_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (<i>S</i>)-2-((Methoxycarbonyl)amino)-2-((2<i>R</i>,4<i>S</i>)-2-methyltetrahydro-2<i>H</i>-pyran-4-yl)acetic Acid (<b>52a</b>)</h3><div class="NLM_p last">2-((Methoxycarbonyl)amino)-2-((2<i>R</i>)-2-methyltetrahydro-2<i>H</i>-pyran-4-yl)acetic acid (10 g, prepared by following a similar procedures as <b>52f</b>) was separated by SFC by the following conditions to give four diastereomers. <b>52a</b> (2 g, 20% yield) is the first eluted peak. LC/MS calcd for C<sub>10</sub>H<sub>17</sub>NO<sub>5</sub> [M + H]<sup>+</sup>: 232.11; found 232.1. SFC conditions: column, AS-H 250 mm Ã 4.0 mm, mobile phase, 35% MeOH (0.05% DEA) in CO<sub>2</sub>. Flow rate: 2.35 mL/min. The absolute stereochemistry was assigned arbitrarily except the chiral center introduced from the starting material.</div></div><div id="sec5_2_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (<i>S</i>)-2-((Methoxycarbonyl)amino)-2-((2<i>S</i>,4<i>S</i>)-2-methyltetrahydro-2<i>H</i>-pyran-4-yl)acetic Acid (<b>52b</b>)</h3><div class="NLM_p last">2-((Methoxycarbonyl)amino)-2-((2<i>S</i>)-2-methyltetrahydro-2<i>H</i>-pyran-4-yl)acetic acid (prepared by following a similar procedures as <b>52f</b>) was separated by chiral SFC by using the same conditions as <b>52a</b>. Four diastereomers were obtained, and <b>52b</b> is the first eluted peak in SFC. The absolute stereochemistry was assigned arbitrarily except the chiral center introduced from the starting material.</div></div><div id="sec5_2_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (2<i>S</i>)-2-(<i>cis</i>-2,6-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetic Acid (<b>52c</b>)</h3><div class="NLM_p last">2-(<i>cis</i>-2,6-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetic acid (16 g, prepared by following a similar procedures as <b>52f</b>) was separated by SFC by the following conditions to give two diastereomers. <b>52c</b> (5.4 g, 34% yield) is the first eluted peak. LC/MS, Anal. Calcd for [M + H]<sup>+</sup> C<sub>11</sub>H<sub>19</sub>NFO<sub>5</sub>: 246.1; found 246.1. SFC conditions: column AY-5, 150 mm Ã 4.6 mm, 5 Î¼m, mobile phase, 5% to 40% MeOH (0.05% DEA) in CO<sub>2</sub>; flow rate, 2.5 mL/min. The absolute stereochemistry was assigned arbitrarily except the chiral center introduced from the starting material.</div></div><div id="sec5_2_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (<i>S</i>)-2-((2<i>R</i>,6<i>R</i>)-2,6-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetic Acid (<b>52d</b>)</h3><div class="NLM_p last">2-((2<i>R</i>,6<i>R</i>)-2,6-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetic acid (1.4 g, prepared by following a similar procedures as <b>52f</b>) was separated by SFC by the following conditions to give two diastereomers. <b>52d</b> (0.5 g, 35% yield) is the first eluted peak. LC/MS, Anal. Calcd for [M + H]<sup>+</sup> C<sub>11</sub>H<sub>19</sub>NO<sub>5</sub>: 246.13; found 246.53. SFC conditions: column, Chiralpak AS-H 250 mm Ã 4.0 mm, mobile phase, 5% to 40% MeOH (0.05% DEA) in CO<sub>2</sub>. Flow rate: 2.35 mL/min. The absolute stereochemistry was assigned arbitrarily except the chiral center introduced from the starting material.</div></div><div id="sec5_2_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (2<i>S</i>)-2-(<i>cis</i>-2,6-Diethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetic Acid (<b>52e</b>)</h3><div class="NLM_p last">2-(<i>cis</i>-2,6-Diethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetic acid (2.5 g, prepared by following a similar procedures as <b>52f</b>) was separated by SFC by the following conditions to give two diastereomers. <b>52e</b> (0.9 g, 36% yield) is the first eluted peak. LC/MS, Anal. Calcd for [M + H]<sup>+</sup> C<sub>13</sub>H<sub>23</sub>NO<sub>5</sub>: 274.16; found 274.12. SFC conditions: column, Chiralpak AD-H 150 mm Ã 4.6 mm, mobile phase, 5% to 40% MeOH (0.05% DEA) in CO<sub>2</sub>. Flow rate: 2.5 mL/min.</div></div><div id="sec5_2_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Methyl 2-(((Benzyloxy)carbonyl)amino)-2-(2,2-dimethyltetrahydro-4<i>H</i>-pyran-4-ylidene)acetate (<b>52f</b>) and (<i>S</i>)-2-((<i>R</i>)-2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetic Acid (<b>52g</b>)</h3><div class="NLM_p">To a solution of <b>51f</b> (1.9 g, 7.34 mmol) in THF/H<sub>2</sub>O (20 mL/4 mL) was added LiOH (0.264 g, 11.00 mL), and the reaction was stirred at 25 Â°C for 4 h. 1 N HCl was added to adjust the pH value to 6. The aqueous layer was extracted by DCM. The organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>. After removal of the solvent, the crude was purified by HPLC (C18 column, CNCH<sub>3</sub>/water: 10% to 70%, with addition of 0.1% TFA) to give a mixture of four isomers as white solid (1.0 g, 56% yield). The mixture (1.0 g) was separated by SFC under the following conditions to give <b>52f</b> (second peak eluted, 170 mg, 17% yield). LC/MS calcd for C<sub>11</sub>H<sub>20</sub>NFO<sub>5</sub> [M + H]<sup>+</sup>: 245.13; found 246.1; <b>52g</b> (first peak eluted, 230 mg, 23% yield), LC/MS calcd for C<sub>11</sub>H<sub>20</sub>NFO<sub>5</sub> [M + H]<sup>+</sup>: 245.13; found: 246.1; and two other isomers. Instrument: Thar SFC. Column: AS-H, 150 mm Ã 4.6 mm, 5 Î¼m. Mobile phase B: EtOH (0.05% DEA). Gradient: 5% to 40% B.</div><div class="NLM_p last">The absolute stereochemistry of <b>52g</b> was determined to be (<i>S</i>)-2-((<i>R</i>)-2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)-2-((methoxycarbonyl)amino)acetic acid by vibrational circular dichroism (VCD) spectroscopy with confidence.</div></div><div id="sec5_2_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> (<i>S</i>)-2-((Methoxycarbonyl)amino)-2-((<i>R</i>)-4-oxaspiro[2.5]octan-7-yl)acetic Acid (<b>52h</b>)</h3><div class="NLM_p last">2-((Methoxycarbonyl)amino)-2-(4-oxaspiro[2.5]octan-7-yl)acetic acid (prepared from <b>47h</b> by following a similar procedures as <b>52f</b>) was separated by chiral SFC by using the same conditions as <b>52f</b>. Four diastereomers were obtained, and <b>52h</b> is the second eluted peak in SFC. The absolute stereochemistry was assigned arbitrarily.</div></div><div id="sec5_2_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 2-(8-Oxabicyclo[3.2.1]octan-3-yl)-2-((methoxycarbonyl)amino)acetic Acid (<b>52i</b>)</h3><div class="NLM_p last">To a solution of <b>57i</b> (60 mg, 0.18 mmol) in MeOH (10 mL) was added Pd/C (10 mg, 0.03 mmol). The mixture was stirred at 25 Â°C under 40 psi of H<sub>2</sub> for 12 h. The reaction mixture was filtered and the filtrate was concentrated to afford 2-(8-oxabicyclo[3.2.1]octan-3-yl)-2-((methoxycarbonyl)amino)acetic acid (40 mg, 93% yield). <sup>1</sup>H NMR (MeOD): Î´ 4.35 (s, 2 H), 3.95 (d, <i>J</i> = 4.4 Hz, 1 H), 3.62 (s, 3 H), 1.85â1.95 (m, 2 H), 1.70â1.80 (m, 2 H), 1.39â1.60(m, 4 H), 1.23â1.35 (m, 1 H), 1.16 (t, <i>J</i> = 7.2 Hz, 1 H). 2-(8-Oxabicyclo[3.2.1]octan-3-yl)-2-((methoxycarbonyl)amino)acetic acid (40 mg) was separated by chiral SFC to give two isomers and <b>52i</b> is the first eluted peak. SFC conditions: column AY-5, 150 mm Ã 4.6 mm, 5 Î¼m; mobile phase, 5% to 40% MeOH (0.05% DEA) in CO<sub>2</sub>. Flow rate: 2.5 mL/min. The absolute stereochemistry was assigned arbitrarily.</div></div><div id="sec5_2_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (<i>S</i>)-2-((Methoxycarbonyl)amino)-2-(2,2,6,6-tetramethyltetrahydro-2<i>H</i>-pyran-4-yl)acetic Acid (<b>52j</b>)</h3><div class="NLM_p last">Benzyl 2-((methoxycarbonyl)amino)-2-(2,2,6,6-tetramethyltetrahydro-2<i>H</i>-pyran-4-yl)acetate (<b>57j</b>, 250 mg, prepared from <b>47j</b> by following a similar procedures as <b>57i</b>) was separated by chiral SFC to give two isomers. SFC conditions. Column: Chiralpak AS-H 250 mm Ã 4.6 mm i.d. Mobile phase: 5% to 40% ethanol (0.05% DEA) in CO<sub>2</sub>. Flow rate: 2.35 mL/min. The second eluted peak (70 mg) in 20 mL of MeOH was added 10 mg Pd/C and stirred at 25 Â°C for 16 h under H<sub>2</sub> (50 psi). The mixture was filtered and the filtrate was concentrated in vacuo to give <b>52j</b> (52 mg, 99% yield). LC/MS, Anal. Calcd for [M + H]<sup>+</sup> C<sub>13</sub>H<sub>23</sub>NO<sub>5</sub>: 274.16; found 274.2.</div></div><div id="sec5_2_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 8-Oxabicyclo[3.2.1]oct-6-en-3-yl 4-methylbenzenesulfonate (<b>53i</b>)</h3><div class="NLM_p last">To a solution of <b>47i</b> (700 mg, 5.64 mmol) in THF (20 mL) was added L-selectride (1 M in THF, 11.3 mL, 11.3 mmol) at â78 Â°C over 100 min. After the mixture was stirred under N<sub>2</sub> at â78 Â°C for 1 h, it was warmed to 25 Â°C for 12 h. Then the mixture was cooled to 0 Â°C, and NaOH (1 N in water, 5 mL) and H<sub>2</sub>O (5 mL) was added. After the mixture was stirred at 25 Â°C for another 1 h, it was quenched with 3 N HCl, and the aqueous layer was extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, filtered, and concentrated to give 8-oxabicyclo[3.2.1]oct-6-en-3-ol (320 mg, 45.4% yield). <sup>1</sup>H NMR: (CDCl<sub>3</sub>) Î´: 6.42 (s, 2 H), 4.68 (d, <i>J</i> = 4.0 Hz, 2 H), 3.89â3.93 (m, 1 H), 2.24 (dd, <i>J</i> = 14.4, 4.0 Hz, 2 H), 1.64 (d, <i>J</i> = 14.4 Hz, 2 H). To a solution of 8-oxabicyclo[3.2.1]oct-6-en-3-ol (320 mg, 2.56 mmol) and pyridine (820 mg, 10.24 mmol) in DCM (20 mL) was added TsCl (973 mg, 5.12 mmol) at 0 Â°C. The mixture was stirred under N<sub>2</sub> at 25 Â°C for 12 h before it was poured into water and extracted with DCM. The organic layer was washed with brine, dried over sodium sulfate. After filtration and concentration, the residue was purified by SiO<sub>2</sub> column chromatography (petroleum ether/EtOAc = 5:1) to give <b>53i</b> (330 mg, 45.9% yield). <sup>1</sup>H NMR: (CDCl<sub>3</sub>) Î´: 7.67 (d, <i>J</i> = 8.0 Hz, 2 H), 7.25 (d, <i>J</i> = 8.0 Hz, 2 H), 6.18 (s, 2 H), 4.68â4.72 (m, 1 H), 4.57 (d, <i>J</i> = 4.0 Hz, 2 H), 2.38 (s, 3 H), 2.11 (dd, <i>J</i> = 15.6, 4.0 Hz, 2 H), 1.64 (d, <i>J</i> = 15.6 Hz, 2 H).</div></div><div id="sec5_2_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Benzyl 2-(8-Oxabicyclo[3.2.1]oct-6-en-3-yl)-2-((diphenylmethylene)amino)acetate (<b>55i</b>)</h3><div class="NLM_p last">To a microwave tube that was charged with <b>53i</b> (330 mg, 1.18 mmol) and benzyl 2-(diphenylmethyleneamino)acetate (<b>54</b>, 466 mg, 1.4 mmol) in toluene (15 mL) was added LiHMDS (1.5 mL, 1.5 mmol) dropwise under N<sub>2</sub>. The mixture was stirred at 100 Â°C under microwave for 4 h. It was then poured into water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate. After filtration and concentration, the residue was purified by SiO<sub>2</sub> column (petroleum ether/EtOAc = 5:1) to give <b>55i</b> (330 mg, 65% yield). LC/MS calcd for C<sub>29</sub>H<sub>28</sub>NO<sub>3</sub> [M + H]<sup>+</sup>: 438.2; found 438.2.</div></div><div id="sec5_2_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Benzyl 2-Amino-2-(8-oxabicyclo[3.2.1]oct-6-en-3-yl)acetate (<b>56i</b>)</h3><div class="NLM_p last">To a solution of <b>55i</b> (330 mg, 0.75 mmol) in THF (20 mL) was added 2 N HCl (5 mL) at 0 Â°C. The mixture was stirred under N<sub>2</sub> at 25 Â°C for 2 h before it was poured into a saturated aqueous NaHCO<sub>3</sub> solution and extracted with DCM. The organic layer was washed with brine, dried over sodium sulfate, filtered, and concentrated to give <b>56i</b> (150 mg, 72.8% yield). LC/MS calcd for C<sub>16</sub>H<sub>20</sub>NO<sub>3</sub> [M + H]<sup>+</sup>: 274.1; found 274.1.</div></div><div id="sec5_2_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Benzyl 2-(8-Oxabicyclo[3.2.1]oct-6-en-3-yl)-2-((methoxycarbonyl)amino)acetate (<b>57i</b>)</h3><div class="NLM_p last">To a solution of <b>56i</b> (150 mg, 0.55 mmol) and Et<sub>3</sub>N (221 mg, 2.2 mmol) in DCM (10 mL) was added MocCl (96 mg, 0.95 mmol) at 0 Â°C. The mixture was stirred under N<sub>2</sub> at 25 Â°C for 12 h before it was poured into water and extracted with DCM. The organic layer was washed with brine, dried over sodium sulfate. After filtration and concentration, the residue was purified by SiO<sub>2</sub> column (eluting with petroleum ether/EtOAc = 1:1) to give <b>57i</b> (60 mg, 60% yield). LC/MS calcd for C<sub>18</sub>H<sub>22</sub>NO<sub>5</sub> [M + H]<sup>+</sup>: 332.1; found 332.1.</div></div><div id="sec5_2_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Methyl (<i>R</i>)-3-((<i>tert</i>-Butyldimethylsilyl)oxy)butanoate (<b>59</b>)</h3><div class="NLM_p last">Methyl (<i>R</i>)-3-hydroxybutanoate <b>(58</b>, 174 g, 1475 mmol) and imidazole (109 g, 1622 mmol) were dissolved in ethyl acetate (1 L). After cooling to 0 Â°C, <i>tert</i>-butyl chlorodimethylsilane (242 g, 1662 mmol) in ethyl acetate (300 mL) was added dropwise and kept the internal temperature below 10 Â°C. After stirring the thick suspension at 25 Â°C for 16 h, water (800 mL) was added. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate (450 mL) one more time. The combined organic layers were washed with brine (450 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give <b>59</b> as colorless oil (322 g, 95% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´: 4.28â4.13 (m, 1H), 3.60 (s, 3H), 2.47â2.36 (m, 1H), 2.35â2.28 (m, 1H), 1.13 (d, <i>J</i> = 6.0 Hz, 3H), 0.80 (s, 9H), 0.00 (d, <i>J</i> = 9.5 Hz, 6H).</div></div><div id="sec5_2_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> (<i>R</i>)-3-((<i>tert</i>-Butyldimethylsilyl)oxy)-<i>N</i>-methoxy-<i>N</i>-methylbutanamide (<b>60</b>)</h3><div class="NLM_p last">Compound <b>59</b> (322 g, 1.4 mol) was dissolved in THF (250 mL) and <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride salt (155 g, 1.6 mol) was added. After cooling the slurry to â20 Â°C, a solution of isopropylmagnesium chloride in THF (2.0 M, 1.6 L, 3.2 mol) was added dropwise over 1 h, maintaining the reaction temperature below 0 Â°C. The reaction was stirred at â20 Â°C for an additional 2 h. The reaction was quenched with saturated aqueous ammonium chloride (2 L) and extracted with ethyl acetate (500 mL Ã 2). The combined organic layers were washed with brine (500 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by SiO<sub>2</sub> chromatography elution with petroleum ether/ethyl acetate = 20:1 to afford <b>60</b> as colorless oil (260 g, 72% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´: 4.39â4.24 (m, 1H), 3.66 (s, 3H), 3.13 (s, 3H), 2.73 (m, 1H), 2.31 (dd, <i>J</i> = 4, 12 Hz, 1H), 1.17 (d, <i>J</i> = 8 Hz, 3H), 0.82 (s, 9H), 0.01 (d, <i>J</i> = 12 Hz, 6H)</div></div><div id="sec5_2_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> (<i>R</i>)-5-((<i>tert</i>-Butyldimethylsilyl)oxy)hex-1-en-3-one (<b>61</b>)</h3><div class="NLM_p last">To a solution of vinylmagnesium bromide in THF (1.0 M, 1.6 L, 1.6 mol) at 0 Â°C under nitrogen atmosphere was added <b>60</b> (260 g, 1 mol) dropwise over 30 min, maintaining the reaction temperature below 5 Â°C. The reaction was stirred between 0 and 5 Â°C for an additional 1 h, then was poured into a stirred mixture of ice, saturated aqueous citric acid (1 L), and ammonium chloride (1000 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (1 L). The combined organic layers were washed with saturated aqueous sodium carbonate and brine, then dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by SiO<sub>2</sub> chromatography, eluting with a 1:100 mixture of ethyl acetate and petroleum ether to provide <b>61</b> as colorless oil (180 g, 79% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 6.36 (dd, <i>J</i><sub>1</sub> = 17.7, <i>J</i><sub>2</sub> = 10.5 Hz, 1H), 6.22 (dd, <i>J</i><sub>1</sub> = 17.7, <i>J</i><sub>2</sub> = 1.3 Hz, 1H), 5.85 (dd, <i>J</i><sub>1</sub> = 10.5, <i>J</i><sub>2</sub> = 1.3 Hz, 1H), 4.37â4.33 (m, 1H), 2.85 (dd, <i>J</i><sub>1</sub> = 14.9, <i>J</i><sub>2</sub> = 7.2 Hz, 1H), 2.54 (dd, <i>J</i><sub>1</sub> = 14.9, <i>J</i><sub>2</sub> = 5.4 Hz, 1H), 1.20 (d, <i>J</i> = 6.2 Hz, 3H), 0.86 (s, 9H), 0.06 (s, 3H), 0.02 (s, 3H).</div></div><div id="sec5_2_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> (<i>cis</i>)-2,6-Dimethyltetrahydro-2<i>H</i>-pyran-4-ol (<b>63</b>)</h3><div class="NLM_p last">To a solution of 2,6-dimethyl-4<i>H</i>-pyran-4-one (<b>62</b>, 73 g, 0.59 mol) in ethanol was added Pd/C (10%, 4 g), and the reaction was stirred at 35 Â°C under H<sub>2</sub> (50 psi) for 17 h. The reaction was filtered through Celite and the volatiles were removed in vacuo to afford <b>63</b> (76 g, 99% yield). <sup>1</sup>H NMR: (CDCl<sub>3</sub>) Î´: 3.75 (s, 1 H), 3.44â3.40 (m, 2 H), 1.88 (d, <i>J</i> = 16 Hz, 2 H), 1.19 (d, <i>J</i> = 8 Hz, 6 H), 1.14â1.08 (m, 2 H).</div></div><div id="sec5_2_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 1-(2,2-Dimethoxyethyl)cyclopropan-1-ol (<b>65</b>)</h3><div class="NLM_p last">To a solution of methyl 3,3-dimethoxypropanoate (<b>64</b>, 100 g, 0.52 mol) in THF/Et<sub>2</sub>O (600/600 mL) was added titanium isopropoxide (29 g, 0.1 mol) at 0 Â°C with stirring. After stirring for 10 min, ethylmagnesium bromide (434 mL, 3 M in Et<sub>2</sub>O, 1.3 mol) was added dropwise at 10â15 Â°C. After addition was complete, the solution was stirred at 25 Â°C for 30 min. The reaction was quenched with 6 mL of water. The mixture was filtered. The filtrate was concentrated in vacuum. The residue was purified by column chromatography (petroleum ether/EtOAc = 20:1 to 4:1) to give <b>65</b> (80 g, 89% yield). <sup>1</sup>H NMR: (CDCl<sub>3</sub>) Î´: 4.61 (t, <i>J</i> = 6.0 Hz, 1 H), 3.32 (s, 6 H), 1.81 (d, <i>J</i> = 6.0 Hz, 2 H), 0.69â0.70 (m, 2 H), 0.37â0.38 (m, 2 H).</div></div><div id="sec5_2_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 2-(1-((<i>tert</i>-Butyldimethylsilyl)oxy)cyclopropyl)acetaldehyde (<b>66</b>)</h3><div class="NLM_p last">To a solution of <b>65</b> (80 g, 0.46 mol) in dichloromethane (600 mL) was added 2,6-lutidine (246 g, 2.3 mol), TBSOTf (121 g, 0.46 mol) at 10 Â°C. The reaction was stirred at 10 Â°C for 30 min, then TMSOTf (153 g, 0.7 mol) was added. The reaction was stirred at 10 Â°C for 1 more hour, it was poured into water, extracted with ethyl acetate (3 times). The combined organic phases were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by column (petroleum ether/EtOAc = 100:1 to 20:1) to give <b>66</b> (40 g, 41% yield). <sup>1</sup>H NMR: (CDCl<sub>3</sub>) Î´:9.84 (t, <i>J</i> = 2.8 Hz, 1H), 2.37 (d, <i>J</i> = 2.8 Hz, 2H), 0.79 (m, 2H), 0.77 (s, 9H), 0.52 (m, 2H), 0.00 (s, 6H).</div></div><div id="sec5_2_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 1-(1-((<i>tert</i>-Butyldimethylsilyl)oxy)cyclopropyl)but-3-en-2-ol (<b>67</b>)</h3><div class="NLM_p last">To a solution of <b>66</b> (40 g, 180 mmol) in THF (400 mL) was added vinylmagnesium bromide (175 mL, 1.6 M in THF, 280 mmol) at â78 Â°C. After the reaction was stirred at â78 Â°C for 30 min, it was quenched with aqueous NH<sub>4</sub>Cl and extracted with ethyl acetate (3 times). The combined organic phases were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by SiO<sub>2</sub> column (petroleum ether/EtOAc, 10:1 to 5:1) to give <b>67</b> (20 g, 41% yield). LC/MS calcd for C<sub>13</sub>H<sub>27</sub>O<sub>2</sub>Si [M + H]<sup>+</sup>: 243.2; found 243.3.</div></div><div id="sec5_2_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 1-(1-((<i>tert</i>-Butyldimethylsilyl)oxy)cyclopropyl)but-3-en-2-one (<b>68</b>)</h3><div class="NLM_p last">To a solution of <b>67</b> (20 g, 82 mmol) in acetonitrile (200 mL) was added IBX (46 g, 165 mmol) at 25 Â°C. The mixture was stirred at 80 Â°C for 2 h, filtered, and concentrated. The crude product was purified by SiO<sub>2</sub> column chromatography chromatography (300 g, EtOAc/hexane, 0% to 50%) to give <b>68</b> (10 g, 50% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´: 6.59 (dd, <i>J</i> = 16.0, 9.6 Hz, 1 H), 6.19 (d, <i>J</i> = 16.0 Hz, 1 H), 5.68 (d, <i>J</i> = 9.6 Hz, 1 H), 2.64 (s, 2 H), 0.73â0.74 (m, 2 H), 0.73 (s, 9 H), 0.52â0.53 (m, 2 H), 0.07 (s, 6 H).</div></div><div id="sec5_2_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 2,4-Dibromo-8-oxabicyclo[3.2.1]oct-6-en-3-one (<b>69</b>)</h3><div class="NLM_p last">To a solution of furan (1.3 g, 18.77 mmol) and Zn powder (2 g, 31 mmol) in THF (3 mL) was added 1,1,3,3-tetrabromopropan-2-one (10.5 g, 28 mmol) and triethyl borate (5.48 g, 38 mmol) dropwise at 25 Â°C during 1 h period in the dark. The resulting dark brown mixture was stirred at 25 Â°C for 17 h. The mixture was cooled to â15 Â°C, and H<sub>2</sub>O (30 mL) was added. The mixture was stirred at 25 Â°C for 30 min and extracted with EtOAc. The combined organic phases were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give <b>69</b> (26.1 g, 100% yield) which was used without further purification.</div></div><div id="sec5_2_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 10-Bromo-3-chloro-6-(5-cyclopropylthiophen-2-yl)-1-fluoro-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole (<b>70</b>)</h3><div class="NLM_p last">To a mixture of <b>39h</b> (2.7 g, 17.5 mmol) and <b>38</b> (4.0 g, 11.7 mmol) in anhydrous CH<sub>3</sub>CN (50 mL) was added TFA (1 mL). The mixture was stirred at 20 Â°C for 6 h. The reaction mixture became a clear solution, and then a solid appeared. The solid was collected by filtration and washed with CH<sub>3</sub>CN to give 10-bromo-3-chloro-6-(5-cyclopropylthiophen-2-yl)-1-fluoro-12,12a-dihydro-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole (4.5 g, 81%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´: 7.21 (s, 2 H), 6.52â6.78 (m, 6 H), 5.07 (d, <i>J</i> = 9.6 Hz, 1H), 3.50 (dd, <i>J</i> = 16.4, 9.2 Hz, 1 H), 3.19 (d, <i>J</i> = 16.4 Hz, 1 H), 1.91â1.96 (m, 1 H), 0.88â0.93 (m, 2 H), 0.63â0.65 (m, 2 H). To a solution of 10-bromo-3-chloro-6-(5-cyclopropylthiophen-2-yl)-1-fluoro-12,12a-dihydro-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole (4.5 g, 9.4 mmol) in dry toluene (50 mL) was added DDQ (3.2 g, 14.2 mmol). After the reaction mixture was stirred under refluxing for 2 h, it was concentrated and diluted with EtOAc. The organic layer was washed with saturated aqueous Na<sub>2</sub>SO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was washed with MeOH (20 mL) to give <b>70</b> (4.0 g, 88%). LC/MS calcd for C<sub>22</sub>H<sub>15</sub>BrClFNOS [M + H]<sup>+</sup>: 476.0; found 476.1.</div></div><div id="sec5_2_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 3-Chloro-6-(5-cyclopropylthiophen-2-yl)-1-fluoro-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indole (<b>71</b>)</h3><div class="NLM_p last">A degassed suspension of <b>70</b> (4.0 g, 8.4 mmol), bis(pinacolato)diboron (2.6 g, 10.1 mmol), KOAc (2.1 g, 21.1 mmol), and Pd(dppf)Cl<sub>2</sub> (310 mg, 0.42 mmol) in dioxane (50 mL) was stirred at 100 Â°C for 2 h under N<sub>2</sub>. The reaction mixture was cooled and concentrated in vacuum, and the residue was purified by SiO<sub>2</sub> chromatography (80 g, EtOAc/hexane 0% to 5%) to give <b>71</b> (4.0 g, 88% yield). LC/MS calcd for C<sub>28</sub>H<sub>27</sub>BClFNO<sub>3</sub>S [M + H]<sup>+</sup>: 522.1; found 522.2.</div></div><div id="sec5_2_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> <i>tert</i>-Butyl (2<i>S</i>)-2-(5-(3-Chloro-6-(5-cyclopropylthiophen-2-yl)-1-fluoro-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidine-1-carboxylate (<b>72</b>)</h3><div class="NLM_p last">A degassed suspension of <b>71</b> (4.4 g, 8.4 mmol), <b>45</b> (3.2 g, 10.2 mmol), Na<sub>2</sub>CO<sub>3</sub> (2.2 g, 21.0 mmol), and Pd(dppf)Cl<sub>2</sub> (310 mg, 0.42 mmol) in THF/H<sub>2</sub>O (v/v = 5/1, 120 mL) was stirred at 80 Â°C overnight under N<sub>2</sub>. After cooling down, water was added and the aqueous layer was extracted with ethyl acetate. The organic layers were combined, washed with brine, and dried over anhydrous sodium sulfate. After concentrated under vacuum, the residue was purified by SiO<sub>2</sub> chromatography (80 g, EtOAc/hexane, 10% to 50%) to give <b>72</b> (4.5 g, 77%). LC/MS calcd for C<sub>34</sub>H<sub>33</sub>ClFN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup>: 631.2; found 631.3.</div></div><div id="sec5_2_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> <i>tert</i>-Butyl (2<i>S</i>)-2-(5-(6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidine-1-carboxylate (<b>73</b>)</h3><div class="NLM_p last">To a degassed mixture of <b>72</b> (4.5 g, 6.5 mmol), bis(pinacolato)diboron (2.0 g, 7.8 mmol), KOAc (1.6 g, 16.3 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (338 mg, 0.33 mmol), X-Phos (312 mg 0.65 mmol) was added dry dioxane under N<sub>2</sub>. The mixture was stirred at 100 Â°C overnight. After cooling to 20 Â°C, the reaction mixture was filtered and concentrated in vacuum. The residue was purified by SiO<sub>2</sub> chromatography (3 g, hexane/EtOAc, 20% to 50%) to give <b>73</b> (4.6 g, 89%). LC/MS calcd for C<sub>40</sub>H<sub>45</sub>BFN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup>: 723.3; found 723.5.</div></div><div id="sec5_2_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> <i>tert</i>-Butyl (<i>S</i>)-2-(5-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-4-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidine-1-carboxylate (<b>75</b>)</h3><div class="NLM_p last">A suspension of <b>73</b> (4.2 g, 5.8 mmol), <b>74</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (3.25 g, 8.7 mmol), Na<sub>2</sub>CO<sub>3</sub> (1.5 g, 14.5 mmol), and Pd(dppf)Cl<sub>2</sub> (222 mg, 0.29 mmol) in THF/H<sub>2</sub>O (72 mL, 5:1) was stirred at 100 Â°C under N<sub>2</sub> protection overnight. After filtration, the filtrate was washed with water (50 mL) and extracted with ethyl acetate (100 mL). The organic layer was washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration and concentration, the residue was purified by SiO<sub>2</sub> chromatography (2 g, MeOH/DCM 0% to 20%) to give <i>tert</i>-butyl (2<i>S</i>)-2-(5-(6-(5-cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-4-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidine-1-carboxylate (3.8 g, 74%). LC/MS calcd for C<sub>48</sub>H<sub>54</sub>FN<sub>8</sub>O<sub>6</sub>S [M + H]<sup>+</sup>: 889.4; found 889.4. <i>tert</i>-Butyl (2<i>S</i>)-2-(5-(6-(5-cyclopropylthiophen-2-yl)-1-fluoro-3-(2-((<i>S</i>)-1-((methoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl)pyrrolidin-2-yl)-1<i>H</i>-imidazol-4-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-10-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidine-1-carboxylate (3.8 g) was separated by SFC by using the following conditions to give <b>75</b> (1.0 g, 26.3%). Column: Chiralpak AS-H 250 mm Ã 4.6 mm i.d., 5 Î¼m. Mobile phase: 40% of isopropanol (0.05% DEA) in CO<sub>2</sub>.</div></div><div id="sec5_2_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Methyl ((<i>S</i>)-1-((<i>S</i>)-2-(4-((<i>S</i>)-6-(5-Cyclopropylthiophen-2-yl)-1-fluoro-10-(2-((<i>S</i>)-pyrrolidin-2-yl)-1<i>H</i>-imidazol-5-yl)-6<i>H</i>-benzo[5,6][1,3]oxazino[3,4-<i>a</i>]indol-3-yl)-1<i>H</i>-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate (<b>76</b>)</h3><div class="NLM_p last">To a solution of <b>75</b> (1.0 g, 1.1 mmol) in dry dioxane (10 mL) was added HClâdioxane (20 mL) through syringe, and the reaction mixture was stirred at 20 Â°C for 2 h. It was concentrated and dried under high vacuum to give the HCl salt of <b>76</b> (0.9 g, 98%). It was assumed that <b>76</b> formed 3HCl salt. The actual number of HCl salt was not determined. LC/MS calcd for C<sub>43</sub>H<sub>46</sub>FN<sub>8</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: 789.3; found 789.5.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01927" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01927" class="ext-link">10.1021/acs.jmedchem.7b01927</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01927/suppl_file/jm7b01927_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR spectra of compounds <b>1</b>â<b>27</b> and <b>29</b>â<b>37</b> and <sup>13</sup>C NMR spectra of compound <b>21</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01927/suppl_file/jm7b01927_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01927/suppl_file/jm7b01927_si_001.csv">jm7b01927_si_001.csv (6.61 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01927/suppl_file/jm7b01927_si_002.pdf">jm7b01927_si_002.pdf (2.91 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01927" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wensheng Yu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5978-9454" title="Orcid link">http://orcid.org/0000-0001-5978-9454</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e295878c918a878c85cc9b97a28f87908189cc818d8f"><span class="__cf_email__" data-cfemail="f7809299849f929990d98e82b79a9285949cd994989a">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ling Tong</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3302-8184" title="Orcid link">http://orcid.org/0000-0003-3302-8184</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oleg Selyutin</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Chen</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bin Hu</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bin Zhong</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinglai Hao</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Ji</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuai Zan</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jingjun Yin</span> - <span class="hlFld-Affiliation affiliation">Department of Process Research
& Development and , Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca T. Ruck</span> - <span class="hlFld-Affiliation affiliation">Department of Process Research
& Development and , Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9980-9675" title="Orcid link">http://orcid.org/0000-0001-9980-9675</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie Curry</span> - <span class="hlFld-Affiliation affiliation">Department of Infectious Diseases, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia McMonagle</span> - <span class="hlFld-Affiliation affiliation">Department of Infectious Diseases, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sony Agrawal</span> - <span class="hlFld-Affiliation affiliation">Department of In Vitro
Pharmacology, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Rokosz</span> - <span class="hlFld-Affiliation affiliation">Department of In Vitro
Pharmacology, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donna Carr</span> - <span class="hlFld-Affiliation affiliation">Department of In Vitro
Pharmacology, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Ingravallo</span> - <span class="hlFld-Affiliation affiliation">Department of Infectious Diseases, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin Bystol</span> - <span class="hlFld-Affiliation affiliation">Department of Infectious Diseases, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick Lahser</span> - <span class="hlFld-Affiliation affiliation">Department of Infectious Diseases, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rong Liu</span> - <span class="hlFld-Affiliation affiliation">Department of Infectious Diseases, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shiying Chen</span> - <span class="hlFld-Affiliation affiliation">Department of PPDM, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kung-I Feng</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Pharmaceutical
Sciences and , Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Cartwright</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Safety, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ernest Asante-Appiah</span> - <span class="hlFld-Affiliation affiliation">Department of Infectious Diseases, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph A. Kozlowski</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, , , , and , Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The authors are either current employees of Merck & Co., Inc. or employed at Merck & Co., Inc. during this work except B.H.; B.Z.; J.H.; T.J., and S.Z. who are employees of a CRO company.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DEA</td><td class="NLM_def"><p class="first last">diethylamine</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIEA or DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">EtOAc or EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">isopropyl alcohol</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">mpk</td><td class="NLM_def"><p class="first last">milligram per kilogram</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">PIFA</td><td class="NLM_def"><p class="first last">[bis(trifluoroacetoxy)iodo]benzene</p></td></tr><tr><td class="NLM_term">GT1a</td><td class="NLM_def"><p class="first last">genotype 1 subtype a</p></td></tr><tr><td class="NLM_term">GT1b</td><td class="NLM_def"><p class="first last">genotype 1 subtype b</p></td></tr><tr><td class="NLM_term">GT2a</td><td class="NLM_def"><p class="first last">genotype 2 subtype a</p></td></tr><tr><td class="NLM_term">GT2b</td><td class="NLM_def"><p class="first last">genotype 2 subtype b</p></td></tr><tr><td class="NLM_term">GT3a</td><td class="NLM_def"><p class="first last">genotype 3 subtype a</p></td></tr><tr><td class="NLM_term">GT4a</td><td class="NLM_def"><p class="first last">genotype 4 subtype a</p></td></tr><tr><td class="NLM_term">GT1a Y93H</td><td class="NLM_def"><p class="first last">genotype 1 subtype a with a tyrosine (Y) to histidine (H) amino acid substitution at position 93</p></td></tr><tr><td class="NLM_term">GT1a L31 V</td><td class="NLM_def"><p class="first last">genotype 1 subtype a with a leucine (L) to valine (V) amino acid substitution at position 31</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i108">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> <i>Global
Hepatitis Report, 2017</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2017</span>; p  <span class="NLM_fpage">7</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global%0AHepatitis+Report%2C+2017%3B+World+Health+Organization%2C+2017%3B+p+7."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlobal%250AHepatitis%2520Report%252C%25202017%26pub%3DWorld%2520Health%2520Organization%26date%3D2017%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span> <i>Global
Hepatitis Report, 2017</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2017</span>; p  <span class="NLM_fpage">12</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global%0AHepatitis+Report%2C+2017%3B+World+Health+Organization%2C+2017%3B+p+12."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlobal%250AHepatitis%2520Report%252C%25202017%26pub%3DWorld%2520Health%2520Organization%26date%3D2017%26spage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span>World Health
Organization Home Page. <a href="http://www.who.int/mediacentre/factsheets/fs164/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs164/en/</a> (accessed April 20, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health%0AOrganization+Home+Page.+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs164%2Fen%2F+%28accessed+April+20%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span> <i>Global
Hepatitis Report, 2017</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2017</span>; p  <span class="NLM_fpage">16</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global%0AHepatitis+Report%2C+2017%3B+World+Health+Organization%2C+2017%3B+p+16."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlobal%250AHepatitis%2520Report%252C%25202017%26pub%3DWorld%2520Health%2520Organization%26date%3D2017%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A.</span></span> <span> </span><span class="NLM_article-title">Interferon-Free Combination Therapies For The Treatment Of Hepatitis C: Current Insights</span>. <i>Hepatic Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_fpage">51</span>â <span class="NLM_lpage">70</span>, <span class="refDoi">Â DOI: 10.2147/HMER.S55864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.2147%2FHMER.S55864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A280%3ADC%252BC28rgsVSqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=51-70&author=J.+Holmesauthor=A.+Thompson&title=Interferon-Free+Combination+Therapies+For+The+Treatment+Of+Hepatitis+C%3A+Current+Insights&doi=10.2147%2FHMER.S55864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-free combination therapies for the treatment of hepatitis C: current insights</span></div><div class="casAuthors">Holmes Jacinta A; Thompson Alexander J</div><div class="citationInfo"><span class="NLM_cas:title">Hepatic medicine : evidence and research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-70</span>
        ISSN:<span class="NLM_cas:issn">1179-1535</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV) treatment landscape has rapidly changed over the past 5 years.  The development of direct-acting antiviral (DAA) agents that specifically target various steps in the HCV lifecycle has revolutionized therapeutic options for patients with HCV, with the development of highly effective and well-tolerated oral interferon-free regimens.  There are many DAAs that are currently in development or have recently been approved, which target different nonstructural HCV proteins and host targets that are essential for HCV replication.  This review will focus on the different classes of DAAs and the various combinations that are in advanced development for the treatment of chronic HCV infection and will focus on the different regimens in specific patient populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaWQI_kNsvcFvAgqb2vdc5fW6udTcc2eb45qRQ6Skn5bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgsVSqtg%253D%253D&md5=132f4de5a7104defd164235b90711976</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2147%2FHMER.S55864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FHMER.S55864%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DA.%26atitle%3DInterferon-Free%2520Combination%2520Therapies%2520For%2520The%2520Treatment%2520Of%2520Hepatitis%2520C%253A%2520Current%2520Insights%26jtitle%3DHepatic%2520Med.%26date%3D2015%26spage%3D51%26epage%3D70%26doi%3D10.2147%2FHMER.S55864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poordad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieterich, D.</span></span> <span> </span><span class="NLM_article-title">Treating Hepatitis C: Current Standard of Care and Emerging Direct-Acting Antiviral Agents</span>. <i>J. Viral Hepat</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">449</span>â <span class="NLM_lpage">464</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2893.2012.01617.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1111%2Fj.1365-2893.2012.01617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=22676357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A280%3ADC%252BC38npvVWlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=449-464&author=F.+Poordadauthor=D.+Dieterich&title=Treating+Hepatitis+C%3A+Current+Standard+of+Care+and+Emerging+Direct-Acting+Antiviral+Agents&doi=10.1111%2Fj.1365-2893.2012.01617.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents</span></div><div class="casAuthors">Poordad F; Dieterich D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">449-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Summary.  During the late 1990s and early 2000s, major advances were made in the treatment of patients with chronic hepatitis C virus (HCV) infection.  Interferon, combination interferon plus ribavirin (RBV) and pegylated interferon plus RBV increased sustained virologic response (SVR) rates from ~5% to ~40-80%, depending on the genotype of HCV infection.  Advances in molecular biology have allowed investigators to begin to understand the mechanisms of HCV infection and replication.  Advances in understanding of viral kinetics have provided tools to identify patients who are most likely to attain SVR.  With the advances in the science of HCV infection, the first part of the 21st century has seen the development and early introduction of a number of direct-acting antiviral (DAA) drugs.  These novel medications interfere with critical steps in HCV replication and have the potential to significantly increase SVR rates.  This article will review the key elements of HCV replication and evaluate the various classes of new and investigational DAA that have the potential to create a revolution in the management of patients with chronic hepatitis C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkf-H-0dt8tGPgL4LrC-0VfW6udTcc2eY2nLQgtyQapbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38npvVWlsQ%253D%253D&md5=4759dc9a094617ac13afd33ef078de6f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2012.01617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2012.01617.x%26sid%3Dliteratum%253Aachs%26aulast%3DPoordad%26aufirst%3DF.%26aulast%3DDieterich%26aufirst%3DD.%26atitle%3DTreating%2520Hepatitis%2520C%253A%2520Current%2520Standard%2520of%2520Care%2520and%2520Emerging%2520Direct-Acting%2520Antiviral%2520Agents%26jtitle%3DJ.%2520Viral%2520Hepat%26date%3D2012%26volume%3D19%26spage%3D449%26epage%3D464%26doi%3D10.1111%2Fj.1365-2893.2012.01617.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, C. M.</span></span> <span> </span><span class="NLM_article-title">Understanding the Hepatitis C Virus Life Cycle Paves the Way for Highly Effective Therapies</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">837</span>â <span class="NLM_lpage">849</span>, <span class="refDoi">Â DOI: 10.1038/nm.3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1038%2Fnm.3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=23836234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=837-849&author=T.+K.+Scheelauthor=C.+M.+Rice&title=Understanding+the+Hepatitis+C+Virus+Life+Cycle+Paves+the+Way+for+Highly+Effective+Therapies&doi=10.1038%2Fnm.3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span></div><div class="casAuthors">Scheel, Troels K. H.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">837-849</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  More than two decades of intense research has provided a detailed understanding of hepatitis C virus (HCV), which chronically infects 2% of the world's population.  This effort has paved the way for the development of antiviral compds. to spare patients from life-threatening liver disease.  An exciting new era in HCV therapy dawned with the recent approval of two viral protease inhibitors, used in combination with pegylated interferon-Î± and ribavirin; however, this is just the beginning.  Multiple classes of antivirals with distinct targets promise highly efficient combinations, and interferon-free regimens with short treatment duration and fewer side effects are the future of HCV therapy.  Ongoing and future trials will det. the best antiviral combinations and whether the current seemingly rich pipeline is sufficient for successful treatment of all patients in the face of major challenges, such as HCV diversity, viral resistance, the influence of host genetics, advanced liver disease and other co-morbidities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpde8altGxkeLVg90H21EOLACvtfcHk0lg5VczjVNm2aw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI&md5=dabc9fbc7dc0bc56115d5ede0d8ae072</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm.3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3248%26sid%3Dliteratum%253Aachs%26aulast%3DScheel%26aufirst%3DT.%2BK.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnderstanding%2520the%2520Hepatitis%2520C%2520Virus%2520Life%2520Cycle%2520Paves%2520the%2520Way%2520for%2520Highly%2520Effective%2520Therapies%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D837%26epage%3D849%26doi%3D10.1038%2Fnm.3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, C.</span></span> <span> </span><span class="NLM_article-title">New Merck and Vertex Drugs Raise Standard of Care in Hepatitis C</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">554</span>, <span class="refDoi">Â DOI: 10.1038/nbt0711-553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1038%2Fnbt0711-553" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=553-554&author=C.+Sheridan&title=New+Merck+and+Vertex+Drugs+Raise+Standard+of+Care+in+Hepatitis+C&doi=10.1038%2Fnbt0711-553"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnbt0711-553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt0711-553%26sid%3Dliteratum%253Aachs%26aulast%3DSheridan%26aufirst%3DC.%26atitle%3DNew%2520Merck%2520and%2520Vertex%2520Drugs%2520Raise%2520Standard%2520of%2520Care%2520in%2520Hepatitis%2520C%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D553%26epage%3D554%26doi%3D10.1038%2Fnbt0711-553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Love, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, C. N.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">4395</span>â <span class="NLM_lpage">4403</span>, <span class="refDoi">Â DOI: 10.1128/JVI.02352-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1128%2FJVI.02352-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=19244328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=4395-4403&author=R.+A.+Loveauthor=O.+Brodskyauthor=M.+J.+Hickeyauthor=P.+A.+Wellsauthor=C.+N.+Cronin&title=Crystal+Structure+of+a+Novel+Dimeric+Form+of+NS5A+Domain+I+Protein+from+Hepatitis+C+Virus&doi=10.1128%2FJVI.02352-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus</span></div><div class="casAuthors">Love, Robert A.; Brodsky, Oleg; Hickey, Michael J.; Wells, Peter A.; Cronin, Ciaran N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4395-4403</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A new protein expression vector design utilizing an N-terminal six-histidine tag and tobacco etch virus protease cleavage site upstream of the hepatitis C virus NS5A sequence has resulted in a more straightforward purifn. method and improved yields of purified NS5A domain I protein.  High-resoln. diffracting crystals of NS5A domain I (amino acids 33 to 202) [NS5A(33-202)] were obtained by using detergent additive crystn. screens, leading to the structure of a homodimer which is organized differently from that published previously, yet is consistent with a membrane assocn. model for NS5A.  The monomer-monomer interface of NS5A(33-202) features an extensive buried surface area involving the most-highly conserved face of each monomer.  The two alternate structural forms of domain I now available may be indicative of the multiple roles emerging for NS5A in viral RNA replication and viral particle assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNYc2eJlR_hLVg90H21EOLACvtfcHk0lg5VczjVNm2aw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqu7s%253D&md5=70ea61461a99afb962e76a4c3f5495db</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FJVI.02352-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02352-08%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DR.%2BA.%26aulast%3DBrodsky%26aufirst%3DO.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DCronin%26aufirst%3DC.%2BN.%26atitle%3DCrystal%2520Structure%2520of%2520a%2520Novel%2520Dimeric%2520Form%2520of%2520NS5A%2520Domain%2520I%2520Protein%2520from%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Virol.%26date%3D2009%26volume%3D83%26spage%3D4395%26epage%3D4403%26doi%3D10.1128%2FJVI.02352-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tellinghuisen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotrigiano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, C. M.</span></span> <span> </span><span class="NLM_article-title">Structure of the Zinc-Binding Domain of an Essential Component of the Hepatitis C Virus Replicase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>435</i></span>,  <span class="NLM_fpage">374</span>â <span class="NLM_lpage">379</span>, <span class="refDoi">Â DOI: 10.1038/nature03580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1038%2Fnature03580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=15902263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Wkt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=374-379&author=T.+L.+Tellinghuisenauthor=J.+Marcotrigianoauthor=C.+M.+Rice&title=Structure+of+the+Zinc-Binding+Domain+of+an+Essential+Component+of+the+Hepatitis+C+Virus+Replicase&doi=10.1038%2Fnature03580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase</span></div><div class="casAuthors">Tellinghuisen, Timothy L.; Marcotrigiano, Joseph; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7040</span>),
    <span class="NLM_cas:pages">374-379</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a human pathogen affecting nearly 3% of the world's population.  Chronic infections can lead to cirrhosis and liver cancer.  The RNA replication machine of HCV is a multi-subunit membrane-assocd. complex.  The non-structural protein NS5A is an active component of HCV replicase, as well as a pivotal regulator of replication and a modulator of cellular processes ranging from innate immunity to dysregulated cell growth.  NS5A is a large phosphoprotein (56-58 kDa) with an amphipathic Î±-helix at its amino terminus that promotes membrane assocn.  After this helix region, NS5A is organized into three domains.  The N-terminal domain (domain I) coordinates a single zinc atom per protein mol.  Mutations disrupting either the membrane anchor or zinc binding of NS5A are lethal for RNA replication.  However, probing the role of NS5A in replication has been hampered by a lack of structural information about this multifunctional protein.  Here we report the structure of NS5A domain I at 2.5-Ã resoln., which contains a novel fold, a new zinc-coordination motif and a disulfide bond.  We use mol. surface anal. to suggest the location of protein-, RNA- and membrane-interaction sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe6tBo4Nrq7rVg90H21EOLACvtfcHk0lixiXH5Unw1iA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Wkt7Y%253D&md5=0f74b457e5921d4aa1993df8e9a08d46</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature03580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03580%26sid%3Dliteratum%253Aachs%26aulast%3DTellinghuisen%26aufirst%3DT.%2BL.%26aulast%3DMarcotrigiano%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DStructure%2520of%2520the%2520Zinc-Binding%2520Domain%2520of%2520an%2520Essential%2520Component%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520Replicase%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D374%26epage%3D379%26doi%3D10.1038%2Fnature03580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettles, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Wu, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâBoyle, D. R.,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colonno, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span> <span> </span><span class="NLM_article-title">Chemical Genetics Strategy Identifies an HCV NS5A Inhibitor with a Potent Clinical Effect</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">96</span>â <span class="NLM_lpage">100</span>, <span class="refDoi">Â DOI: 10.1038/nature08960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+Genetics+Strategy+Identifies+an+HCV+NS5A+Inhibitor+with+a+Potent+Clinical+Effect&doi=10.1038%2Fnature08960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-Î± and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0lixiXH5Unw1iA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520Genetics%2520Strategy%2520Identifies%2520an%2520HCV%2520NS5A%2520Inhibitor%2520with%2520a%2520Potent%2520Clinical%2520Effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100%26doi%3D10.1038%2Fnature08960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5057</span>â <span class="NLM_lpage">5071</span>, <span class="refDoi">Â DOI: 10.1021/jm500335h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500335h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5057-5071&author=M.+Belemaauthor=N.+A.+Meanwell&title=Discovery+of+Daclatasvir%2C+a+Pan-Genotypic+Hepatitis+C+Virus+NS5A+Replication+Complex+Inhibitor+with+Potent+Clinical+Effect&doi=10.1021%2Fjm500335h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect</span></div><div class="casAuthors">Belema, Makonen; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5057-5071</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review. The discovery and development of the first-in-class hepatitis C virus (HCV) NS5A replication complex inhibitor daclatasvir provides a compelling example of the power of phenotypic screening to identify leads engaging novel targets in mechanistically unique ways.  HCV NS5A replication complex inhibitors are pan-genotypic in spectrum, and this mechanistic class provides the most potent HCV inhibitors in vitro that have been described to date.  Clin. trials with daclatasvir demonstrated a potent effect on reducing plasma viral load and, in combination with mechanistically orthogonal HCV inhibitors, established the ability to cure even the most difficult infections without the need for immune stimulation.  In this Drug Annotation, the authors describe the discovery of the original high-throughput screening lead BMS-858 and the chem. conundrum and challenges resolved in optimizing to daclatasvir as a clin. candidate and finally the authors summarize the results of select clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiU5qkfNyqXLVg90H21EOLACvtfcHk0lgM3igtkvwtaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurs%253D&md5=1428746b49ba356ce6993a58b143e5dc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm500335h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500335h%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520of%2520Daclatasvir%252C%2520a%2520Pan-Genotypic%2520Hepatitis%2520C%2520Virus%2520NS5A%2520Replication%2520Complex%2520Inhibitor%2520with%2520Potent%2520Clinical%2520Effect%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5057%26epage%3D5071%26doi%3D10.1021%2Fjm500335h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogalian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornpropst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Ledipasvir (GS-5885): A potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2033</span>â <span class="NLM_lpage">2046</span>, <span class="refDoi">Â DOI: 10.1021/jm401499g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401499g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2033-2046&author=J.+O.+Linkauthor=J.+G.+Taylorauthor=L.+Xuauthor=M.+Mitchellauthor=H.+Guoauthor=H.+Liuauthor=D.+Katoauthor=T.+Kirschbergauthor=J.+Sunauthor=N.+Squiresauthor=J.+Parrishauthor=T.+Kellerauthor=Z.+Yangauthor=C.+Yangauthor=M.+Matlesauthor=Y.+Wangauthor=K.+Wangauthor=G.+Chengauthor=Y.+Tianauthor=E.+Mogalianauthor=E.+Mondouauthor=M.+Cornpropstauthor=J.+Perryauthor=M.+C.+Desai&title=Discovery+of+Ledipasvir+%28GS-5885%29%3A+A+potent%2C+Once-Daily+Oral+NS5A+Inhibitor+for+the+Treatment+of+Hepatitis+C+Virus+Infection&doi=10.1021%2Fjm401499g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection</span></div><div class="casAuthors">Link, John O.; Taylor, James G.; Xu, Lianhong; Mitchell, Michael; Guo, Hongyan; Liu, Hongtao; Kato, Darryl; Kirschberg, Thorsten; Sun, Jianyu; Squires, Neil; Parrish, Jay; Kellar, Terry; Yang, Zheng-Yu; Yang, Chris; Matles, Mike; Wang, Yujin; Wang, Kelly; Cheng, Guofeng; Tian, Yang; Mogalian, Erik; Mondou, Elsa; Cornpropst, Melanie; Perry, Jason; Desai, Manoj C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2033-2046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of highly potent NS5A inhibitors with an unsym. benzimidazole-difluorofluorene-imidazole core and distal [2.2.1]-azabicyclic ring system was discovered.  Optimization of antiviral potency and pharmacokinetics led to the identification of ledipasvir (GS-5885).  Ledipasvir (GT1a replicon EC50 = 31 pM) has an extended plasma half-life of 37-45 h in healthy volunteers and produces a rapid >3 log viral load redn. in monotherapy at oral doses of 3 mg or greater with once-daily dosing in genotype 1a HCV-infected patients. ledipasvir has been shown to be safe and efficacious, with SVR12 rates up to 100% when used in combination with direct-acting antivirals having complementary mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiLazFwyH5rrVg90H21EOLACvtfcHk0lgM3igtkvwtaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb3I&md5=30cec1d10b7b7dd02faae4fba4b88bd8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm401499g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401499g%26sid%3Dliteratum%253Aachs%26aulast%3DLink%26aufirst%3DJ.%2BO.%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DD.%26aulast%3DKirschberg%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DSquires%26aufirst%3DN.%26aulast%3DParrish%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMatles%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DMogalian%26aufirst%3DE.%26aulast%3DMondou%26aufirst%3DE.%26aulast%3DCornpropst%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DDesai%26aufirst%3DM.%2BC.%26atitle%3DDiscovery%2520of%2520Ledipasvir%2520%2528GS-5885%2529%253A%2520A%2520potent%252C%2520Once-Daily%2520Oral%2520NS5A%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2033%26epage%3D2046%26doi%3D10.1021%2Fjm401499g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motter, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keddy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tufano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspi, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koev, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maring, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2047</span>â <span class="NLM_lpage">2057</span>, <span class="refDoi">Â DOI: 10.1021/jm401398x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401398x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvFKhsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2047-2057&author=D.+A.+DeGoeyauthor=J.+T.+Randolphauthor=D.+Liuauthor=J.+Prattauthor=C.+Hutchinsauthor=P.+Donnerauthor=A.+C.+Kruegerauthor=M.+Matulenkoauthor=S.+Patelauthor=C.+E.+Motterauthor=L.+Nelsonauthor=R.+Keddyauthor=M.+Tufanoauthor=D.+D.+Caspiauthor=P.+Krishnanauthor=N.+Mistryauthor=G.+Koevauthor=T.+J.+Reischauthor=R.+Mondalauthor=T.+Pilot-Matiasauthor=Y.+Gaoauthor=D.+A.+Benoauthor=C.+J.+Maringauthor=A.+Mollaauthor=E.+Dumasauthor=A.+Campbellauthor=L.+Williamsauthor=C.+Collinsauthor=R.+Wagnerauthor=W.+M.+Kati&title=Discovery+of+ABT-267%2C+a+Pan-Genotypic+Inhibitor+of+HCV+NS5A&doi=10.1021%2Fjm401398x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A</span></div><div class="casAuthors">DeGoey, David A.; Randolph, John T.; Liu, Dachun; Pratt, John; Hutchins, Charles; Donner, Pamela; Krueger, A. Chris; Matulenko, Mark; Patel, Sachin; Motter, Christopher E.; Nelson, Lissa; Keddy, Ryan; Tufano, Michael; Caspi, Daniel D.; Krishnan, Preethi; Mistry, Neeta; Koev, Gennadiy; Reisch, Thomas J.; Mondal, Rubina; Pilot-Matias, Tami; Gao, Yi; Beno, David W. A.; Maring, Clarence J.; Molla, Akhter; Dumas, Emily; Campbell, Andrew; Williams, Laura; Collins, Christine; Wagner, Rolf; Kati, Warren M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2047-2057</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe here N-phenylpyrrolidine-based inhibitors of HCV NS5A with excellent potency, metabolic stability, and pharmacokinetics.  Compds. with 2S,5S stereochem. at the pyrrolidine ring provided improved genotype 1 (GT1) potency compared to the 2R,5R analogs.  Furthermore, the attachment of substituents at the 4-position of the central N-Ph group resulted in compds. with improved potency.  Substitution with tert-Bu, as in compd. 38 (ABT-267)(I), provided compds. with low-picomolar EC50 values and superior pharmacokinetics.  It was discovered that compd. 38 was a pan-genotypic HCV inhibitor, with an EC50 range of 1.7-19.3 pM against GT1a, -1b, -2a, -2b, -3a, -4a, and -5a and 366 pM against GT6a.  Compd. 38 decreased HCV RNA up to 3.10 log10 IU/mL during 3-day monotherapy in treatment-naive HCV GT1-infected subjects and is currently in phase 3 clin. trials in combination with an NS3 protease inhibitor with ritonavir (r) (ABT-450/r) and an NS5B non-nucleoside polymerase inhibitor (ABT-333), with and without ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQLXZPjB144rVg90H21EOLACvtfcHk0li_spGkRd6aAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvFKhsQ%253D%253D&md5=70f0d0f8e9751b533617fecc1b4a8016</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm401398x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401398x%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DRandolph%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPratt%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DC.%26aulast%3DDonner%26aufirst%3DP.%26aulast%3DKrueger%26aufirst%3DA.%2BC.%26aulast%3DMatulenko%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DMotter%26aufirst%3DC.%2BE.%26aulast%3DNelson%26aufirst%3DL.%26aulast%3DKeddy%26aufirst%3DR.%26aulast%3DTufano%26aufirst%3DM.%26aulast%3DCaspi%26aufirst%3DD.%2BD.%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DMistry%26aufirst%3DN.%26aulast%3DKoev%26aufirst%3DG.%26aulast%3DReisch%26aufirst%3DT.%2BJ.%26aulast%3DMondal%26aufirst%3DR.%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DBeno%26aufirst%3DD.%2BA.%26aulast%3DMaring%26aufirst%3DC.%2BJ.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DDumas%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DDiscovery%2520of%2520ABT-267%252C%2520a%2520Pan-Genotypic%2520Inhibitor%2520of%2520HCV%2520NS5A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2047%26epage%3D2057%26doi%3D10.1021%2Fjm401398x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8742: an HCV NS5A Inhibitor with Broad Genotype Activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1930</span>â <span class="NLM_lpage">1940</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201300343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1002%2Fcmdc.201300343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=24127258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SkurzN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1930-1940&author=C.+A.+Coburnauthor=P.+T.+Meinkeauthor=W.+Changauthor=C.+A.+Fandozziauthor=D.+J.+Grahamauthor=B.+Huauthor=Q.+Huangauthor=S.+Kargmanauthor=J.+Kozlowskiauthor=R.+Liuauthor=J.+A.+McCauleyauthor=A.+A.+Nomeirauthor=R.+M.+Sollauthor=J.+P.+Vaccaauthor=D.+Wangauthor=H.+Wuauthor=B.+Zhongauthor=D.+B.+Olsenauthor=S.+W.+Ludmerer&title=Discovery+of+MK-8742%3A+an+HCV+NS5A+Inhibitor+with+Broad+Genotype+Activity&doi=10.1002%2Fcmdc.201300343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity</span></div><div class="casAuthors">Coburn, Craig A.; Meinke, Peter T.; Chang, Wei; Fandozzi, Christine M.; Graham, Donald J.; Hu, Bin; Huang, Qian; Kargman, Stacia; Kozlowski, Joseph; Liu, Rong; McCauley, John A.; Nomeir, Amin A.; Soll, Richard M.; Vacca, Joseph P.; Wang, Dahai; Wu, Hao; Zhong, Bin; Olsen, David B.; Ludmerer, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1930-1940</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The NS5A protein plays a crit. role in the replication of HCV and has been the focus of numerous research efforts over the past few years.  NS5A inhibitors have shown impressive in vitro potency profiles in HCV replicon assays, making them attractive components for inclusion in all oral combination regimens.  Early work in the NS5A arena led to the discovery of our first clin. candidate, MK-4882 [2-((S)-pyrrolidin-2-yl)-5-(2-(4-(5-((S)-pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole].  While preclin. proof-of-concept studies in HCV-infected chimpanzees harboring chronic genotype 1 infections resulted in significant decreases in viral load after both single- and multiple-dose treatments, viral breakthrough proved to be a concern, thus necessitating the development of compds. with increased potency against a no. of genotypes and NS5A resistance mutations.  Modification of the MK-4882 core scaffold by introduction of a cyclic constraint afforded a series of tetracyclic inhibitors, which showed improved virol. profiles.  Herein we describe the research efforts that led to the discovery of MK-8742, a tetracyclic indole-based NS5A inhibitor, which is currently in phase 2b clin. trials as part of an all-oral, interferon-free regimen for the treatment of HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqknZKO01aZlLVg90H21EOLACvtfcHk0li_spGkRd6aAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SkurzN&md5=2f2b3ed2281c43e39b24d4197b9f57ee</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300343%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFandozzi%26aufirst%3DC.%2BA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520MK-8742%253A%2520an%2520HCV%2520NS5A%2520Inhibitor%2520with%2520Broad%2520Genotype%2520Activity%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1930%26epage%3D1940%26doi%3D10.1002%2Fcmdc.201300343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span>; <span class="NLM_string-name">Rosenblum, S. B.</span>; <span class="NLM_string-name">Coburn, C. A.</span>; <span class="NLM_string-name">Shankar, B. B.</span>; <span class="NLM_string-name">Anilkumar, G. N.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Dwyer, M.
P.</span>; <span class="NLM_string-name">Jiang, Y.</span>; <span class="NLM_string-name">Keertikar, K. M.</span>; <span class="NLM_string-name">Lavey, B. J.</span>; <span class="NLM_string-name">Seluytin, O. B.</span>; <span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Wong, M.</span>; <span class="NLM_string-name">Yang, D.-Y.</span>; <span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Zhao, G.</span>; <span class="NLM_string-name">Wu, H.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Zhong, B.</span>; <span class="NLM_string-name">Sun, F.</span>; <span class="NLM_string-name">Ji, T.</span>; <span class="NLM_string-name">Shen, C.</span>; <span class="NLM_string-name">Rizvi, R.</span>; <span class="NLM_string-name">Zeng, Q.</span></span> <span> </span><span class="NLM_article-title">Tetracyclic Indole Derivatives for Treating Hepatitis C Virus Infection</span>. <span class="NLM_patent">WO 2012041014 A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+A.+Kozlowski&author=S.+B.+Rosenblum&author=C.+A.+Coburn&author=B.+B.+Shankar&author=G.+N.+Anilkumar&author=L.+Chen&author=M.%0AP.+Dwyer&author=Y.+Jiang&author=K.+M.+Keertikar&author=B.+J.+Lavey&author=O.+B.+Seluytin&author=L.+Tong&author=M.+Wong&author=D.-Y.+Yang&author=W.+Yu&author=G.+Zhao&author=H.+Wu&author=B.+Hu&author=B.+Zhong&author=F.+Sun&author=T.+Ji&author=C.+Shen&author=R.+Rizvi&author=Q.+Zeng&title=Tetracyclic+Indole+Derivatives+for+Treating+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DTetracyclic%2520Indole%2520Derivatives%2520for%2520Treating%2520Hepatitis%2520C%2520Virus%2520Infection%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawitz, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvory-Sobol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doehle, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worth, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brainard, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, H.</span></span> <span> </span><span class="NLM_article-title">Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5368</span>â <span class="NLM_lpage">5378</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00763-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1128%2FAAC.00763-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=27353271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKksbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=5368-5378&author=E.+J.+Lawitzauthor=H.+Dvory-Sobolauthor=B.+P.+Doehleauthor=A.+S.+Worthauthor=J.+McNallyauthor=D.+M.+Brainardauthor=J.+O.+Linkauthor=M.+D.+Millerauthor=H.+Mo&title=Clinical+Resistance+to+Velpatasvir+%28GS-5816%29%2C+a+Novel+Pan-Genotypic+Inhibitor+of+the+Hepatitis+C+Virus+NS5A+Protein&doi=10.1128%2FAAC.00763-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical resistance to velpatasvir (GS-5816), a novel pan-genotypic inhibitor of the hepatitis C virus NS5A protein</span></div><div class="casAuthors">Lawitz, Eric J.; Dvory-Sobol, Hadas; Doehle, Brian P.; Worth, Angela S.; McNally, John; Brainard, Diana M.; Link, John O.; Miller, Michael D.; Mo, Hongmei</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5368-5378</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons.  In a phase 1b 3-day monotherapy study, patients treated with a 150-mg dose of GS-5816 had a mean maximal HCV RNA decline ofâ¥3.3 log10 IU/mL in GT1a, -1b, -2, -3, and -4.  This report characterizes virol. resistance to VEL in these patients.  NS5A resistance-assocd. substitutions (RASs) were detected by deep sequencing (1% cutoff) pretreatment in 22/70 patients, i.e., 10/35 (29%) patients with GT1a, 1/8 (13%) with GT1b, 4/8 (50.0%) with GT2, 5/17 (29.4%) with GT3, and 2/2 (100.0%) with GT4.  In GT1a and GT3 patients, pretreatment RASs were assocd. with a slightly reduced HCV RNA response compared to that of patients without pretreatment RASs; among patients with GT1b, GT2, and GT4, no significant difference in response was obsd. in those with or without pretreatment RASs.  Following treatment, the pattern of emergent RASs was more complex for GT1a than for the other genotypes.  In GT1a, substitutions emerged at positions M28, Q30, L31, P32, H58, E92, and Y93, with the most prevalent substitutions at positions Y93, M28, and L31.  RASs were obsd. at two positions in GT1b and GT2 (Y93 and L31), three positions in GT3 (Y93, L31, and E92), and four positions in GT4 (L28, M31, P32L, and Y93).  RASs that were present pretreatment persisted through the 48-wk follow-up period; however, RASs emerging during treatment were more likely to decline both in prevalence and in frequency within the viral population during follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcz7ZV8QWTkbVg90H21EOLACvtfcHk0lgjrlPoO_oVSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKksbk%253D&md5=5b6faa0f793f362ce5c1c11a2729d656</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FAAC.00763-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00763-16%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DDvory-Sobol%26aufirst%3DH.%26aulast%3DDoehle%26aufirst%3DB.%2BP.%26aulast%3DWorth%26aufirst%3DA.%2BS.%26aulast%3DMcNally%26aufirst%3DJ.%26aulast%3DBrainard%26aufirst%3DD.%2BM.%26aulast%3DLink%26aufirst%3DJ.%2BO.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DMo%26aufirst%3DH.%26atitle%3DClinical%2520Resistance%2520to%2520Velpatasvir%2520%2528GS-5816%2529%252C%2520a%2520Novel%2520Pan-Genotypic%2520Inhibitor%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS5A%2520Protein%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D5368%26epage%3D5378%26doi%3D10.1128%2FAAC.00763-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maring, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span> <span> </span><span class="NLM_article-title">In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e02558-16</span>, <span class="refDoi">Â DOI: 10.1128/AAC.02558-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1128%2FAAC.02558-16" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e02558-16&author=T.+I.+Ngauthor=P.+Krishnanauthor=T.+Pilot-Matiasauthor=W.+Katiauthor=G.+Schnellauthor=J.+Beyerauthor=T.+Reischauthor=L.+Luauthor=T.+Dekhtyarauthor=M.+Irvinauthor=R.+Tripathiauthor=C.+Maringauthor=J.+T.+Randolphauthor=R.+Wagnerauthor=C.+Collins&title=In+Vitro+Antiviral+Activity+and+Resistance+Profile+of+the+Next-Generation+Hepatitis+C+Virus+NS5A+Inhibitor+Pibrentasvir&doi=10.1128%2FAAC.02558-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.02558-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02558-16%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DT.%2BI.%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DSchnell%26aufirst%3DG.%26aulast%3DBeyer%26aufirst%3DJ.%26aulast%3DReisch%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DIrvin%26aufirst%3DM.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DMaring%26aufirst%3DC.%26aulast%3DRandolph%26aufirst%3DJ.%2BT.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DCollins%26aufirst%3DC.%26atitle%3DIn%2520Vitro%2520Antiviral%2520Activity%2520and%2520Resistance%2520Profile%2520of%2520the%2520Next-Generation%2520Hepatitis%2520C%2520Virus%2520NS5A%2520Inhibitor%2520Pibrentasvir%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De02558-16%26doi%3D10.1128%2FAAC.02558-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keertikar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauuan, P. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naicker, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellekoop, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Silyl Proline Containing HCV NS5A Inhibitors with Pan-Genotype Activity: SAR Development</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1475</span>â <span class="NLM_lpage">1479</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.01.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.01.050" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1475-1479&author=A.+G.+Nairauthor=Q.+Zengauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Y.+Jiangauthor=D.-Y.+Yangauthor=K.+Keertikarauthor=G.+Zhouauthor=M.+Dwyerauthor=S.+H.+Kimauthor=B.+Shankarauthor=W.+Yuauthor=L.+Tongauthor=L.+Chenauthor=R.+Mazzolaauthor=J.+Caldwellauthor=H.+Tangauthor=M.+Allardauthor=R.+N.+Buckleauthor=P.+J.+F.+Gauuanauthor=C.+L.+Holstauthor=G.+S.+Martinauthor=K.+P.+Naickerauthor=S.+Vellekoopauthor=S.+Agrawalauthor=R.+Liuauthor=R.+Kongauthor=P.+Ingravalloauthor=E.+Xiaauthor=Y.+Zhaiauthor=A.+Nomeirauthor=J.+A.+Kozlowski&title=Discovery+of+Silyl+Proline+Containing+HCV+NS5A+Inhibitors+with+Pan-Genotype+Activity%3A+SAR+Development&doi=10.1016%2Fj.bmcl.2016.01.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.050%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DKeertikar%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DDwyer%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DShankar%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DAllard%26aufirst%3DM.%26aulast%3DBuckle%26aufirst%3DR.%2BN.%26aulast%3DGauuan%26aufirst%3DP.%2BJ.%2BF.%26aulast%3DHolst%26aufirst%3DC.%2BL.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DNaicker%26aufirst%3DK.%2BP.%26aulast%3DVellekoop%26aufirst%3DS.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520Silyl%2520Proline%2520Containing%2520HCV%2520NS5A%2520Inhibitors%2520with%2520Pan-Genotype%2520Activity%253A%2520SAR%2520Development%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1475%26epage%3D1479%26doi%3D10.1016%2Fj.bmcl.2016.01.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Fused Tricyclic Core Containing HCV NS5A Inhibitors with Pan-Genotype Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3158</span>â <span class="NLM_lpage">3162</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.04.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.04.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=27180013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFKksL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3158-3162&author=W.+Yuauthor=C.+A.+Coburnauthor=D.-Y.+Yangauthor=P.+T.+Meinkeauthor=M.+Wongauthor=S.+B.+Rosenblumauthor=K.+X.+Chenauthor=G.+F.+Njorogeauthor=L.+Chenauthor=M.+P.+Dwyerauthor=Y.+Jiangauthor=A.+G.+Nairauthor=O.+Selyutinauthor=L.+Tongauthor=Q.+Zengauthor=B.+Zhongauthor=T.+Jiauthor=B.+Huauthor=S.+Agrawalauthor=E.+Xiaauthor=Y.+Zhaiauthor=R.+Liuauthor=R.+Kongauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=A.+Nomeirauthor=J.+Fellsauthor=J.+A.+Kozlowski&title=Discovery+of+Fused+Tricyclic+Core+Containing+HCV+NS5A+Inhibitors+with+Pan-Genotype+Activity&doi=10.1016%2Fj.bmcl.2016.04.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity</span></div><div class="casAuthors">Yu, Wensheng; Coburn, Craig A.; Yang, De-Yi; Meinke, Peter T.; Wong, Michael; Rosenblum, Stuart B.; Chen, Kevin X.; Njoroge, George F.; Chen, Lei; Dwyer, Michael P.; Jiang, Yueheng; Nair, Anilkumar G.; Selyutin, Oleg; Tong, Ling; Zeng, Qingbei; Zhong, Bin; Ji, Tao; Hu, Bin; Agrawal, Sony; Xia, Ellen; Zhai, Ying; Liu, Rong; Kong, Rong; Ingravallo, Paul; Asante-Appiah, Ernest; Nomeir, Amin; Fells, James; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3158-3162</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HCV NS5A inhibitors have demonstrated impressive in vitro potency profiles in HCV replicon assays and robust HCV RNA titer redn. in the clinic making them attractive components for inclusion in an all oral fixed dose combination regimen for the treatment of HCV infection.  Herein, the authors describe research efforts that led to the discovery of a series of fused tricyclic core contg. HCV NS5A inhibitors which have pan-genotype activity and are orally bioavailable in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbNVloDNfNu7Vg90H21EOLACvtfcHk0li2tnnwXObkeg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFKksL4%253D&md5=fb4395a0816a44bfe30aa2ff6e9ca2e1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.084%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DG.%2BF.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DFells%26aufirst%3DJ.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520Fused%2520Tricyclic%2520Core%2520Containing%2520HCV%2520NS5A%2520Inhibitors%2520with%2520Pan-Genotype%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3158%26epage%3D3162%26doi%3D10.1016%2Fj.bmcl.2016.04.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vibulbhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellekoop, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Macrocyclic HCV NS5A Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3793</span>â <span class="NLM_lpage">3799</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=27282743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1yhu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3793-3799&author=W.+Yuauthor=B.+Vibulbhanauthor=S.+B.+Rosenblumauthor=G.+S.+Martinauthor=A.+S.+Vellekoopauthor=C.+L.+Holstauthor=C.+A.+Coburnauthor=M.+Wongauthor=O.+Selyutinauthor=T.+Jiauthor=B.+Zhongauthor=B.+Huauthor=L.+Chenauthor=M.+P.+Dwyerauthor=Y.+Jiangauthor=A.+G.+Nairauthor=L.+Tongauthor=Q.+Zengauthor=S.+Agrawalauthor=D.+Carrauthor=L.+Rokoszauthor=R.+Liuauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=F.+Lahserauthor=E.+Asante-Appiahauthor=J.+Fellsauthor=J.+A.+Kozlowski&title=Discovery+of+Potent+Macrocyclic+HCV+NS5A+Inhibitors&doi=10.1016%2Fj.bmcl.2016.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent macrocyclic HCV NS5A inhibitors</span></div><div class="casAuthors">Yu, Wensheng; Vibulbhan, Bancha; Rosenblum, Stuart B.; Martin, Gregory S.; Vellekoop, A. Samuel; Holst, Christian L.; Coburn, Craig A.; Wong, Michael; Selyutin, Oleg; Ji, Tao; Zhong, Bin; Hu, Bin; Chen, Lei; Dwyer, Michael P.; Jiang, Yueheng; Nair, Anilkumar G.; Tong, Ling; Zeng, Qingbei; Agrawal, Sony; Carr, Donna; Rokosz, Laura; Liu, Rong; Curry, Stephanie; McMonagle, Patricia; Ingravallo, Paul; Lahser, Fred; Asante-Appiah, Ernest; Fells, James; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3793-3799</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HCV NS5A inhibitors have demonstrated impressive in vitro virol. profiles in HCV replicon assays and robust HCV RNA titer redn. in the clinic making them attractive components for inclusion in an all oral fixed-dose combination (FDC) regimen for the treatment of HCV infection.  Merck's effort in this area identified MK-4882 and MK-8325 as early development leads.  Herein, the authors describe the discovery of potent macrocyclic NS5A inhibitors bearing the MK-8325 or MK-4882 core structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ3NOWpHOwfbVg90H21EOLACvtfcHk0lh8xqxNwRo57g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1yhu7Y%253D&md5=6321a9abda45e67b5054273731bdabbb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DVellekoop%26aufirst%3DA.%2BS.%26aulast%3DHolst%26aufirst%3DC.%2BL.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DFells%26aufirst%3DJ.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520Potent%2520Macrocyclic%2520HCV%2520NS5A%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3793%26epage%3D3799%26doi%3D10.1016%2Fj.bmcl.2016.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A.</span>; <span class="NLM_string-name">Zeng, Q.</span>; <span class="NLM_string-name">Selyutin, O.</span>; <span class="NLM_string-name">Rosenblum, S. B.</span>; <span class="NLM_string-name">Jiang, Y.</span>; <span class="NLM_string-name">Yang, D.-Y.</span>; <span class="NLM_string-name">Keertikar, K.</span>; <span class="NLM_string-name">Zhou, G.</span>; <span class="NLM_string-name">Dwyer, M.</span>; <span class="NLM_string-name">Kim, S. H.</span>; <span class="NLM_string-name">Shankar, B.</span>; <span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Mazzola, R.</span>; <span class="NLM_string-name">Caldwell, J.</span>; <span class="NLM_string-name">Tang, H.</span>; <span class="NLM_string-name">Agrawal, S.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Kong, R.</span>; <span class="NLM_string-name">Ingravallo, P.</span>; <span class="NLM_string-name">Xia, E.</span>; <span class="NLM_string-name">Zhai, Y.</span>; <span class="NLM_string-name">Nomeir, A.</span>; <span class="NLM_string-name">Asante-Appiah, E.</span>; <span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">MK-8325: A Silyl Proline-Containing NS5A Inhibitor with Pan-Genotype Activity for Treatment of HCV</span>.  <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, DOI: <span class="refDoi">Â DOI: 10.1016/j.bmcl.2018.03.049</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2018.03.049" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+Nair&author=Q.+Zeng&author=O.+Selyutin&author=S.+B.+Rosenblum&author=Y.+Jiang&author=D.-Y.+Yang&author=K.+Keertikar&author=G.+Zhou&author=M.+Dwyer&author=S.+H.+Kim&author=B.+Shankar&author=W.+Yu&author=L.+Tong&author=L.+Chen&author=R.+Mazzola&author=J.+Caldwell&author=H.+Tang&author=S.+Agrawal&author=R.+Liu&author=R.+Kong&author=P.+Ingravallo&author=E.+Xia&author=Y.+Zhai&author=A.+Nomeir&author=E.+Asante-Appiah&author=J.+A.+Kozlowski&title=MK-8325%3A+A+Silyl+Proline-Containing+NS5A+Inhibitor+with+Pan-Genotype+Activity+for+Treatment+of+HCV&doi=10.1016%2Fj.bmcl.2018.03.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DA.%26atitle%3DMK-8325%253A%2520A%2520Silyl%2520Proline-Containing%2520NS5A%2520Inhibitor%2520with%2520Pan-Genotype%2520Activity%2520for%2520Treatment%2520of%2520HCV%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26doi%3D10.1016%2Fj.bmcl.2018.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Alternative Core Development Around the Tetracyclic Indole Class of HCV NS5A Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5132</span>â <span class="NLM_lpage">5137</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.07.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.07.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=27634194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWitrvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5132-5137&author=L.+Tongauthor=W.+Yuauthor=C.+A.+Coburnauthor=P.+T.+Meinkeauthor=A.+G.+Nairauthor=M.+P.+Dwyerauthor=L.+Chenauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Y.+Jiangauthor=J.+Fellsauthor=B.+Huauthor=B.+Zhongauthor=R.+M.+Sollauthor=R.+Liuauthor=S.+Agrawalauthor=E.+Xiaauthor=Y.+Zhaiauthor=R.+Kongauthor=P.+Ingravalloauthor=A.+Nomeirauthor=E.+Asante-Appiahauthor=J.+A.+Kozlowski&title=Alternative+Core+Development+Around+the+Tetracyclic+Indole+Class+of+HCV+NS5A+Inhibitors&doi=10.1016%2Fj.bmcl.2016.07.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors</span></div><div class="casAuthors">Tong, Ling; Yu, Wensheng; Coburn, Craig A.; Meinke, Peter T.; Nair, Anilkumar G.; Dwyer, Michael P.; Chen, Lei; Selyutin, Oleg; Rosenblum, Stuart B.; Jiang, Yueheng; Fells, James; Hu, Bin; Zhong, Bin; Soll, Richard M.; Liu, Rong; Agrawal, Sony; Xia, Ellen; Zhai, Ying; Kong, Rong; Ingravallo, Paul; Nomeir, Amin; Asante-Appiah, Ernest; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5132-5137</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein, the authors describe the research efforts to develop unique cores in mols. which function as HCV nonstructural protein 5A (NS5A) inhibitors.  In particular, various fused tetracyclic cores were identified which showed genotype and mutant activities comparable to the indole-based tetracyclic core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEF0RZFkG817Vg90H21EOLACvtfcHk0ljh43-i6ixEfg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWitrvK&md5=c58058200ecae97babae141556489479</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.057%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DFells%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DAlternative%2520Core%2520Development%2520Around%2520the%2520Tetracyclic%2520Indole%2520Class%2520of%2520HCV%2520NS5A%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5132%26epage%3D5137%26doi%3D10.1016%2Fj.bmcl.2016.07.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keertikar, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Substituted Tetracyclic Indole Core Derivatives of HCV NS5A Inhibitor MK-8742</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4851</span>â <span class="NLM_lpage">4856</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.08.002" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4851-4856&author=W.+Yuauthor=G.+Zhouauthor=C.+A.+Coburnauthor=Q.+Zengauthor=L.+Tongauthor=M.+P.+Dwyerauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=L.+Chenauthor=R.+Mazzolaauthor=J.-H.+Kimauthor=D.+Shaauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=B.+Laveyauthor=A.+G.+Nairauthor=S.+H.+Kimauthor=K.+M.+Keertikarauthor=L.+Rokoszauthor=S.+Agrawalauthor=R.+Liuauthor=E.+Xiaauthor=Y.+Zhaiauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=S.+Chenauthor=J.+A.+Kozlowski&title=Substituted+Tetracyclic+Indole+Core+Derivatives+of+HCV+NS5A+Inhibitor+MK-8742&doi=10.1016%2Fj.bmcl.2016.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DSha%26aufirst%3DD.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DLavey%26aufirst%3DB.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKeertikar%26aufirst%3DK.%2BM.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DSubstituted%2520Tetracyclic%2520Indole%2520Core%2520Derivatives%2520of%2520HCV%2520NS5A%2520Inhibitor%2520MK-8742%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4851%26epage%3D4856%26doi%3D10.1016%2Fj.bmcl.2016.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keertikar, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Matched and Mixed Cap Derivatives of the HCV NS5A Inhibitor MK-8742</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4106</span>â <span class="NLM_lpage">4111</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.06.063" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4106-4111&author=M.+P.+Dwyerauthor=K.+M.+Keertikarauthor=L.+Chenauthor=L.+Tongauthor=O.+Selyutinauthor=A.+G.+Nairauthor=W.+Yuauthor=G.+Zhouauthor=B.+J.+Laveyauthor=D.-Y.+Yangauthor=M.+Wongauthor=S.+H.+Kimauthor=C.+A.+Coburnauthor=S.+B.+Rosenblumauthor=Q.+Zengauthor=Y.+Jiangauthor=B.+B.+Shankarauthor=R.+Rizviauthor=A.+A.+Nomeirauthor=R.+Liuauthor=S.+Agrawalauthor=E.+Xiaauthor=R.+Kongauthor=Y.+Zhaiauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=J.+A.+Kozlowski&title=Matched+and+Mixed+Cap+Derivatives+of+the+HCV+NS5A+Inhibitor+MK-8742&doi=10.1016%2Fj.bmcl.2016.06.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DKeertikar%26aufirst%3DK.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DLavey%26aufirst%3DB.%2BJ.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DShankar%26aufirst%3DB.%2BB.%26aulast%3DRizvi%26aufirst%3DR.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DMatched%2520and%2520Mixed%2520Cap%2520Derivatives%2520of%2520the%2520HCV%2520NS5A%2520Inhibitor%2520MK-8742%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4106%26epage%3D4111%26doi%3D10.1016%2Fj.bmcl.2016.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Alkyl Substituted Aminal Derivatives of HCV NS5A Inhibitor MK-8742</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3800</span>â <span class="NLM_lpage">3805</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.05.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.05.041" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3800-3805&author=W.+Yuauthor=C.+A.+Coburnauthor=A.+G.+Nairauthor=M.+Wongauthor=L.+Tongauthor=M.+P.+Dwyerauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=D.-Y.+Yangauthor=O.+Selyutinauthor=Y.+Jiangauthor=S.+B.+Rosenblumauthor=S.+H.+Kimauthor=B.+J.+Laveyauthor=G.+Zhouauthor=R.+Rizviauthor=B.+B.+Shankarauthor=Q.+Zengauthor=L.+Chenauthor=S.+Agrawalauthor=D.+Carrauthor=L.+Rokoszauthor=R.+Liuauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=F.+Lahserauthor=E.+Asante-Appiahauthor=A.+Nomeirauthor=J.+A.+Kozlowski&title=Alkyl+Substituted+Aminal+Derivatives+of+HCV+NS5A+Inhibitor+MK-8742&doi=10.1016%2Fj.bmcl.2016.05.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.041%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLavey%26aufirst%3DB.%2BJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DRizvi%26aufirst%3DR.%26aulast%3DShankar%26aufirst%3DB.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DAlkyl%2520Substituted%2520Aminal%2520Derivatives%2520of%2520HCV%2520NS5A%2520Inhibitor%2520MK-8742%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3800%26epage%3D3805%26doi%3D10.1016%2Fj.bmcl.2016.05.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Aryl or Heteroaryl Substituted Aminal Derivatives of HCV NS5A Inhibitor MK-8742</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3414</span>â <span class="NLM_lpage">3420</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.06.056" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3414-3420&author=W.+Yuauthor=C.+A.+Coburnauthor=A.+G.+Nairauthor=M.+Wongauthor=S.+B.+Rosenblumauthor=G.+Zhouauthor=M.+P.+Dwyerauthor=L.+Tongauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=S.+H.+Kimauthor=Q.+Zengauthor=O.+Selyutinauthor=L.+Chenauthor=F.+Masseauthor=S.+Agrawalauthor=R.+Liuauthor=E.+Xiaauthor=Y.+Zhaiauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=X.+Linauthor=J.+A.+Kozlowski&title=Aryl+or+Heteroaryl+Substituted+Aminal+Derivatives+of+HCV+NS5A+Inhibitor+MK-8742&doi=10.1016%2Fj.bmcl.2016.06.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DAryl%2520or%2520Heteroaryl%2520Substituted%2520Aminal%2520Derivatives%2520of%2520HCV%2520NS5A%2520Inhibitor%2520MK-8742%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3414%26epage%3D3420%26doi%3D10.1016%2Fj.bmcl.2016.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bystol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">StructureâActivity Relationships of Proline Modifications Around the Tetracyclic-Indole Class of NS5A Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5354</span>â <span class="NLM_lpage">5360</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.08.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.08.097" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5354-5360&author=L.+Tongauthor=W.+Yuauthor=C.+A.+Coburnauthor=L.+Chenauthor=O.+Selyutinauthor=Q.+Zengauthor=M.+P.+Dwyerauthor=A.+G.+Nairauthor=B.+B.+Shankarauthor=S.+H.+Kimauthor=D.-Y.+Yangauthor=S.+B.+Rosenblumauthor=R.+T.+Ruckauthor=I.+W.+Daviesauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=R.+Liuauthor=S.+Agrawalauthor=D.+Carrauthor=S.+Curryauthor=P.+McMonagleauthor=K.+Bystolauthor=F.+Lahserauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=S.+Chenauthor=J.+A.+Kozlowski&title=Structure%E2%80%93Activity+Relationships+of+Proline+Modifications+Around+the+Tetracyclic-Indole+Class+of+NS5A+Inhibitors&doi=10.1016%2Fj.bmcl.2016.08.097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.097%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DShankar%26aufirst%3DB.%2BB.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DRuck%26aufirst%3DR.%2BT.%26aulast%3DDavies%26aufirst%3DI.%2BW.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DBystol%26aufirst%3DK.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520of%2520Proline%2520Modifications%2520Around%2520the%2520Tetracyclic-Indole%2520Class%2520of%2520NS5A%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5354%26epage%3D5360%26doi%3D10.1016%2Fj.bmcl.2016.08.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Chromane Containing HCV NS5A Inhibitors with Improved Potency Against Resistance Associate Variants</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10228</span>â <span class="NLM_lpage">10243</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01234</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01234" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10228-10243&author=W.+Yuauthor=L.+Tongauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=C.+A.+Coburnauthor=O.+Selyutinauthor=L.+Chenauthor=L.+Rokoszauthor=S.+Agrawalauthor=R.+Liuauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=S.+Chenauthor=J.+A.+Kozlowski&title=Discovery+of+Chromane+Containing+HCV+NS5A+Inhibitors+with+Improved+Potency+Against+Resistance+Associate+Variants&doi=10.1021%2Facs.jmedchem.6b01234"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01234%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520Chromane%2520Containing%2520HCV%2520NS5A%2520Inhibitors%2520with%2520Improved%2520Potency%2520Against%2520Resistance%2520Associate%2520Variants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10228%26epage%3D10243%26doi%3D10.1021%2Facs.jmedchem.6b01234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bystol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartwright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity Against Common Resistance-Associated Polymorphisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">290</span>â <span class="NLM_lpage">306</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01310</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01310" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslygt7jN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=290-306&author=L.+Tongauthor=W.+Yuauthor=L.+Chenauthor=O.+Selyutinauthor=M.+P.+Dwyerauthor=A.+G.+Nairauthor=R.+Mazzolaauthor=J.-H.+Kimauthor=D.+Shaauthor=J.+Yinauthor=R.+T.+Ruckauthor=I.+W.+Daviesauthor=R.+Liuauthor=S.+Agrawalauthor=E.+Xiaauthor=S.+Curryauthor=P.+McMonagleauthor=K.+Bystolauthor=F.+Lahserauthor=D.+Carrauthor=L.+Rokoszauthor=P.+Ingravalloauthor=S.+Chenauthor=K.-I.+Fengauthor=M.+Cartwrightauthor=E.+Asante-Appiahauthor=J.+A.+Kozlowskiauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zan&title=Discovery+of+Ruzasvir+%28MK-8408%29%3A+A+Potent%2C+Pan-Genotype+HCV+NS5A+Inhibitor+with+Optimized+Activity+Against+Common+Resistance-Associated+Polymorphisms&doi=10.1021%2Facs.jmedchem.6b01310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms</span></div><div class="casAuthors">Tong, Ling; Yu, Wensheng; Chen, Lei; Selyutin, Oleg; Dwyer, Michael P.; Nair, Anilkumar G.; Mazzola, Robert; Kim, Jae-Hun; Sha, Deyou; Yin, Jingjun; Ruck, Rebecca T.; Davies, Ian W.; Hu, Bin; Zhong, Bin; Hao, Jinglai; Ji, Tao; Zan, Shuai; Liu, Rong; Agrawal, Sony; Xia, Ellen; Curry, Stephanie; McMonagle, Patricia; Bystol, Karin; Lahser, Frederick; Carr, Donna; Rokosz, Laura; Ingravallo, Paul; Chen, Shiying; Feng, Kung-I.; Cartwright, Mark; Asante-Appiah, Ernest; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">290-306</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the research that led to the discovery of compd. 40 (ruzasvir, MK-8408), a pan-genotypic HCV nonstructural protein 5A (NS5A) inhibitor with a "flat" GT1 mutant profile.  This NS5A inhibitor contains a unique tetracyclic indole core, while maintaining the imidazole-proline-valine Moc motifs of the authors' previous NS5A inhibitors.  Compd. 40 is currently in early clin. trials and is under evaluation as part of an all-oral DAA regimen for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FD27q2S7fLVg90H21EOLACvtfcHk0lh_LtNsedKOmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslygt7jN&md5=6224e41b940abfb96cda518ecebf3e0f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01310%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DSha%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DRuck%26aufirst%3DR.%2BT.%26aulast%3DDavies%26aufirst%3DI.%2BW.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DBystol%26aufirst%3DK.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DK.-I.%26aulast%3DCartwright%26aufirst%3DM.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Ruzasvir%2520%2528MK-8408%2529%253A%2520A%2520Potent%252C%2520Pan-Genotype%2520HCV%2520NS5A%2520Inhibitor%2520with%2520Optimized%2520Activity%2520Against%2520Common%2520Resistance-Associated%2520Polymorphisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D290%26epage%3D306%26doi%3D10.1021%2Facs.jmedchem.6b01310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Kozlowski, J. A.</span>; <span class="NLM_string-name">Selyutin, O.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Kim, J.-H.</span>; <span class="NLM_string-name">Sha, D.</span>; <span class="NLM_string-name">Rizvi, R.</span>; <span class="NLM_string-name">Shankar, B.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Zhong, B.</span>; <span class="NLM_string-name">Wai, D.</span>; <span class="NLM_string-name">Hao, J.</span>; <span class="NLM_string-name">Wei, W.</span>; <span class="NLM_string-name">Ji, T.</span>; <span class="NLM_string-name">Zan, S.</span></span> <span> </span><span class="NLM_article-title">Heterocycle-Substituted Tetracyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases</span>. <span class="NLM_patent">WO 2014110705 A9</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=W.+Yu&author=L.+Tong&author=J.+A.+Kozlowski&author=O.+Selyutin&author=L.+Chen&author=J.-H.+Kim&author=D.+Sha&author=R.+Rizvi&author=B.+Shankar&author=B.+Hu&author=B.+Zhong&author=D.+Wai&author=J.+Hao&author=W.+Wei&author=T.+Ji&author=S.+Zan&title=Heterocycle-Substituted+Tetracyclic+Compounds+and+Methods+of+Use+Thereof+for+the+Treatment+of+Viral+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26atitle%3DHeterocycle-Substituted%2520Tetracyclic%2520Compounds%2520and%2520Methods%2520of%2520Use%2520Thereof%2520for%2520the%2520Treatment%2520of%2520Viral%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Kozlowski, J. A.</span>; <span class="NLM_string-name">Selyutin, O.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Kim, J.-H.</span>; <span class="NLM_string-name">Sha, D.</span>; <span class="NLM_string-name">Rizvi, R.</span>; <span class="NLM_string-name">Shankar, B.</span></span> <span> </span><span class="NLM_article-title">Heterocycle-Substituted Tetracyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases</span>. <span class="NLM_patent">US 9555038 B2</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=W.+Yu&author=L.+Tong&author=J.+A.+Kozlowski&author=O.+Selyutin&author=L.+Chen&author=J.-H.+Kim&author=D.+Sha&author=R.+Rizvi&author=B.+Shankar&title=Heterocycle-Substituted+Tetracyclic+Compounds+and+Methods+of+Use+Thereof+for+the+Treatment+of+Viral+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26atitle%3DHeterocycle-Substituted%2520Tetracyclic%2520Compounds%2520and%2520Methods%2520of%2520Use%2520Thereof%2520for%2520the%2520Treatment%2520of%2520Viral%2520Diseases%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Kozlowski, J. A.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Selyutin, O.</span>; <span class="NLM_string-name">Kim, S. H.</span>; <span class="NLM_string-name">Dwyer, M.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Zhong, B.</span>; <span class="NLM_string-name">Wai, D.</span>; <span class="NLM_string-name">Hao, J.</span>; <span class="NLM_string-name">Shen, C.</span>; <span class="NLM_string-name">Lei, Z.</span>; <span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">Preparation of Thiophene-Substituted Tetracyclic Compounds End-Capped with Peptide Derivatives as Antiviral Agents for Treating Hepatitis C Virus Infection</span>. <span class="NLM_patent">WO 2014110706 A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Tong&author=W.+Yu&author=J.+A.+Kozlowski&author=L.+Chen&author=O.+Selyutin&author=S.+H.+Kim&author=M.+Dwyer&author=B.+Hu&author=B.+Zhong&author=D.+Wai&author=J.+Hao&author=C.+Shen&author=Z.+Lei&author=W.+Wang&title=Preparation+of+Thiophene-Substituted+Tetracyclic+Compounds+End-Capped+with+Peptide+Derivatives+as+Antiviral+Agents+for+Treating+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26atitle%3DPreparation%2520of%2520Thiophene-Substituted%2520Tetracyclic%2520Compounds%2520End-Capped%2520with%2520Peptide%2520Derivatives%2520as%2520Antiviral%2520Agents%2520for%2520Treating%2520Hepatitis%2520C%2520Virus%2520Infection%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saksena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralston, R.</span></span> <span> </span><span class="NLM_article-title">Characterization of Resistance Mutations Against HCV Ketoamide Protease Inhibitors</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">177</span>â <span class="NLM_lpage">185</span>, <span class="refDoi">Â DOI: 10.1016/j.antiviral.2007.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.antiviral.2007.11.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2008&pages=177-185&author=X.+Tongauthor=S.+Bogenauthor=R.+Chaseauthor=V.+Girijavallabhanauthor=Z.+Guoauthor=F.+G.+Njorogeauthor=A.+Prongayauthor=A.+Saksenaauthor=A.+Skeltonauthor=E.+Xiaauthor=R.+Ralston&title=Characterization+of+Resistance+Mutations+Against+HCV+Ketoamide+Protease+Inhibitors&doi=10.1016%2Fj.antiviral.2007.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2007.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2007.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DX.%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSaksena%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DRalston%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520Resistance%2520Mutations%2520Against%2520HCV%2520Ketoamide%2520Protease%2520Inhibitors%26jtitle%3DAntiviral%2520Res.%26date%3D2008%26volume%3D77%26spage%3D177%26epage%3D185%26doi%3D10.1016%2Fj.antiviral.2007.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeplinger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span> <span> </span><span class="NLM_article-title">Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">926</span>â <span class="NLM_lpage">934</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01032-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1128%2FAAC.01032-08" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=926-934&author=S.+S.+Carrollauthor=S.+W.+Ludmererauthor=L.+Handtauthor=K.+Koeplingerauthor=N.+R.+Zhangauthor=D.+Grahamauthor=M.+E.+Daviesauthor=M.+MacCossauthor=D.+J.+Hazudaauthor=D.+B.+Olsen&title=Robust+Antiviral+Efficacy+upon+Administration+of+a+Nucleoside+Analog+to+Hepatitis+C+Virus-Infected+Chimpanzees&doi=10.1128%2FAAC.01032-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1128%2FAAC.01032-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01032-08%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DHandt%26aufirst%3DL.%26aulast%3DKoeplinger%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DN.%2BR.%26aulast%3DGraham%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DM.%2BE.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26atitle%3DRobust%2520Antiviral%2520Efficacy%2520upon%2520Administration%2520of%2520a%2520Nucleoside%2520Analog%2520to%2520Hepatitis%2520C%2520Virus-Infected%2520Chimpanzees%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D926%26epage%3D934%26doi%3D10.1128%2FAAC.01032-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong-Jin Wu, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9786-9874. <a href="https://doi.org/10.1021/acs.jmedchem.1c00790" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeminal%252BDiheteroatomic%252BMotifs%25253A%252BSome%252BApplications%252Bof%252BAcetals%25252C%252BKetals%25252C%252Band%252BTheir%252BSulfur%252Band%252BNitrogen%252BHomologues%252Bin%252BMedicinal%252BChemistry%252Band%252BDrug%252BDesign%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30042021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D9786%26epage%3D9874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wieslaw M. Kazmierski, Sam Baskaran, Jill T. Walker, Nagaraju Miriyala, Ramu Meesala, Mallesh Beesu, George Adjabeng, Richard M. Grimes, Robert Hamatake, Martin R. Leivers, Renae Crosby, Bing Xia, <span class="NLM_string-name hlFld-ContribAuthor">Katja Remlinger</span>. </span><span class="cited-content_cbyCitation_article-title">GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 4155-4170. <a href="https://doi.org/10.1021/acs.jmedchem.9b02176" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02176%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGSK2818713%25252C%252Ba%252BNovel%252BBiphenylene%252BScaffold-Based%252BHepatitis%252BC%252BNS5A%252BReplication%252BComplex%252BInhibitor%252Bwith%252BBroad%252BGenotype%252BCoverage%26aulast%3DKazmierski%26aufirst%3DWieslaw%2BM.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30122019%26date%3D07042020%26date%3D23032020%26volume%3D63%26issue%3D8%26spage%3D4155%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wayne Vuong, Fabricio Mosquera-Guagua, Randy Sanichar, Tyler R. McDonald, Oliver P. Ernst, Lei Wang, <span class="NLM_string-name hlFld-ContribAuthor">John C. Vederas</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Chiral Spin-Labeled Amino Acids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (24)
                                     , 10149-10153. <a href="https://doi.org/10.1021/acs.orglett.9b04216" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b04216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b04216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b04216%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BChiral%252BSpin-Labeled%252BAmino%252BAcids%26aulast%3DVuong%26aufirst%3DWayne%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24112019%26date%3D10122019%26volume%3D21%26issue%3D24%26spage%3D10149%26epage%3D10153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrey A.  Ivashchenko</span>, <span class="hlFld-ContribAuthor ">Yan A.  Ivanenkov</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Aladinskiy</span>, <span class="hlFld-ContribAuthor ">Ruben N.  Karapetian</span>, <span class="hlFld-ContribAuthor ">Angela G.  Koryakova</span>, <span class="hlFld-ContribAuthor ">Alexey A.  Ryakhovskiy</span>, <span class="hlFld-ContribAuthor ">Oleg D.  Mitkin</span>, <span class="hlFld-ContribAuthor ">Dmitry V.  Kravchenko</span>, <span class="hlFld-ContribAuthor ">Nikolai P.  Savchuk</span>, <span class="hlFld-ContribAuthor ">Bogdan A.  Zagribelnyy</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Ivashchenko</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (20)
                                     , 115716. <a href="https://doi.org/10.1016/j.bmc.2020.115716" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115716%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bin%252Bsilico%252Bmodeling%252Bof%252Bnovel%252Bpan-genotypic%252BNS5A%252Binhibitors%26aulast%3DIvashchenko%26aufirst%3DAndrey%2BA.%26date%3D2020%26volume%3D28%26issue%3D20%26spage%3D115716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Z.  Qin</span>, <span class="hlFld-ContribAuthor ">A.  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR studies on hepatitis C virus NS5A protein tetracyclic inhibitors in wild type and mutants by CoMFA and CoMSIA. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2020,</strong> <em>31 </em>
                                    (4)
                                     , 281-311. <a href="https://doi.org/10.1080/1062936X.2020.1740889" title="DOI URL">https://doi.org/10.1080/1062936X.2020.1740889</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2020.1740889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2020.1740889%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DQSAR%252Bstudies%252Bon%252Bhepatitis%252BC%252Bvirus%252BNS5A%252Bprotein%252Btetracyclic%252Binhibitors%252Bin%252Bwild%252Btype%252Band%252Bmutants%252Bby%252BCoMFA%252Band%252BCoMSIA%26aulast%3DQin%26aufirst%3DZ.%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D4%26spage%3D281%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroshi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Yusuke  Akagi</span>, <span class="hlFld-ContribAuthor ">Takashi  Terui</span>, <span class="hlFld-ContribAuthor ">Shingo  Fujioka</span>, <span class="hlFld-ContribAuthor ">Yasumasa  Komoda</span>, <span class="hlFld-ContribAuthor ">Wataru  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Kimiya  Maeda</span>, <span class="hlFld-ContribAuthor ">Yutaka  Ukaji</span>, <span class="hlFld-ContribAuthor ">Takashi  Inaba</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel unsymmetrical structural class of HCV NS5A inhibitors with low picomolar antiviral activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (5)
                                     , 126932. <a href="https://doi.org/10.1016/j.bmcl.2019.126932" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126932</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126932%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bunsymmetrical%252Bstructural%252Bclass%252Bof%252BHCV%252BNS5A%252Binhibitors%252Bwith%252Blow%252Bpicomolar%252Bantiviral%252Bactivity%26aulast%3DNakamura%26aufirst%3DHiroshi%26date%3D2020%26volume%3D30%26issue%3D5%26spage%3D126932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Idham Darussalam  Mardjan</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5â6 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: One Extra Heteroatom 0:1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00032-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00032-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00032-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00032-9%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525936%252BSystems%252BWith%252BOne%252BBridgehead%252B%252528Ring%252BJunction%252529%252BNitrogen%252BAtom%25253A%252BOne%252BExtra%252BHeteroatom%252B0%25253A1%26aulast%3DMardjan%26aufirst%3DMuhammad%2BIdham%2BDarussalam%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amir H.  Nasiri</span>, <span class="hlFld-ContribAuthor ">Hamid R.  Nasiri</span>. </span><span class="cited-content_cbyCitation_article-title">Polymerase assays for lead discovery: An overall review of methodologies and approaches. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2018,</strong> <em>563 </em>, 40-50. <a href="https://doi.org/10.1016/j.ab.2018.09.022" title="DOI URL">https://doi.org/10.1016/j.ab.2018.09.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2018.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2018.09.022%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DPolymerase%252Bassays%252Bfor%252Blead%252Bdiscovery%25253A%252BAn%252Boverall%252Breview%252Bof%252Bmethodologies%252Band%252Bapproaches%26aulast%3DNasiri%26aufirst%3DAmir%2BH.%26date%3D2018%26volume%3D563%26spage%3D40%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HCV NS5A inhibitors approved by FDA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Strategy for the modification of MK-8742 molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compounds <b>1</b>â<b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) TFA, CH<sub>3</sub>CN, 25 Â°C, 6 h; (ii) DDQ, toluene, 115 Â°C, 2 h, then chiral SFC separation; (iii) bis(pinacolato)diboron, Pd(dppf)Cl<sub>2</sub>, KOAc, dioxane, 90 Â°C, 16 h; (iv) <b>42</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), 90 Â°C, 16 h; (v) bis(pinacolato)diboron, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, dioxane, 110 Â°C, 2 h; (vi) <b>45</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), 90 Â°C, 16 h; (vii) HCl, MeOH, 0.5 h; (viii) (<i>S</i>)-2-((methoxycarbonyl)amino)-2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetic acid, BOP, DIPEA, DMF, 10 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compounds <b>52a</b>â<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) DBU, CH<sub>2</sub>Cl<sub>2</sub>, 25 Â°C, 5 h; (ii) Pd/C (10%), H<sub>2</sub> (35 psi), MeOH, 25 Â°C, 8 h; (iii) LiOH, MeOH, H<sub>2</sub>O, 25 Â°C, 15 h; (iv) methyl chloroformate, LiOH, H<sub>2</sub>O, 25 Â°C, 3 h, then chiral SFC separation.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compounds <b>52i</b>â<b>j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) L-selectride, THF, â78 to 25 Â°C, 12 h, then NaOH, H<sub>2</sub>O; (ii) TsCl, pyridine, DCM, 25 Â°C, 12 h; (iii) <b>54</b>, LiHMDS, toluene, 100 Â°C, 4 h; (iv) HCl, THF, 25 Â°C, 2 h; (v) methyl chloroformate, DCM, Et<sub>3</sub>N, 25 Â°C, 12 h; (vi) Pd/C (10%), H<sub>2</sub> (40 psi), MeOH, 25 Â°C, 12 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compound <b>47a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) TBSCl, imidazole, EtOAc, 0â25 Â°C, 12 h, 95%; (ii) <i>N</i>,<i>O</i>-dimethylhydroxylamine, <i>i</i>-PrMgCl, THF, â20 Â°C, 2 h, 72%; (iii) vinylmagnesium bromide, THF, 0â5 Â°C, 1 h, 79%; (iv) Amberlyst 15 resin, CHCl<sub>3</sub>, 25 Â°C, 15 h, used without purification.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Compound <b>47c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd/C (10%), H<sub>2</sub> (50 psi), EtOH, 35 Â°C, 17 h, 99%; (ii) TEMPO, NaHCO<sub>3</sub>, KBr, NaClO, DCM, H<sub>2</sub>O, 25 Â°C, 5 h, 99%.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Compound <b>47h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Ti(<i>i</i>-PrO)<sub>4</sub>, EtMgBr, THF/Et<sub>2</sub>O (1:1), 0â25 Â°C, 12 h, 89%; (ii) TBSOTf, 2,6-lutidine, DCM, 10 Â°C, 1 h, 41%; (iii) vinylmagnesium bromide, THF, â78 Â°C, 0.5 h, 41%; (iv) IBX, CH<sub>3</sub>CN, 80 Â°C, 2 h, 50%; (v) Amberlyst 15 resin, DCM, reflux, 4 h, used without purification.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of Compound <b>47i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 1,1,3,3-tetrabromopropan-2-one, Zn, (EtO)<sub>3</sub>B, THF, 25 Â°C, 17 h; (ii) Zn, CuCl, MeOH, 25 Â°C, 19 h, 30% for two steps.</p></p></figure><figure data-id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/medium/jm-2017-01927j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of Compounds <b>15</b>â<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01927/20180504/images/large/jm-2017-01927j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01927&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) TFA, CH<sub>3</sub>CN, 25 Â°C, 6 h, 81%; (ii) DDQ, toluene, reflux, 2 h, 88%; (iii) bis(pinacolato)diboron, Pd(dppf)Cl<sub>2</sub>, KOAc, dioxane, 90 Â°C, 16 h, 88%; (iv) <b>45</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), 90 Â°C, 16 h, 77%; (v) bis(pinacolato)diboron, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, dioxane, 110 Â°C, 2 h, 89%; (vi) <b>72</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), 90 Â°C, 16 h, 74%, then chiral SFC separation, 26%; (vii) HCl, MeOH, 2 h, 98%; (viii) <b>52a</b>â<b>j</b>, BOP, DIPEA, DMF, 10 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i108">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> <i>Global
Hepatitis Report, 2017</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2017</span>; p  <span class="NLM_fpage">7</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global%0AHepatitis+Report%2C+2017%3B+World+Health+Organization%2C+2017%3B+p+7."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlobal%250AHepatitis%2520Report%252C%25202017%26pub%3DWorld%2520Health%2520Organization%26date%3D2017%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span> <i>Global
Hepatitis Report, 2017</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2017</span>; p  <span class="NLM_fpage">12</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global%0AHepatitis+Report%2C+2017%3B+World+Health+Organization%2C+2017%3B+p+12."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlobal%250AHepatitis%2520Report%252C%25202017%26pub%3DWorld%2520Health%2520Organization%26date%3D2017%26spage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span>World Health
Organization Home Page. <a href="http://www.who.int/mediacentre/factsheets/fs164/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs164/en/</a> (accessed April 20, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health%0AOrganization+Home+Page.+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs164%2Fen%2F+%28accessed+April+20%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span> <i>Global
Hepatitis Report, 2017</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2017</span>; p  <span class="NLM_fpage">16</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global%0AHepatitis+Report%2C+2017%3B+World+Health+Organization%2C+2017%3B+p+16."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlobal%250AHepatitis%2520Report%252C%25202017%26pub%3DWorld%2520Health%2520Organization%26date%3D2017%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A.</span></span> <span> </span><span class="NLM_article-title">Interferon-Free Combination Therapies For The Treatment Of Hepatitis C: Current Insights</span>. <i>Hepatic Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_fpage">51</span>â <span class="NLM_lpage">70</span>, <span class="refDoi">Â DOI: 10.2147/HMER.S55864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.2147%2FHMER.S55864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A280%3ADC%252BC28rgsVSqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=51-70&author=J.+Holmesauthor=A.+Thompson&title=Interferon-Free+Combination+Therapies+For+The+Treatment+Of+Hepatitis+C%3A+Current+Insights&doi=10.2147%2FHMER.S55864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-free combination therapies for the treatment of hepatitis C: current insights</span></div><div class="casAuthors">Holmes Jacinta A; Thompson Alexander J</div><div class="citationInfo"><span class="NLM_cas:title">Hepatic medicine : evidence and research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-70</span>
        ISSN:<span class="NLM_cas:issn">1179-1535</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV) treatment landscape has rapidly changed over the past 5 years.  The development of direct-acting antiviral (DAA) agents that specifically target various steps in the HCV lifecycle has revolutionized therapeutic options for patients with HCV, with the development of highly effective and well-tolerated oral interferon-free regimens.  There are many DAAs that are currently in development or have recently been approved, which target different nonstructural HCV proteins and host targets that are essential for HCV replication.  This review will focus on the different classes of DAAs and the various combinations that are in advanced development for the treatment of chronic HCV infection and will focus on the different regimens in specific patient populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaWQI_kNsvcFvAgqb2vdc5fW6udTcc2eajJmikoorONrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgsVSqtg%253D%253D&md5=132f4de5a7104defd164235b90711976</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2147%2FHMER.S55864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FHMER.S55864%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DA.%26atitle%3DInterferon-Free%2520Combination%2520Therapies%2520For%2520The%2520Treatment%2520Of%2520Hepatitis%2520C%253A%2520Current%2520Insights%26jtitle%3DHepatic%2520Med.%26date%3D2015%26spage%3D51%26epage%3D70%26doi%3D10.2147%2FHMER.S55864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poordad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieterich, D.</span></span> <span> </span><span class="NLM_article-title">Treating Hepatitis C: Current Standard of Care and Emerging Direct-Acting Antiviral Agents</span>. <i>J. Viral Hepat</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">449</span>â <span class="NLM_lpage">464</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2893.2012.01617.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1111%2Fj.1365-2893.2012.01617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=22676357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A280%3ADC%252BC38npvVWlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=449-464&author=F.+Poordadauthor=D.+Dieterich&title=Treating+Hepatitis+C%3A+Current+Standard+of+Care+and+Emerging+Direct-Acting+Antiviral+Agents&doi=10.1111%2Fj.1365-2893.2012.01617.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents</span></div><div class="casAuthors">Poordad F; Dieterich D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">449-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Summary.  During the late 1990s and early 2000s, major advances were made in the treatment of patients with chronic hepatitis C virus (HCV) infection.  Interferon, combination interferon plus ribavirin (RBV) and pegylated interferon plus RBV increased sustained virologic response (SVR) rates from ~5% to ~40-80%, depending on the genotype of HCV infection.  Advances in molecular biology have allowed investigators to begin to understand the mechanisms of HCV infection and replication.  Advances in understanding of viral kinetics have provided tools to identify patients who are most likely to attain SVR.  With the advances in the science of HCV infection, the first part of the 21st century has seen the development and early introduction of a number of direct-acting antiviral (DAA) drugs.  These novel medications interfere with critical steps in HCV replication and have the potential to significantly increase SVR rates.  This article will review the key elements of HCV replication and evaluate the various classes of new and investigational DAA that have the potential to create a revolution in the management of patients with chronic hepatitis C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkf-H-0dt8tGPgL4LrC-0VfW6udTcc2ebyZj-ixch9Hbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38npvVWlsQ%253D%253D&md5=4759dc9a094617ac13afd33ef078de6f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2012.01617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2012.01617.x%26sid%3Dliteratum%253Aachs%26aulast%3DPoordad%26aufirst%3DF.%26aulast%3DDieterich%26aufirst%3DD.%26atitle%3DTreating%2520Hepatitis%2520C%253A%2520Current%2520Standard%2520of%2520Care%2520and%2520Emerging%2520Direct-Acting%2520Antiviral%2520Agents%26jtitle%3DJ.%2520Viral%2520Hepat%26date%3D2012%26volume%3D19%26spage%3D449%26epage%3D464%26doi%3D10.1111%2Fj.1365-2893.2012.01617.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, C. M.</span></span> <span> </span><span class="NLM_article-title">Understanding the Hepatitis C Virus Life Cycle Paves the Way for Highly Effective Therapies</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">837</span>â <span class="NLM_lpage">849</span>, <span class="refDoi">Â DOI: 10.1038/nm.3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1038%2Fnm.3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=23836234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=837-849&author=T.+K.+Scheelauthor=C.+M.+Rice&title=Understanding+the+Hepatitis+C+Virus+Life+Cycle+Paves+the+Way+for+Highly+Effective+Therapies&doi=10.1038%2Fnm.3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span></div><div class="casAuthors">Scheel, Troels K. H.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">837-849</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  More than two decades of intense research has provided a detailed understanding of hepatitis C virus (HCV), which chronically infects 2% of the world's population.  This effort has paved the way for the development of antiviral compds. to spare patients from life-threatening liver disease.  An exciting new era in HCV therapy dawned with the recent approval of two viral protease inhibitors, used in combination with pegylated interferon-Î± and ribavirin; however, this is just the beginning.  Multiple classes of antivirals with distinct targets promise highly efficient combinations, and interferon-free regimens with short treatment duration and fewer side effects are the future of HCV therapy.  Ongoing and future trials will det. the best antiviral combinations and whether the current seemingly rich pipeline is sufficient for successful treatment of all patients in the face of major challenges, such as HCV diversity, viral resistance, the influence of host genetics, advanced liver disease and other co-morbidities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpde8altGxkeLVg90H21EOLACvtfcHk0lgv5CGJYlA7LQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI&md5=dabc9fbc7dc0bc56115d5ede0d8ae072</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm.3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3248%26sid%3Dliteratum%253Aachs%26aulast%3DScheel%26aufirst%3DT.%2BK.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnderstanding%2520the%2520Hepatitis%2520C%2520Virus%2520Life%2520Cycle%2520Paves%2520the%2520Way%2520for%2520Highly%2520Effective%2520Therapies%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D837%26epage%3D849%26doi%3D10.1038%2Fnm.3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, C.</span></span> <span> </span><span class="NLM_article-title">New Merck and Vertex Drugs Raise Standard of Care in Hepatitis C</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">554</span>, <span class="refDoi">Â DOI: 10.1038/nbt0711-553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1038%2Fnbt0711-553" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=553-554&author=C.+Sheridan&title=New+Merck+and+Vertex+Drugs+Raise+Standard+of+Care+in+Hepatitis+C&doi=10.1038%2Fnbt0711-553"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnbt0711-553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt0711-553%26sid%3Dliteratum%253Aachs%26aulast%3DSheridan%26aufirst%3DC.%26atitle%3DNew%2520Merck%2520and%2520Vertex%2520Drugs%2520Raise%2520Standard%2520of%2520Care%2520in%2520Hepatitis%2520C%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D553%26epage%3D554%26doi%3D10.1038%2Fnbt0711-553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Love, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, C. N.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">4395</span>â <span class="NLM_lpage">4403</span>, <span class="refDoi">Â DOI: 10.1128/JVI.02352-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1128%2FJVI.02352-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=19244328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=4395-4403&author=R.+A.+Loveauthor=O.+Brodskyauthor=M.+J.+Hickeyauthor=P.+A.+Wellsauthor=C.+N.+Cronin&title=Crystal+Structure+of+a+Novel+Dimeric+Form+of+NS5A+Domain+I+Protein+from+Hepatitis+C+Virus&doi=10.1128%2FJVI.02352-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus</span></div><div class="casAuthors">Love, Robert A.; Brodsky, Oleg; Hickey, Michael J.; Wells, Peter A.; Cronin, Ciaran N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4395-4403</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A new protein expression vector design utilizing an N-terminal six-histidine tag and tobacco etch virus protease cleavage site upstream of the hepatitis C virus NS5A sequence has resulted in a more straightforward purifn. method and improved yields of purified NS5A domain I protein.  High-resoln. diffracting crystals of NS5A domain I (amino acids 33 to 202) [NS5A(33-202)] were obtained by using detergent additive crystn. screens, leading to the structure of a homodimer which is organized differently from that published previously, yet is consistent with a membrane assocn. model for NS5A.  The monomer-monomer interface of NS5A(33-202) features an extensive buried surface area involving the most-highly conserved face of each monomer.  The two alternate structural forms of domain I now available may be indicative of the multiple roles emerging for NS5A in viral RNA replication and viral particle assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNYc2eJlR_hLVg90H21EOLACvtfcHk0lgv5CGJYlA7LQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqu7s%253D&md5=70ea61461a99afb962e76a4c3f5495db</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FJVI.02352-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02352-08%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DR.%2BA.%26aulast%3DBrodsky%26aufirst%3DO.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DCronin%26aufirst%3DC.%2BN.%26atitle%3DCrystal%2520Structure%2520of%2520a%2520Novel%2520Dimeric%2520Form%2520of%2520NS5A%2520Domain%2520I%2520Protein%2520from%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Virol.%26date%3D2009%26volume%3D83%26spage%3D4395%26epage%3D4403%26doi%3D10.1128%2FJVI.02352-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tellinghuisen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotrigiano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, C. M.</span></span> <span> </span><span class="NLM_article-title">Structure of the Zinc-Binding Domain of an Essential Component of the Hepatitis C Virus Replicase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>435</i></span>,  <span class="NLM_fpage">374</span>â <span class="NLM_lpage">379</span>, <span class="refDoi">Â DOI: 10.1038/nature03580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1038%2Fnature03580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=15902263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Wkt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=374-379&author=T.+L.+Tellinghuisenauthor=J.+Marcotrigianoauthor=C.+M.+Rice&title=Structure+of+the+Zinc-Binding+Domain+of+an+Essential+Component+of+the+Hepatitis+C+Virus+Replicase&doi=10.1038%2Fnature03580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase</span></div><div class="casAuthors">Tellinghuisen, Timothy L.; Marcotrigiano, Joseph; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7040</span>),
    <span class="NLM_cas:pages">374-379</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a human pathogen affecting nearly 3% of the world's population.  Chronic infections can lead to cirrhosis and liver cancer.  The RNA replication machine of HCV is a multi-subunit membrane-assocd. complex.  The non-structural protein NS5A is an active component of HCV replicase, as well as a pivotal regulator of replication and a modulator of cellular processes ranging from innate immunity to dysregulated cell growth.  NS5A is a large phosphoprotein (56-58 kDa) with an amphipathic Î±-helix at its amino terminus that promotes membrane assocn.  After this helix region, NS5A is organized into three domains.  The N-terminal domain (domain I) coordinates a single zinc atom per protein mol.  Mutations disrupting either the membrane anchor or zinc binding of NS5A are lethal for RNA replication.  However, probing the role of NS5A in replication has been hampered by a lack of structural information about this multifunctional protein.  Here we report the structure of NS5A domain I at 2.5-Ã resoln., which contains a novel fold, a new zinc-coordination motif and a disulfide bond.  We use mol. surface anal. to suggest the location of protein-, RNA- and membrane-interaction sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe6tBo4Nrq7rVg90H21EOLACvtfcHk0liR4FosD6Jcwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Wkt7Y%253D&md5=0f74b457e5921d4aa1993df8e9a08d46</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature03580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03580%26sid%3Dliteratum%253Aachs%26aulast%3DTellinghuisen%26aufirst%3DT.%2BL.%26aulast%3DMarcotrigiano%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DStructure%2520of%2520the%2520Zinc-Binding%2520Domain%2520of%2520an%2520Essential%2520Component%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520Replicase%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D374%26epage%3D379%26doi%3D10.1038%2Fnature03580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettles, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Wu, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâBoyle, D. R.,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colonno, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span> <span> </span><span class="NLM_article-title">Chemical Genetics Strategy Identifies an HCV NS5A Inhibitor with a Potent Clinical Effect</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">96</span>â <span class="NLM_lpage">100</span>, <span class="refDoi">Â DOI: 10.1038/nature08960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+Genetics+Strategy+Identifies+an+HCV+NS5A+Inhibitor+with+a+Potent+Clinical+Effect&doi=10.1038%2Fnature08960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-Î± and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0liR4FosD6Jcwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520Genetics%2520Strategy%2520Identifies%2520an%2520HCV%2520NS5A%2520Inhibitor%2520with%2520a%2520Potent%2520Clinical%2520Effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100%26doi%3D10.1038%2Fnature08960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5057</span>â <span class="NLM_lpage">5071</span>, <span class="refDoi">Â DOI: 10.1021/jm500335h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500335h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5057-5071&author=M.+Belemaauthor=N.+A.+Meanwell&title=Discovery+of+Daclatasvir%2C+a+Pan-Genotypic+Hepatitis+C+Virus+NS5A+Replication+Complex+Inhibitor+with+Potent+Clinical+Effect&doi=10.1021%2Fjm500335h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect</span></div><div class="casAuthors">Belema, Makonen; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5057-5071</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review. The discovery and development of the first-in-class hepatitis C virus (HCV) NS5A replication complex inhibitor daclatasvir provides a compelling example of the power of phenotypic screening to identify leads engaging novel targets in mechanistically unique ways.  HCV NS5A replication complex inhibitors are pan-genotypic in spectrum, and this mechanistic class provides the most potent HCV inhibitors in vitro that have been described to date.  Clin. trials with daclatasvir demonstrated a potent effect on reducing plasma viral load and, in combination with mechanistically orthogonal HCV inhibitors, established the ability to cure even the most difficult infections without the need for immune stimulation.  In this Drug Annotation, the authors describe the discovery of the original high-throughput screening lead BMS-858 and the chem. conundrum and challenges resolved in optimizing to daclatasvir as a clin. candidate and finally the authors summarize the results of select clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiU5qkfNyqXLVg90H21EOLACvtfcHk0ljhJMAKW1HDbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurs%253D&md5=1428746b49ba356ce6993a58b143e5dc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm500335h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500335h%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520of%2520Daclatasvir%252C%2520a%2520Pan-Genotypic%2520Hepatitis%2520C%2520Virus%2520NS5A%2520Replication%2520Complex%2520Inhibitor%2520with%2520Potent%2520Clinical%2520Effect%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5057%26epage%3D5071%26doi%3D10.1021%2Fjm500335h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogalian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornpropst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Ledipasvir (GS-5885): A potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2033</span>â <span class="NLM_lpage">2046</span>, <span class="refDoi">Â DOI: 10.1021/jm401499g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401499g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2033-2046&author=J.+O.+Linkauthor=J.+G.+Taylorauthor=L.+Xuauthor=M.+Mitchellauthor=H.+Guoauthor=H.+Liuauthor=D.+Katoauthor=T.+Kirschbergauthor=J.+Sunauthor=N.+Squiresauthor=J.+Parrishauthor=T.+Kellerauthor=Z.+Yangauthor=C.+Yangauthor=M.+Matlesauthor=Y.+Wangauthor=K.+Wangauthor=G.+Chengauthor=Y.+Tianauthor=E.+Mogalianauthor=E.+Mondouauthor=M.+Cornpropstauthor=J.+Perryauthor=M.+C.+Desai&title=Discovery+of+Ledipasvir+%28GS-5885%29%3A+A+potent%2C+Once-Daily+Oral+NS5A+Inhibitor+for+the+Treatment+of+Hepatitis+C+Virus+Infection&doi=10.1021%2Fjm401499g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection</span></div><div class="casAuthors">Link, John O.; Taylor, James G.; Xu, Lianhong; Mitchell, Michael; Guo, Hongyan; Liu, Hongtao; Kato, Darryl; Kirschberg, Thorsten; Sun, Jianyu; Squires, Neil; Parrish, Jay; Kellar, Terry; Yang, Zheng-Yu; Yang, Chris; Matles, Mike; Wang, Yujin; Wang, Kelly; Cheng, Guofeng; Tian, Yang; Mogalian, Erik; Mondou, Elsa; Cornpropst, Melanie; Perry, Jason; Desai, Manoj C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2033-2046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of highly potent NS5A inhibitors with an unsym. benzimidazole-difluorofluorene-imidazole core and distal [2.2.1]-azabicyclic ring system was discovered.  Optimization of antiviral potency and pharmacokinetics led to the identification of ledipasvir (GS-5885).  Ledipasvir (GT1a replicon EC50 = 31 pM) has an extended plasma half-life of 37-45 h in healthy volunteers and produces a rapid >3 log viral load redn. in monotherapy at oral doses of 3 mg or greater with once-daily dosing in genotype 1a HCV-infected patients. ledipasvir has been shown to be safe and efficacious, with SVR12 rates up to 100% when used in combination with direct-acting antivirals having complementary mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiLazFwyH5rrVg90H21EOLACvtfcHk0ljhJMAKW1HDbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb3I&md5=30cec1d10b7b7dd02faae4fba4b88bd8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm401499g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401499g%26sid%3Dliteratum%253Aachs%26aulast%3DLink%26aufirst%3DJ.%2BO.%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DD.%26aulast%3DKirschberg%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DSquires%26aufirst%3DN.%26aulast%3DParrish%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMatles%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DMogalian%26aufirst%3DE.%26aulast%3DMondou%26aufirst%3DE.%26aulast%3DCornpropst%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DDesai%26aufirst%3DM.%2BC.%26atitle%3DDiscovery%2520of%2520Ledipasvir%2520%2528GS-5885%2529%253A%2520A%2520potent%252C%2520Once-Daily%2520Oral%2520NS5A%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2033%26epage%3D2046%26doi%3D10.1021%2Fjm401499g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motter, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keddy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tufano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspi, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koev, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maring, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2047</span>â <span class="NLM_lpage">2057</span>, <span class="refDoi">Â DOI: 10.1021/jm401398x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401398x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvFKhsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2047-2057&author=D.+A.+DeGoeyauthor=J.+T.+Randolphauthor=D.+Liuauthor=J.+Prattauthor=C.+Hutchinsauthor=P.+Donnerauthor=A.+C.+Kruegerauthor=M.+Matulenkoauthor=S.+Patelauthor=C.+E.+Motterauthor=L.+Nelsonauthor=R.+Keddyauthor=M.+Tufanoauthor=D.+D.+Caspiauthor=P.+Krishnanauthor=N.+Mistryauthor=G.+Koevauthor=T.+J.+Reischauthor=R.+Mondalauthor=T.+Pilot-Matiasauthor=Y.+Gaoauthor=D.+A.+Benoauthor=C.+J.+Maringauthor=A.+Mollaauthor=E.+Dumasauthor=A.+Campbellauthor=L.+Williamsauthor=C.+Collinsauthor=R.+Wagnerauthor=W.+M.+Kati&title=Discovery+of+ABT-267%2C+a+Pan-Genotypic+Inhibitor+of+HCV+NS5A&doi=10.1021%2Fjm401398x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A</span></div><div class="casAuthors">DeGoey, David A.; Randolph, John T.; Liu, Dachun; Pratt, John; Hutchins, Charles; Donner, Pamela; Krueger, A. Chris; Matulenko, Mark; Patel, Sachin; Motter, Christopher E.; Nelson, Lissa; Keddy, Ryan; Tufano, Michael; Caspi, Daniel D.; Krishnan, Preethi; Mistry, Neeta; Koev, Gennadiy; Reisch, Thomas J.; Mondal, Rubina; Pilot-Matias, Tami; Gao, Yi; Beno, David W. A.; Maring, Clarence J.; Molla, Akhter; Dumas, Emily; Campbell, Andrew; Williams, Laura; Collins, Christine; Wagner, Rolf; Kati, Warren M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2047-2057</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe here N-phenylpyrrolidine-based inhibitors of HCV NS5A with excellent potency, metabolic stability, and pharmacokinetics.  Compds. with 2S,5S stereochem. at the pyrrolidine ring provided improved genotype 1 (GT1) potency compared to the 2R,5R analogs.  Furthermore, the attachment of substituents at the 4-position of the central N-Ph group resulted in compds. with improved potency.  Substitution with tert-Bu, as in compd. 38 (ABT-267)(I), provided compds. with low-picomolar EC50 values and superior pharmacokinetics.  It was discovered that compd. 38 was a pan-genotypic HCV inhibitor, with an EC50 range of 1.7-19.3 pM against GT1a, -1b, -2a, -2b, -3a, -4a, and -5a and 366 pM against GT6a.  Compd. 38 decreased HCV RNA up to 3.10 log10 IU/mL during 3-day monotherapy in treatment-naive HCV GT1-infected subjects and is currently in phase 3 clin. trials in combination with an NS3 protease inhibitor with ritonavir (r) (ABT-450/r) and an NS5B non-nucleoside polymerase inhibitor (ABT-333), with and without ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQLXZPjB144rVg90H21EOLACvtfcHk0lgLtn4gBMQ0rQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvFKhsQ%253D%253D&md5=70f0d0f8e9751b533617fecc1b4a8016</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm401398x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401398x%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DRandolph%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPratt%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DC.%26aulast%3DDonner%26aufirst%3DP.%26aulast%3DKrueger%26aufirst%3DA.%2BC.%26aulast%3DMatulenko%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DMotter%26aufirst%3DC.%2BE.%26aulast%3DNelson%26aufirst%3DL.%26aulast%3DKeddy%26aufirst%3DR.%26aulast%3DTufano%26aufirst%3DM.%26aulast%3DCaspi%26aufirst%3DD.%2BD.%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DMistry%26aufirst%3DN.%26aulast%3DKoev%26aufirst%3DG.%26aulast%3DReisch%26aufirst%3DT.%2BJ.%26aulast%3DMondal%26aufirst%3DR.%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DBeno%26aufirst%3DD.%2BA.%26aulast%3DMaring%26aufirst%3DC.%2BJ.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DDumas%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DDiscovery%2520of%2520ABT-267%252C%2520a%2520Pan-Genotypic%2520Inhibitor%2520of%2520HCV%2520NS5A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2047%26epage%3D2057%26doi%3D10.1021%2Fjm401398x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8742: an HCV NS5A Inhibitor with Broad Genotype Activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1930</span>â <span class="NLM_lpage">1940</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201300343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1002%2Fcmdc.201300343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=24127258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SkurzN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1930-1940&author=C.+A.+Coburnauthor=P.+T.+Meinkeauthor=W.+Changauthor=C.+A.+Fandozziauthor=D.+J.+Grahamauthor=B.+Huauthor=Q.+Huangauthor=S.+Kargmanauthor=J.+Kozlowskiauthor=R.+Liuauthor=J.+A.+McCauleyauthor=A.+A.+Nomeirauthor=R.+M.+Sollauthor=J.+P.+Vaccaauthor=D.+Wangauthor=H.+Wuauthor=B.+Zhongauthor=D.+B.+Olsenauthor=S.+W.+Ludmerer&title=Discovery+of+MK-8742%3A+an+HCV+NS5A+Inhibitor+with+Broad+Genotype+Activity&doi=10.1002%2Fcmdc.201300343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity</span></div><div class="casAuthors">Coburn, Craig A.; Meinke, Peter T.; Chang, Wei; Fandozzi, Christine M.; Graham, Donald J.; Hu, Bin; Huang, Qian; Kargman, Stacia; Kozlowski, Joseph; Liu, Rong; McCauley, John A.; Nomeir, Amin A.; Soll, Richard M.; Vacca, Joseph P.; Wang, Dahai; Wu, Hao; Zhong, Bin; Olsen, David B.; Ludmerer, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1930-1940</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The NS5A protein plays a crit. role in the replication of HCV and has been the focus of numerous research efforts over the past few years.  NS5A inhibitors have shown impressive in vitro potency profiles in HCV replicon assays, making them attractive components for inclusion in all oral combination regimens.  Early work in the NS5A arena led to the discovery of our first clin. candidate, MK-4882 [2-((S)-pyrrolidin-2-yl)-5-(2-(4-(5-((S)-pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole].  While preclin. proof-of-concept studies in HCV-infected chimpanzees harboring chronic genotype 1 infections resulted in significant decreases in viral load after both single- and multiple-dose treatments, viral breakthrough proved to be a concern, thus necessitating the development of compds. with increased potency against a no. of genotypes and NS5A resistance mutations.  Modification of the MK-4882 core scaffold by introduction of a cyclic constraint afforded a series of tetracyclic inhibitors, which showed improved virol. profiles.  Herein we describe the research efforts that led to the discovery of MK-8742, a tetracyclic indole-based NS5A inhibitor, which is currently in phase 2b clin. trials as part of an all-oral, interferon-free regimen for the treatment of HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqknZKO01aZlLVg90H21EOLACvtfcHk0lgLtn4gBMQ0rQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SkurzN&md5=2f2b3ed2281c43e39b24d4197b9f57ee</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300343%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFandozzi%26aufirst%3DC.%2BA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520MK-8742%253A%2520an%2520HCV%2520NS5A%2520Inhibitor%2520with%2520Broad%2520Genotype%2520Activity%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1930%26epage%3D1940%26doi%3D10.1002%2Fcmdc.201300343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span>; <span class="NLM_string-name">Rosenblum, S. B.</span>; <span class="NLM_string-name">Coburn, C. A.</span>; <span class="NLM_string-name">Shankar, B. B.</span>; <span class="NLM_string-name">Anilkumar, G. N.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Dwyer, M.
P.</span>; <span class="NLM_string-name">Jiang, Y.</span>; <span class="NLM_string-name">Keertikar, K. M.</span>; <span class="NLM_string-name">Lavey, B. J.</span>; <span class="NLM_string-name">Seluytin, O. B.</span>; <span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Wong, M.</span>; <span class="NLM_string-name">Yang, D.-Y.</span>; <span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Zhao, G.</span>; <span class="NLM_string-name">Wu, H.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Zhong, B.</span>; <span class="NLM_string-name">Sun, F.</span>; <span class="NLM_string-name">Ji, T.</span>; <span class="NLM_string-name">Shen, C.</span>; <span class="NLM_string-name">Rizvi, R.</span>; <span class="NLM_string-name">Zeng, Q.</span></span> <span> </span><span class="NLM_article-title">Tetracyclic Indole Derivatives for Treating Hepatitis C Virus Infection</span>. <span class="NLM_patent">WO 2012041014 A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+A.+Kozlowski&author=S.+B.+Rosenblum&author=C.+A.+Coburn&author=B.+B.+Shankar&author=G.+N.+Anilkumar&author=L.+Chen&author=M.%0AP.+Dwyer&author=Y.+Jiang&author=K.+M.+Keertikar&author=B.+J.+Lavey&author=O.+B.+Seluytin&author=L.+Tong&author=M.+Wong&author=D.-Y.+Yang&author=W.+Yu&author=G.+Zhao&author=H.+Wu&author=B.+Hu&author=B.+Zhong&author=F.+Sun&author=T.+Ji&author=C.+Shen&author=R.+Rizvi&author=Q.+Zeng&title=Tetracyclic+Indole+Derivatives+for+Treating+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DTetracyclic%2520Indole%2520Derivatives%2520for%2520Treating%2520Hepatitis%2520C%2520Virus%2520Infection%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawitz, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvory-Sobol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doehle, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worth, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brainard, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, H.</span></span> <span> </span><span class="NLM_article-title">Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5368</span>â <span class="NLM_lpage">5378</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00763-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1128%2FAAC.00763-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=27353271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKksbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=5368-5378&author=E.+J.+Lawitzauthor=H.+Dvory-Sobolauthor=B.+P.+Doehleauthor=A.+S.+Worthauthor=J.+McNallyauthor=D.+M.+Brainardauthor=J.+O.+Linkauthor=M.+D.+Millerauthor=H.+Mo&title=Clinical+Resistance+to+Velpatasvir+%28GS-5816%29%2C+a+Novel+Pan-Genotypic+Inhibitor+of+the+Hepatitis+C+Virus+NS5A+Protein&doi=10.1128%2FAAC.00763-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical resistance to velpatasvir (GS-5816), a novel pan-genotypic inhibitor of the hepatitis C virus NS5A protein</span></div><div class="casAuthors">Lawitz, Eric J.; Dvory-Sobol, Hadas; Doehle, Brian P.; Worth, Angela S.; McNally, John; Brainard, Diana M.; Link, John O.; Miller, Michael D.; Mo, Hongmei</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5368-5378</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons.  In a phase 1b 3-day monotherapy study, patients treated with a 150-mg dose of GS-5816 had a mean maximal HCV RNA decline ofâ¥3.3 log10 IU/mL in GT1a, -1b, -2, -3, and -4.  This report characterizes virol. resistance to VEL in these patients.  NS5A resistance-assocd. substitutions (RASs) were detected by deep sequencing (1% cutoff) pretreatment in 22/70 patients, i.e., 10/35 (29%) patients with GT1a, 1/8 (13%) with GT1b, 4/8 (50.0%) with GT2, 5/17 (29.4%) with GT3, and 2/2 (100.0%) with GT4.  In GT1a and GT3 patients, pretreatment RASs were assocd. with a slightly reduced HCV RNA response compared to that of patients without pretreatment RASs; among patients with GT1b, GT2, and GT4, no significant difference in response was obsd. in those with or without pretreatment RASs.  Following treatment, the pattern of emergent RASs was more complex for GT1a than for the other genotypes.  In GT1a, substitutions emerged at positions M28, Q30, L31, P32, H58, E92, and Y93, with the most prevalent substitutions at positions Y93, M28, and L31.  RASs were obsd. at two positions in GT1b and GT2 (Y93 and L31), three positions in GT3 (Y93, L31, and E92), and four positions in GT4 (L28, M31, P32L, and Y93).  RASs that were present pretreatment persisted through the 48-wk follow-up period; however, RASs emerging during treatment were more likely to decline both in prevalence and in frequency within the viral population during follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcz7ZV8QWTkbVg90H21EOLACvtfcHk0li-8To6iUdu6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKksbk%253D&md5=5b6faa0f793f362ce5c1c11a2729d656</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FAAC.00763-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00763-16%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DDvory-Sobol%26aufirst%3DH.%26aulast%3DDoehle%26aufirst%3DB.%2BP.%26aulast%3DWorth%26aufirst%3DA.%2BS.%26aulast%3DMcNally%26aufirst%3DJ.%26aulast%3DBrainard%26aufirst%3DD.%2BM.%26aulast%3DLink%26aufirst%3DJ.%2BO.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DMo%26aufirst%3DH.%26atitle%3DClinical%2520Resistance%2520to%2520Velpatasvir%2520%2528GS-5816%2529%252C%2520a%2520Novel%2520Pan-Genotypic%2520Inhibitor%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS5A%2520Protein%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D5368%26epage%3D5378%26doi%3D10.1128%2FAAC.00763-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maring, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span> <span> </span><span class="NLM_article-title">In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e02558-16</span>, <span class="refDoi">Â DOI: 10.1128/AAC.02558-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1128%2FAAC.02558-16" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e02558-16&author=T.+I.+Ngauthor=P.+Krishnanauthor=T.+Pilot-Matiasauthor=W.+Katiauthor=G.+Schnellauthor=J.+Beyerauthor=T.+Reischauthor=L.+Luauthor=T.+Dekhtyarauthor=M.+Irvinauthor=R.+Tripathiauthor=C.+Maringauthor=J.+T.+Randolphauthor=R.+Wagnerauthor=C.+Collins&title=In+Vitro+Antiviral+Activity+and+Resistance+Profile+of+the+Next-Generation+Hepatitis+C+Virus+NS5A+Inhibitor+Pibrentasvir&doi=10.1128%2FAAC.02558-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.02558-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02558-16%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DT.%2BI.%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DSchnell%26aufirst%3DG.%26aulast%3DBeyer%26aufirst%3DJ.%26aulast%3DReisch%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DIrvin%26aufirst%3DM.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DMaring%26aufirst%3DC.%26aulast%3DRandolph%26aufirst%3DJ.%2BT.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DCollins%26aufirst%3DC.%26atitle%3DIn%2520Vitro%2520Antiviral%2520Activity%2520and%2520Resistance%2520Profile%2520of%2520the%2520Next-Generation%2520Hepatitis%2520C%2520Virus%2520NS5A%2520Inhibitor%2520Pibrentasvir%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De02558-16%26doi%3D10.1128%2FAAC.02558-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keertikar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauuan, P. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naicker, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellekoop, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Silyl Proline Containing HCV NS5A Inhibitors with Pan-Genotype Activity: SAR Development</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1475</span>â <span class="NLM_lpage">1479</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.01.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.01.050" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1475-1479&author=A.+G.+Nairauthor=Q.+Zengauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Y.+Jiangauthor=D.-Y.+Yangauthor=K.+Keertikarauthor=G.+Zhouauthor=M.+Dwyerauthor=S.+H.+Kimauthor=B.+Shankarauthor=W.+Yuauthor=L.+Tongauthor=L.+Chenauthor=R.+Mazzolaauthor=J.+Caldwellauthor=H.+Tangauthor=M.+Allardauthor=R.+N.+Buckleauthor=P.+J.+F.+Gauuanauthor=C.+L.+Holstauthor=G.+S.+Martinauthor=K.+P.+Naickerauthor=S.+Vellekoopauthor=S.+Agrawalauthor=R.+Liuauthor=R.+Kongauthor=P.+Ingravalloauthor=E.+Xiaauthor=Y.+Zhaiauthor=A.+Nomeirauthor=J.+A.+Kozlowski&title=Discovery+of+Silyl+Proline+Containing+HCV+NS5A+Inhibitors+with+Pan-Genotype+Activity%3A+SAR+Development&doi=10.1016%2Fj.bmcl.2016.01.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.050%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DKeertikar%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DDwyer%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DShankar%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DAllard%26aufirst%3DM.%26aulast%3DBuckle%26aufirst%3DR.%2BN.%26aulast%3DGauuan%26aufirst%3DP.%2BJ.%2BF.%26aulast%3DHolst%26aufirst%3DC.%2BL.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DNaicker%26aufirst%3DK.%2BP.%26aulast%3DVellekoop%26aufirst%3DS.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520Silyl%2520Proline%2520Containing%2520HCV%2520NS5A%2520Inhibitors%2520with%2520Pan-Genotype%2520Activity%253A%2520SAR%2520Development%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1475%26epage%3D1479%26doi%3D10.1016%2Fj.bmcl.2016.01.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Fused Tricyclic Core Containing HCV NS5A Inhibitors with Pan-Genotype Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3158</span>â <span class="NLM_lpage">3162</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.04.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.04.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=27180013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFKksL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3158-3162&author=W.+Yuauthor=C.+A.+Coburnauthor=D.-Y.+Yangauthor=P.+T.+Meinkeauthor=M.+Wongauthor=S.+B.+Rosenblumauthor=K.+X.+Chenauthor=G.+F.+Njorogeauthor=L.+Chenauthor=M.+P.+Dwyerauthor=Y.+Jiangauthor=A.+G.+Nairauthor=O.+Selyutinauthor=L.+Tongauthor=Q.+Zengauthor=B.+Zhongauthor=T.+Jiauthor=B.+Huauthor=S.+Agrawalauthor=E.+Xiaauthor=Y.+Zhaiauthor=R.+Liuauthor=R.+Kongauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=A.+Nomeirauthor=J.+Fellsauthor=J.+A.+Kozlowski&title=Discovery+of+Fused+Tricyclic+Core+Containing+HCV+NS5A+Inhibitors+with+Pan-Genotype+Activity&doi=10.1016%2Fj.bmcl.2016.04.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity</span></div><div class="casAuthors">Yu, Wensheng; Coburn, Craig A.; Yang, De-Yi; Meinke, Peter T.; Wong, Michael; Rosenblum, Stuart B.; Chen, Kevin X.; Njoroge, George F.; Chen, Lei; Dwyer, Michael P.; Jiang, Yueheng; Nair, Anilkumar G.; Selyutin, Oleg; Tong, Ling; Zeng, Qingbei; Zhong, Bin; Ji, Tao; Hu, Bin; Agrawal, Sony; Xia, Ellen; Zhai, Ying; Liu, Rong; Kong, Rong; Ingravallo, Paul; Asante-Appiah, Ernest; Nomeir, Amin; Fells, James; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3158-3162</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HCV NS5A inhibitors have demonstrated impressive in vitro potency profiles in HCV replicon assays and robust HCV RNA titer redn. in the clinic making them attractive components for inclusion in an all oral fixed dose combination regimen for the treatment of HCV infection.  Herein, the authors describe research efforts that led to the discovery of a series of fused tricyclic core contg. HCV NS5A inhibitors which have pan-genotype activity and are orally bioavailable in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbNVloDNfNu7Vg90H21EOLACvtfcHk0lisxEDLJeKghg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFKksL4%253D&md5=fb4395a0816a44bfe30aa2ff6e9ca2e1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.084%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DG.%2BF.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DFells%26aufirst%3DJ.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520Fused%2520Tricyclic%2520Core%2520Containing%2520HCV%2520NS5A%2520Inhibitors%2520with%2520Pan-Genotype%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3158%26epage%3D3162%26doi%3D10.1016%2Fj.bmcl.2016.04.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vibulbhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellekoop, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Macrocyclic HCV NS5A Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3793</span>â <span class="NLM_lpage">3799</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=27282743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1yhu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3793-3799&author=W.+Yuauthor=B.+Vibulbhanauthor=S.+B.+Rosenblumauthor=G.+S.+Martinauthor=A.+S.+Vellekoopauthor=C.+L.+Holstauthor=C.+A.+Coburnauthor=M.+Wongauthor=O.+Selyutinauthor=T.+Jiauthor=B.+Zhongauthor=B.+Huauthor=L.+Chenauthor=M.+P.+Dwyerauthor=Y.+Jiangauthor=A.+G.+Nairauthor=L.+Tongauthor=Q.+Zengauthor=S.+Agrawalauthor=D.+Carrauthor=L.+Rokoszauthor=R.+Liuauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=F.+Lahserauthor=E.+Asante-Appiahauthor=J.+Fellsauthor=J.+A.+Kozlowski&title=Discovery+of+Potent+Macrocyclic+HCV+NS5A+Inhibitors&doi=10.1016%2Fj.bmcl.2016.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent macrocyclic HCV NS5A inhibitors</span></div><div class="casAuthors">Yu, Wensheng; Vibulbhan, Bancha; Rosenblum, Stuart B.; Martin, Gregory S.; Vellekoop, A. Samuel; Holst, Christian L.; Coburn, Craig A.; Wong, Michael; Selyutin, Oleg; Ji, Tao; Zhong, Bin; Hu, Bin; Chen, Lei; Dwyer, Michael P.; Jiang, Yueheng; Nair, Anilkumar G.; Tong, Ling; Zeng, Qingbei; Agrawal, Sony; Carr, Donna; Rokosz, Laura; Liu, Rong; Curry, Stephanie; McMonagle, Patricia; Ingravallo, Paul; Lahser, Fred; Asante-Appiah, Ernest; Fells, James; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3793-3799</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HCV NS5A inhibitors have demonstrated impressive in vitro virol. profiles in HCV replicon assays and robust HCV RNA titer redn. in the clinic making them attractive components for inclusion in an all oral fixed-dose combination (FDC) regimen for the treatment of HCV infection.  Merck's effort in this area identified MK-4882 and MK-8325 as early development leads.  Herein, the authors describe the discovery of potent macrocyclic NS5A inhibitors bearing the MK-8325 or MK-4882 core structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ3NOWpHOwfbVg90H21EOLACvtfcHk0lgLsf1QajoQfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1yhu7Y%253D&md5=6321a9abda45e67b5054273731bdabbb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DVellekoop%26aufirst%3DA.%2BS.%26aulast%3DHolst%26aufirst%3DC.%2BL.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DFells%26aufirst%3DJ.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520Potent%2520Macrocyclic%2520HCV%2520NS5A%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3793%26epage%3D3799%26doi%3D10.1016%2Fj.bmcl.2016.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A.</span>; <span class="NLM_string-name">Zeng, Q.</span>; <span class="NLM_string-name">Selyutin, O.</span>; <span class="NLM_string-name">Rosenblum, S. B.</span>; <span class="NLM_string-name">Jiang, Y.</span>; <span class="NLM_string-name">Yang, D.-Y.</span>; <span class="NLM_string-name">Keertikar, K.</span>; <span class="NLM_string-name">Zhou, G.</span>; <span class="NLM_string-name">Dwyer, M.</span>; <span class="NLM_string-name">Kim, S. H.</span>; <span class="NLM_string-name">Shankar, B.</span>; <span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Mazzola, R.</span>; <span class="NLM_string-name">Caldwell, J.</span>; <span class="NLM_string-name">Tang, H.</span>; <span class="NLM_string-name">Agrawal, S.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Kong, R.</span>; <span class="NLM_string-name">Ingravallo, P.</span>; <span class="NLM_string-name">Xia, E.</span>; <span class="NLM_string-name">Zhai, Y.</span>; <span class="NLM_string-name">Nomeir, A.</span>; <span class="NLM_string-name">Asante-Appiah, E.</span>; <span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">MK-8325: A Silyl Proline-Containing NS5A Inhibitor with Pan-Genotype Activity for Treatment of HCV</span>.  <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, DOI: <span class="refDoi">Â DOI: 10.1016/j.bmcl.2018.03.049</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2018.03.049" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+Nair&author=Q.+Zeng&author=O.+Selyutin&author=S.+B.+Rosenblum&author=Y.+Jiang&author=D.-Y.+Yang&author=K.+Keertikar&author=G.+Zhou&author=M.+Dwyer&author=S.+H.+Kim&author=B.+Shankar&author=W.+Yu&author=L.+Tong&author=L.+Chen&author=R.+Mazzola&author=J.+Caldwell&author=H.+Tang&author=S.+Agrawal&author=R.+Liu&author=R.+Kong&author=P.+Ingravallo&author=E.+Xia&author=Y.+Zhai&author=A.+Nomeir&author=E.+Asante-Appiah&author=J.+A.+Kozlowski&title=MK-8325%3A+A+Silyl+Proline-Containing+NS5A+Inhibitor+with+Pan-Genotype+Activity+for+Treatment+of+HCV&doi=10.1016%2Fj.bmcl.2018.03.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DA.%26atitle%3DMK-8325%253A%2520A%2520Silyl%2520Proline-Containing%2520NS5A%2520Inhibitor%2520with%2520Pan-Genotype%2520Activity%2520for%2520Treatment%2520of%2520HCV%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26doi%3D10.1016%2Fj.bmcl.2018.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Alternative Core Development Around the Tetracyclic Indole Class of HCV NS5A Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5132</span>â <span class="NLM_lpage">5137</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.07.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.07.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=27634194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWitrvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5132-5137&author=L.+Tongauthor=W.+Yuauthor=C.+A.+Coburnauthor=P.+T.+Meinkeauthor=A.+G.+Nairauthor=M.+P.+Dwyerauthor=L.+Chenauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Y.+Jiangauthor=J.+Fellsauthor=B.+Huauthor=B.+Zhongauthor=R.+M.+Sollauthor=R.+Liuauthor=S.+Agrawalauthor=E.+Xiaauthor=Y.+Zhaiauthor=R.+Kongauthor=P.+Ingravalloauthor=A.+Nomeirauthor=E.+Asante-Appiahauthor=J.+A.+Kozlowski&title=Alternative+Core+Development+Around+the+Tetracyclic+Indole+Class+of+HCV+NS5A+Inhibitors&doi=10.1016%2Fj.bmcl.2016.07.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors</span></div><div class="casAuthors">Tong, Ling; Yu, Wensheng; Coburn, Craig A.; Meinke, Peter T.; Nair, Anilkumar G.; Dwyer, Michael P.; Chen, Lei; Selyutin, Oleg; Rosenblum, Stuart B.; Jiang, Yueheng; Fells, James; Hu, Bin; Zhong, Bin; Soll, Richard M.; Liu, Rong; Agrawal, Sony; Xia, Ellen; Zhai, Ying; Kong, Rong; Ingravallo, Paul; Nomeir, Amin; Asante-Appiah, Ernest; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5132-5137</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein, the authors describe the research efforts to develop unique cores in mols. which function as HCV nonstructural protein 5A (NS5A) inhibitors.  In particular, various fused tetracyclic cores were identified which showed genotype and mutant activities comparable to the indole-based tetracyclic core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEF0RZFkG817Vg90H21EOLACvtfcHk0ljgWOVCQwEbsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWitrvK&md5=c58058200ecae97babae141556489479</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.057%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DFells%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DAlternative%2520Core%2520Development%2520Around%2520the%2520Tetracyclic%2520Indole%2520Class%2520of%2520HCV%2520NS5A%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5132%26epage%3D5137%26doi%3D10.1016%2Fj.bmcl.2016.07.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keertikar, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Substituted Tetracyclic Indole Core Derivatives of HCV NS5A Inhibitor MK-8742</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4851</span>â <span class="NLM_lpage">4856</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.08.002" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4851-4856&author=W.+Yuauthor=G.+Zhouauthor=C.+A.+Coburnauthor=Q.+Zengauthor=L.+Tongauthor=M.+P.+Dwyerauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=L.+Chenauthor=R.+Mazzolaauthor=J.-H.+Kimauthor=D.+Shaauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=B.+Laveyauthor=A.+G.+Nairauthor=S.+H.+Kimauthor=K.+M.+Keertikarauthor=L.+Rokoszauthor=S.+Agrawalauthor=R.+Liuauthor=E.+Xiaauthor=Y.+Zhaiauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=S.+Chenauthor=J.+A.+Kozlowski&title=Substituted+Tetracyclic+Indole+Core+Derivatives+of+HCV+NS5A+Inhibitor+MK-8742&doi=10.1016%2Fj.bmcl.2016.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DSha%26aufirst%3DD.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DLavey%26aufirst%3DB.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKeertikar%26aufirst%3DK.%2BM.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DSubstituted%2520Tetracyclic%2520Indole%2520Core%2520Derivatives%2520of%2520HCV%2520NS5A%2520Inhibitor%2520MK-8742%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4851%26epage%3D4856%26doi%3D10.1016%2Fj.bmcl.2016.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keertikar, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Matched and Mixed Cap Derivatives of the HCV NS5A Inhibitor MK-8742</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4106</span>â <span class="NLM_lpage">4111</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.06.063" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4106-4111&author=M.+P.+Dwyerauthor=K.+M.+Keertikarauthor=L.+Chenauthor=L.+Tongauthor=O.+Selyutinauthor=A.+G.+Nairauthor=W.+Yuauthor=G.+Zhouauthor=B.+J.+Laveyauthor=D.-Y.+Yangauthor=M.+Wongauthor=S.+H.+Kimauthor=C.+A.+Coburnauthor=S.+B.+Rosenblumauthor=Q.+Zengauthor=Y.+Jiangauthor=B.+B.+Shankarauthor=R.+Rizviauthor=A.+A.+Nomeirauthor=R.+Liuauthor=S.+Agrawalauthor=E.+Xiaauthor=R.+Kongauthor=Y.+Zhaiauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=J.+A.+Kozlowski&title=Matched+and+Mixed+Cap+Derivatives+of+the+HCV+NS5A+Inhibitor+MK-8742&doi=10.1016%2Fj.bmcl.2016.06.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DKeertikar%26aufirst%3DK.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DLavey%26aufirst%3DB.%2BJ.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DShankar%26aufirst%3DB.%2BB.%26aulast%3DRizvi%26aufirst%3DR.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DMatched%2520and%2520Mixed%2520Cap%2520Derivatives%2520of%2520the%2520HCV%2520NS5A%2520Inhibitor%2520MK-8742%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4106%26epage%3D4111%26doi%3D10.1016%2Fj.bmcl.2016.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Alkyl Substituted Aminal Derivatives of HCV NS5A Inhibitor MK-8742</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3800</span>â <span class="NLM_lpage">3805</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.05.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.05.041" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3800-3805&author=W.+Yuauthor=C.+A.+Coburnauthor=A.+G.+Nairauthor=M.+Wongauthor=L.+Tongauthor=M.+P.+Dwyerauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=D.-Y.+Yangauthor=O.+Selyutinauthor=Y.+Jiangauthor=S.+B.+Rosenblumauthor=S.+H.+Kimauthor=B.+J.+Laveyauthor=G.+Zhouauthor=R.+Rizviauthor=B.+B.+Shankarauthor=Q.+Zengauthor=L.+Chenauthor=S.+Agrawalauthor=D.+Carrauthor=L.+Rokoszauthor=R.+Liuauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=F.+Lahserauthor=E.+Asante-Appiahauthor=A.+Nomeirauthor=J.+A.+Kozlowski&title=Alkyl+Substituted+Aminal+Derivatives+of+HCV+NS5A+Inhibitor+MK-8742&doi=10.1016%2Fj.bmcl.2016.05.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.041%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLavey%26aufirst%3DB.%2BJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DRizvi%26aufirst%3DR.%26aulast%3DShankar%26aufirst%3DB.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DAlkyl%2520Substituted%2520Aminal%2520Derivatives%2520of%2520HCV%2520NS5A%2520Inhibitor%2520MK-8742%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3800%26epage%3D3805%26doi%3D10.1016%2Fj.bmcl.2016.05.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Aryl or Heteroaryl Substituted Aminal Derivatives of HCV NS5A Inhibitor MK-8742</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3414</span>â <span class="NLM_lpage">3420</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.06.056" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3414-3420&author=W.+Yuauthor=C.+A.+Coburnauthor=A.+G.+Nairauthor=M.+Wongauthor=S.+B.+Rosenblumauthor=G.+Zhouauthor=M.+P.+Dwyerauthor=L.+Tongauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=S.+H.+Kimauthor=Q.+Zengauthor=O.+Selyutinauthor=L.+Chenauthor=F.+Masseauthor=S.+Agrawalauthor=R.+Liuauthor=E.+Xiaauthor=Y.+Zhaiauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=X.+Linauthor=J.+A.+Kozlowski&title=Aryl+or+Heteroaryl+Substituted+Aminal+Derivatives+of+HCV+NS5A+Inhibitor+MK-8742&doi=10.1016%2Fj.bmcl.2016.06.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DAryl%2520or%2520Heteroaryl%2520Substituted%2520Aminal%2520Derivatives%2520of%2520HCV%2520NS5A%2520Inhibitor%2520MK-8742%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3414%26epage%3D3420%26doi%3D10.1016%2Fj.bmcl.2016.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bystol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">StructureâActivity Relationships of Proline Modifications Around the Tetracyclic-Indole Class of NS5A Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5354</span>â <span class="NLM_lpage">5360</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.08.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.bmcl.2016.08.097" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5354-5360&author=L.+Tongauthor=W.+Yuauthor=C.+A.+Coburnauthor=L.+Chenauthor=O.+Selyutinauthor=Q.+Zengauthor=M.+P.+Dwyerauthor=A.+G.+Nairauthor=B.+B.+Shankarauthor=S.+H.+Kimauthor=D.-Y.+Yangauthor=S.+B.+Rosenblumauthor=R.+T.+Ruckauthor=I.+W.+Daviesauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=R.+Liuauthor=S.+Agrawalauthor=D.+Carrauthor=S.+Curryauthor=P.+McMonagleauthor=K.+Bystolauthor=F.+Lahserauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=S.+Chenauthor=J.+A.+Kozlowski&title=Structure%E2%80%93Activity+Relationships+of+Proline+Modifications+Around+the+Tetracyclic-Indole+Class+of+NS5A+Inhibitors&doi=10.1016%2Fj.bmcl.2016.08.097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.097%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DShankar%26aufirst%3DB.%2BB.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DD.-Y.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DRuck%26aufirst%3DR.%2BT.%26aulast%3DDavies%26aufirst%3DI.%2BW.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DBystol%26aufirst%3DK.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520of%2520Proline%2520Modifications%2520Around%2520the%2520Tetracyclic-Indole%2520Class%2520of%2520NS5A%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5354%26epage%3D5360%26doi%3D10.1016%2Fj.bmcl.2016.08.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Chromane Containing HCV NS5A Inhibitors with Improved Potency Against Resistance Associate Variants</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10228</span>â <span class="NLM_lpage">10243</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01234</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01234" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10228-10243&author=W.+Yuauthor=L.+Tongauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=C.+A.+Coburnauthor=O.+Selyutinauthor=L.+Chenauthor=L.+Rokoszauthor=S.+Agrawalauthor=R.+Liuauthor=S.+Curryauthor=P.+McMonagleauthor=P.+Ingravalloauthor=E.+Asante-Appiahauthor=S.+Chenauthor=J.+A.+Kozlowski&title=Discovery+of+Chromane+Containing+HCV+NS5A+Inhibitors+with+Improved+Potency+Against+Resistance+Associate+Variants&doi=10.1021%2Facs.jmedchem.6b01234"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01234%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520Chromane%2520Containing%2520HCV%2520NS5A%2520Inhibitors%2520with%2520Improved%2520Potency%2520Against%2520Resistance%2520Associate%2520Variants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10228%26epage%3D10243%26doi%3D10.1021%2Facs.jmedchem.6b01234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bystol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartwright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity Against Common Resistance-Associated Polymorphisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">290</span>â <span class="NLM_lpage">306</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01310</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01310" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslygt7jN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=290-306&author=L.+Tongauthor=W.+Yuauthor=L.+Chenauthor=O.+Selyutinauthor=M.+P.+Dwyerauthor=A.+G.+Nairauthor=R.+Mazzolaauthor=J.-H.+Kimauthor=D.+Shaauthor=J.+Yinauthor=R.+T.+Ruckauthor=I.+W.+Daviesauthor=R.+Liuauthor=S.+Agrawalauthor=E.+Xiaauthor=S.+Curryauthor=P.+McMonagleauthor=K.+Bystolauthor=F.+Lahserauthor=D.+Carrauthor=L.+Rokoszauthor=P.+Ingravalloauthor=S.+Chenauthor=K.-I.+Fengauthor=M.+Cartwrightauthor=E.+Asante-Appiahauthor=J.+A.+Kozlowskiauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zan&title=Discovery+of+Ruzasvir+%28MK-8408%29%3A+A+Potent%2C+Pan-Genotype+HCV+NS5A+Inhibitor+with+Optimized+Activity+Against+Common+Resistance-Associated+Polymorphisms&doi=10.1021%2Facs.jmedchem.6b01310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms</span></div><div class="casAuthors">Tong, Ling; Yu, Wensheng; Chen, Lei; Selyutin, Oleg; Dwyer, Michael P.; Nair, Anilkumar G.; Mazzola, Robert; Kim, Jae-Hun; Sha, Deyou; Yin, Jingjun; Ruck, Rebecca T.; Davies, Ian W.; Hu, Bin; Zhong, Bin; Hao, Jinglai; Ji, Tao; Zan, Shuai; Liu, Rong; Agrawal, Sony; Xia, Ellen; Curry, Stephanie; McMonagle, Patricia; Bystol, Karin; Lahser, Frederick; Carr, Donna; Rokosz, Laura; Ingravallo, Paul; Chen, Shiying; Feng, Kung-I.; Cartwright, Mark; Asante-Appiah, Ernest; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">290-306</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the research that led to the discovery of compd. 40 (ruzasvir, MK-8408), a pan-genotypic HCV nonstructural protein 5A (NS5A) inhibitor with a "flat" GT1 mutant profile.  This NS5A inhibitor contains a unique tetracyclic indole core, while maintaining the imidazole-proline-valine Moc motifs of the authors' previous NS5A inhibitors.  Compd. 40 is currently in early clin. trials and is under evaluation as part of an all-oral DAA regimen for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FD27q2S7fLVg90H21EOLACvtfcHk0lgdSLQSIrkMpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslygt7jN&md5=6224e41b940abfb96cda518ecebf3e0f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01310%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DSha%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DRuck%26aufirst%3DR.%2BT.%26aulast%3DDavies%26aufirst%3DI.%2BW.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DBystol%26aufirst%3DK.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DK.-I.%26aulast%3DCartwright%26aufirst%3DM.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Ruzasvir%2520%2528MK-8408%2529%253A%2520A%2520Potent%252C%2520Pan-Genotype%2520HCV%2520NS5A%2520Inhibitor%2520with%2520Optimized%2520Activity%2520Against%2520Common%2520Resistance-Associated%2520Polymorphisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D290%26epage%3D306%26doi%3D10.1021%2Facs.jmedchem.6b01310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Kozlowski, J. A.</span>; <span class="NLM_string-name">Selyutin, O.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Kim, J.-H.</span>; <span class="NLM_string-name">Sha, D.</span>; <span class="NLM_string-name">Rizvi, R.</span>; <span class="NLM_string-name">Shankar, B.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Zhong, B.</span>; <span class="NLM_string-name">Wai, D.</span>; <span class="NLM_string-name">Hao, J.</span>; <span class="NLM_string-name">Wei, W.</span>; <span class="NLM_string-name">Ji, T.</span>; <span class="NLM_string-name">Zan, S.</span></span> <span> </span><span class="NLM_article-title">Heterocycle-Substituted Tetracyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases</span>. <span class="NLM_patent">WO 2014110705 A9</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=W.+Yu&author=L.+Tong&author=J.+A.+Kozlowski&author=O.+Selyutin&author=L.+Chen&author=J.-H.+Kim&author=D.+Sha&author=R.+Rizvi&author=B.+Shankar&author=B.+Hu&author=B.+Zhong&author=D.+Wai&author=J.+Hao&author=W.+Wei&author=T.+Ji&author=S.+Zan&title=Heterocycle-Substituted+Tetracyclic+Compounds+and+Methods+of+Use+Thereof+for+the+Treatment+of+Viral+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26atitle%3DHeterocycle-Substituted%2520Tetracyclic%2520Compounds%2520and%2520Methods%2520of%2520Use%2520Thereof%2520for%2520the%2520Treatment%2520of%2520Viral%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Kozlowski, J. A.</span>; <span class="NLM_string-name">Selyutin, O.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Kim, J.-H.</span>; <span class="NLM_string-name">Sha, D.</span>; <span class="NLM_string-name">Rizvi, R.</span>; <span class="NLM_string-name">Shankar, B.</span></span> <span> </span><span class="NLM_article-title">Heterocycle-Substituted Tetracyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases</span>. <span class="NLM_patent">US 9555038 B2</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=W.+Yu&author=L.+Tong&author=J.+A.+Kozlowski&author=O.+Selyutin&author=L.+Chen&author=J.-H.+Kim&author=D.+Sha&author=R.+Rizvi&author=B.+Shankar&title=Heterocycle-Substituted+Tetracyclic+Compounds+and+Methods+of+Use+Thereof+for+the+Treatment+of+Viral+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26atitle%3DHeterocycle-Substituted%2520Tetracyclic%2520Compounds%2520and%2520Methods%2520of%2520Use%2520Thereof%2520for%2520the%2520Treatment%2520of%2520Viral%2520Diseases%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span>; <span class="NLM_string-name">Yu, W.</span>; <span class="NLM_string-name">Kozlowski, J. A.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Selyutin, O.</span>; <span class="NLM_string-name">Kim, S. H.</span>; <span class="NLM_string-name">Dwyer, M.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Zhong, B.</span>; <span class="NLM_string-name">Wai, D.</span>; <span class="NLM_string-name">Hao, J.</span>; <span class="NLM_string-name">Shen, C.</span>; <span class="NLM_string-name">Lei, Z.</span>; <span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">Preparation of Thiophene-Substituted Tetracyclic Compounds End-Capped with Peptide Derivatives as Antiviral Agents for Treating Hepatitis C Virus Infection</span>. <span class="NLM_patent">WO 2014110706 A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Tong&author=W.+Yu&author=J.+A.+Kozlowski&author=L.+Chen&author=O.+Selyutin&author=S.+H.+Kim&author=M.+Dwyer&author=B.+Hu&author=B.+Zhong&author=D.+Wai&author=J.+Hao&author=C.+Shen&author=Z.+Lei&author=W.+Wang&title=Preparation+of+Thiophene-Substituted+Tetracyclic+Compounds+End-Capped+with+Peptide+Derivatives+as+Antiviral+Agents+for+Treating+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26atitle%3DPreparation%2520of%2520Thiophene-Substituted%2520Tetracyclic%2520Compounds%2520End-Capped%2520with%2520Peptide%2520Derivatives%2520as%2520Antiviral%2520Agents%2520for%2520Treating%2520Hepatitis%2520C%2520Virus%2520Infection%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saksena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralston, R.</span></span> <span> </span><span class="NLM_article-title">Characterization of Resistance Mutations Against HCV Ketoamide Protease Inhibitors</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">177</span>â <span class="NLM_lpage">185</span>, <span class="refDoi">Â DOI: 10.1016/j.antiviral.2007.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1016%2Fj.antiviral.2007.11.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2008&pages=177-185&author=X.+Tongauthor=S.+Bogenauthor=R.+Chaseauthor=V.+Girijavallabhanauthor=Z.+Guoauthor=F.+G.+Njorogeauthor=A.+Prongayauthor=A.+Saksenaauthor=A.+Skeltonauthor=E.+Xiaauthor=R.+Ralston&title=Characterization+of+Resistance+Mutations+Against+HCV+Ketoamide+Protease+Inhibitors&doi=10.1016%2Fj.antiviral.2007.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2007.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2007.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DX.%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSaksena%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DRalston%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520Resistance%2520Mutations%2520Against%2520HCV%2520Ketoamide%2520Protease%2520Inhibitors%26jtitle%3DAntiviral%2520Res.%26date%3D2008%26volume%3D77%26spage%3D177%26epage%3D185%26doi%3D10.1016%2Fj.antiviral.2007.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeplinger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span> <span> </span><span class="NLM_article-title">Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">926</span>â <span class="NLM_lpage">934</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01032-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;key=10.1128%2FAAC.01032-08" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=926-934&author=S.+S.+Carrollauthor=S.+W.+Ludmererauthor=L.+Handtauthor=K.+Koeplingerauthor=N.+R.+Zhangauthor=D.+Grahamauthor=M.+E.+Daviesauthor=M.+MacCossauthor=D.+J.+Hazudaauthor=D.+B.+Olsen&title=Robust+Antiviral+Efficacy+upon+Administration+of+a+Nucleoside+Analog+to+Hepatitis+C+Virus-Infected+Chimpanzees&doi=10.1128%2FAAC.01032-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1128%2FAAC.01032-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01032-08%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DHandt%26aufirst%3DL.%26aulast%3DKoeplinger%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DN.%2BR.%26aulast%3DGraham%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DM.%2BE.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26atitle%3DRobust%2520Antiviral%2520Efficacy%2520upon%2520Administration%2520of%2520a%2520Nucleoside%2520Analog%2520to%2520Hepatitis%2520C%2520Virus-Infected%2520Chimpanzees%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D926%26epage%3D934%26doi%3D10.1128%2FAAC.01032-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i106"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01927">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_35667"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01927">10.1021/acs.jmedchem.7b01927</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01927/suppl_file/jm7b01927_si_001.csv">CSV</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR spectra of compounds <b>1</b>â<b>27</b> and <b>29</b>â<b>37</b> and <sup>13</sup>C NMR spectra of compound <b>21</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01927/suppl_file/jm7b01927_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01927/suppl_file/jm7b01927_si_001.csv">jm7b01927_si_001.csv (6.61 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01927/suppl_file/jm7b01927_si_002.pdf">jm7b01927_si_002.pdf (2.91 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01927&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01927%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01927" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799bec4b9a0234a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
